Study of total synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin and 3-O- Feruloylcassine by  copper-mediated nucleophilic substitution and gold-catalyzed cycloisomerization by Zhang, Yang
  
Study of Total Synthesis of 9α,10β-
Bisangeloyloxy-7-epi-3E-agerafastin and 3-O-
Feruloylcassine by Copper-mediated 
Nucleophilic Substitution and Gold-catalyzed 
Cycloisomerization 
 
Dissertation 
For the achievement of the academic degree of the  
Doctors in Natural Sciences 
 (Dr. rer. nat.) 
 
Submitted to 
The Faculty of Chemistry and Chemical Biology 
TU Dortmund University 
 
By 
 
M. Sc. Yang Zhang  
From Hubei, China 
 
Dortmund 2019 
 
 
  
 
 
The work described in this Dissertation was performed from October 2015 to 
March 2019 at the department of Organic Chemistry of the Technical 
University of Dortmund under the guidance of Prof. Dr. Norbert Krause. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Erster Gutachter: Prof. Dr. Norbert Krause 
Zweiter Gutachter: Prof. Dr. Ralf Weberskirch 
Eingereicht am: 
Datum der mündlichen Prüfung:                                                 
 
 
  
 
 
 
 
 
 
 
 
 
 
Although the road is endless and faraway, I still want to find
 and pursue the truth in the world. 
Yuan Qu (339 B.C.~278 B.C.) 
A poet of the State of Chu, China 
 
 
 
 
 
 
 
 
 
 
 
                                                       Dedicated to my parents and my wife during my PhD study 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Table of Contents 
Abstract ...................................................................................................................................... I 
Kurzfassung ............................................................................................................................... II 
Chapter 1. Introduction ............................................................................................................. 1 
1.1    Copper-catalyzed nucleophilic substitution for synthesizing functionalized allenes ... 2 
1.2    Gold-catalyzed cycloisomerization of functionalized allenes and their application in 
total synthesis of natural products ......................................................................................... 8 
1.3    Objectives ................................................................................................................... 12 
Chapter 2. The total synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin .................... 15 
2.1    Introduction ................................................................................................................ 16 
2.2    Retrosynthetic analysis I ............................................................................................. 17 
2.3    Synthesis of 2-methylhept-1-en-5-yn-4-ol 2.11 ......................................................... 18 
2.4    Sharpless dihydroxylation of homoallylic alcohol derivatives .................................. 21 
2.5    Copper-mediated SN2'-substitution for synthesis of β-hydroxyallenes ...................... 24 
2.6    Gold-catalyzed cycloisomerization ............................................................................ 29 
2.7    Epoxidation of dihydropyran for synthesis of tetrahydropyran ................................. 29 
2.8    Ring opening of epoxide ............................................................................................ 30 
2.9    Synthesis of the side chain ......................................................................................... 32 
2.10  Synthesis of racemic 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin .......................... 33 
2.11  Retrosynthetic analysis II ........................................................................................... 39 
2.12  Enantioselective synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin ............. 40 
2.13  Summary ..................................................................................................................... 48 
2.14  Experimental Part ....................................................................................................... 49 
Chapter 3. Studies on the total synthesis of (+)-3-O-Feruloylcassine .................................. 137 
3.1    Introduction .............................................................................................................. 138 
3.2    Retrosynthetic Analysis ............................................................................................ 139 
3.3    Synthesis of β-aminoallene....................................................................................... 140 
3.4    Gold catalyzed cycloisomerization of β-aminoallene .............................................. 145 
3.5    Summary and outlook ............................................................................................... 146 
3.6    Experimental Part ..................................................................................................... 147 
Chapter 4. Summary and Perspective ................................................................................... 169 
I. Abbreviations ..................................................................................................................... 177 
  
II. Acknowledgements ........................................................................................................... 181 
III. Curriculum Vitae ............................................................................................................. 183 
IV. Eidesstattliche Versicherung (Affidavit) ......................................................................... 185 
  
  Abstract 
I 
Abstract 
In this dissertation, the main work is the synthesis of 6-membered heterocyclic natural 
products by using the synthetic methods developed in our group, i.e. the copper-mediated 
nucleophilic substitution for synthesizing functionalized allenes, as well as, the gold-
catalyzed cycloisomerization of functionalized allenes for synthesizing heterocycles. 
Chapter 2 demonstrates the journey of the first total synthesis of 9α,10β-Bisangeloyloxy-7-
epi-3E-agerafastin including the racemic synthesis route and enantioselective synthesis route. 
In the racemic synthesis route, starting from the commercially available but-2-yn-1-ol, 
through the key steps of the copper-mediated SN2'-substitution of propargyl acetates and the 
gold-catalyzed cycloisomerization of β-hydroxyallenes, the core ring system of agerafastin 
was obtained. Subsequently, a sequence of epoxidation/esterification/oxidation/olefination 
was performed to afford the final racemic natural product. Based on the racemic synthesis, 
changing the starting material to the allyl alcohol, the three chiral centers of agerafastin were 
obtained by the Sharpless dihydroxylation, asymmetric epoxidation and selective opening of 
epoxide to provide enantiomerically pure core ring system. Finally, the last step of modified 
Julia olefination affords the natural product with high stereoselectivity as well as good E/Z 
ratio. 
Chapter 3 studies the total synthesis of (+)-3-O-Feruloylcassine based on our previous work. 
Starting from the propargyl alcohol, through a sequence of HWE reaction/ 
reduction/Mitsunobu reaction/Sharpless dihydroxylation, the important intermediate 
propargyl dicarbonate was obtained. Then, the NHC-ligand for the key step of CuH-catalyzed 
SN2'-reduction was synthesized. After that, the CuH-catalyzed SN2'-reduction of propargyl 
dicarbonates was optimized to give desired β-aminoallene. The other key step, gold-catalyzed 
cycloisomerization of β-aminoallenes, will be further optimized by using more active gold 
catalysts until the desired core ring system of natural product (+)-3-O-Feruloylcassine is 
formed with good results and the total synthesis will be continued. 
 
 
 
 
 
 
 
 
 
 
 
  Kurzfassung 
II 
 
Kurzfassung 
Diese Dissertation befasst sich mit der Synthese von 6-gliedrigen heterocyclischen 
Naturstoffen unter Verwendung zweier in unserer Gruppe entwickelten Synthesemethoden, 
der Kupfer-vermittelten nucleophilen Substitution zur Synthese funktionalisierter Allene, 
sowie deren Gold-katalysierter Cycloisomerisierung zur Synthese von Heterocyclen. 
Kapitel 2 beschreibt die erste Totalsynthese von racemischem und enantiomerenreinem 
9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin. Bei der Synthese des racemischen Naturstoffs, 
ausgehend vom kommerziell erhältlichen But-2-in-1-ol, wurde durch die Schlüsselschritte, 
der Kupfer-vermittelten SN2'-Substitution von Propargylacetaten und der Gold-katalysierten 
Cycloisomerisierung von β-Hydroxyallenen, das Ringsystem des Agerafastins erhalten. 
Anschließend wurde der Naturstoff durch Epoxidierung, Epoxidöffnung, Veresterung, 
Oxidation und Olefinierung erhalten. Für den enantioselektiven Syntheseweg wurde zunächst 
das Ausgangsmaterial modifiziert, und die drei Chiralitätszentren des Agerafastins konnten 
durch Sharpless-Dihydroxylierung, diastereoselektive Epoxidierung und anschließende regio- 
und stereoselektive Öffnung des Epoxids erhalten werden. Schließlich lieferte der letzte 
Schritt, eine modifizierte Julia-Olefinierung, den Naturstoff mit hoher Stereoselektivität. 
Durch die erste enantioselektive Synthese konnte auch die absolute Konfiguration des 
natürlich vorkommenden 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastins bestimmt werden. 
In Kapitel 3 werden die Schlüsselschritte der Totalsynthese von (+)-3-O-Feruloylcassin auf 
der Grundlage früherer Arbeiten untersucht. Ausgehend von Propargylalkohol konnte durch 
HWE-Reaktion, Reduktion, Mitsunobu-Reaktion und Sharpless-Dihydroxylierung das 
benötigte Propargyldicarbonat erhalten werden. Die Kupferhydrid-katalysierte SN2'-
Reduktion des Propargyldicarbonats zum β-Aminoallen wurde optimiert. Der abschließende 
Syntheseschritt, die Gold-katalysierte Cycloisomerisierung des β-Aminoallens zum 
Ringbaustein des Naturstoffs, bedarf weiterer Verbesserung unter Verwendung von 
hochreaktiven Goldkatalysatoren. 
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1.1  Copper-catalyzed nucleophilic substitution for synthesizing 
functionalized allenes 
The use of organometallic reagents for the synthesis of allenes is highly developed
[1]
 and 
several fundamentally different methods, including substitution reactions,
[2]
 addition 
reactions,
[3]
 elimination reactions
[4]
 and isomerization reactions,
[5]
 are well established. In 
these transformations, organocopper compounds are favored in the metal-mediated synthesis 
of allenes, although other metals such as aluminum, titanium, samarium and indium have also 
shown their good capacities to synthesize allenes. Furthermore, the copper-mediated SN2'-
substitution is one of the most useful methods for synthesizing allenes because this kind of 
reaction with organocopper reagents has broad substrate scope and high isolated yield as well 
as high anti-stereoselectivity. 
[1]
 
The first examples of allene synthesis by means of copper-mediated SN2'-substitution was 
reported by Rona and Crabbé in 1968. The reaction of propargylic acetates 1.1 with lithium 
dialkylcuprates led to the formation of allenes 1.2 with moderate to good yields (Scheme 
1.1).
[6]
 
 
The propargylic acetates are very classic substrates of the copper-mediated SN2'-substitution 
for synthesizing allenes. The reaction of functionalized pyridyl-substituted propargylic 
                                                          
[1] (a) Modern Allene Chemistry, Eds.: N. Krause, A. S. K. Hashmi, Wiley-VCH: Weinheim, 2004; (b) N. Krause, A. 
Hoffmann-Röder, Tetrahedron 2004, 60, 11671-11694. 
[2] (a) The Chemistry of the Allenes, Ed.: S. R. Landor, Academic Press: London, 1982; (b): Allenes in Organic Synthesis, 
Eds.: H. F. Schuster, G. M. Coppola, Wiley: New York, 1984. 
[3] (a) T. Kusumoto, T. Hiyama, Chem. Lett. 1985, 1405-1408; (b) T. Kusumoto, K. Ando, T. Hiyama, Bull. Chem. Soc. Jpn. 
1992, 65, 1280-1290. 
[4] M. Suginome, A. Matsumoto, Y. Ito, J. Org. Chem. 1996, 61, 4884-4885. 
[5] (a) The Chemistry of Ketenes, Allenes and Related Compounds, Part 2, Ed.: S. Patai, Wiley: Chichester, 1980; (b) S. Dai, 
R. S. Pappas, G.-F. Chen, Q.-X. Guo, J. T. Wang, F. Williams, J. Am. Chem. Soc. 1989, 111, 8759-8761. 
[6] (a) P. Rona, P. Crabbé, J. Am. Chem. Soc. 1968, 90, 4733-4734; (b) P. Rona, P. Crabbé, J. Am. Chem. Soc. 1969, 91, 
3289-3292. 
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acetate 1.3 with the magnesium cuprate MeMgCl-CuI-LiBr was performed efficiently to 
afford functionalized pyridylallene 1.4
[7]
 with high yield of 89%. The allene 1.6
[8]
 and allene 
1.8
[9]
 were also efficiently formed by copper-mediated SN2'-substitution of the corresponding 
propargylic acetates 1.5 and 1.7 (Scheme 1.2). 
 
The mechanism of this copper-mediated SN2'-substitution of propargylic electrophiles was 
proposed to involve an interaction of a copper-centered d-orbital with the σ and π* orbitals of 
the substrate 1.9. This leads to the formation of a σ-copper(III) species 1.10, which finally 
undergoes a reductive elimination of an alkylcopper compound to furnish the anti-
substitution product 1.11 (Scheme 1.3).
[1]
 
                                                          
[7] A. Jansen, N. Krause, Synthesis 2002, 14, 1987-1992. 
[8] A. Jansen, N. Krause, Inorg. Chim. Acta 2006, 359, 1761-1766. 
[9] S. W. Djuric, M. Miyano, M. Clare, R. M. Rydzewski, Tetrahedron Lett. 1987, 28, 299-302. 
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Owing to the reliability and excellent center-to-axis chirality transfer of the SN2'-substitution, 
enantiomerically enriched allenes were synthesized. The anti-selective SN2'-substitution of 
the chiral propargylic acetates (R)-(+)-1.12 and (S)-(+)-1.14, achieved through lipase-
catalyzed kinetic resolution (KR), with magnesium cuprates obtained from Grignard reagents, 
copper(I) bromide and lithium bromide gave chiral allenes (+)-1.13 (91% ee) and (-)-1.15 (60% 
ee) with the same enantiomeric excess as substrates, which proved a complete center-to-axis 
chirality transfer in the SN2'-substitution (Scheme 1.4).
[10]
 
 
Propargyl oxiranes are also very interesting substrates for the copper-mediated SN2'-
substitution for synthesizing functionalized allenes. The SN2'-substitution of propargyl 
epoxide of 1.16 with cuprates formed from 2 equivalents of Grignard reagent and 1 
equivalent of CuCN in the presence of 1 equivalent of tri-n-butylphosphine or triethyl 
phosphite, which improve the chemo- and stereoselectivity of the SN2'-substitution of 
propargyl epoxides, consistently afforded the desired functionalized allenes 1.17 with good 
yields and high anti-diastereoselectivity (Scheme 1.4).
 [11]
 
                                                          
[10] C. Zelder, N. Krause, Eur. J. Org. Chem. 2004, 3968-3971. 
[11] (a) N. Krause, A. Hoffmann-Röder, J. Canisius, Synthesis 2002, 1759-1774; (b) A. Hoffmann-Röder, PhD Thesis, TU 
Dortmund, 2003. 
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In addition to propargyl acetates and oxiranes, various propargyl derivatives (benzoates and 
carbonates,
[12-13]
 propargylic sulfonates,
[14]
 ethers and acetals,
[15]
 halides
[16]
 and aziridines
[17]
) 
have been utilized as substrates of copper-mediated SN2'-substitution successfully.  
Interestingly, when the nucleophile is a “hydride” in the reaction, the SN2'-substitution is also 
called SN2'-reduction. The CuH-catalyzed SN2'-reduction for synthesizing allenes was only 
reported by Stryker et al. and by Brummond and Lu, who treated terminal propargyl acetates 
with the hexameric copper hydride complex [(Ph3P)CuH]6 (Stryker’s reagent) (Scheme 
1.6).
[18]
 
                                                          
[12] (a) A. Alexakis, P. Mangeney, A. Ghribi, I. Marek, R. Sedrani, C. Guir, J. F. Normant, Pure Appl. Chem. 1988, 60, 49-
56; (b) A. Alexakis, Pure Appl. Chem. 1992, 64, 387-392; (c) E. Erdik, Tetrahedron Lett. 1992, 48, 9577-9648. 
[13] (a) K.-M. Wu, M. M. Midland, W. H. Okamura, J. Org. Chem. 1990, 55, 4381-4392; (b) S.-K. Kang, S.-G. Kim, D.-G. 
Cho, Tetrahedron: Asymmetry 1992, 3, 1509-1510; (c) C. Spino, C. Thibault, S. Gingras, J. Org. Chem. 1998, 63, 5283-
5287. 
[14] (a) I. Gridnev, G. Kanai, N. Miyaura, A. Suzuki, J. Organomet. Chem. 1994, 481, C4-C7; (b) C. Agami, F. Couty, G. 
Evano, H. Mathieu, Tetrahedron 2000, 56, 367-376; (c) H. Ohno, M. Anzai, A. Toda, S. Ohishi, N. Fujii, T. Tanaka, Y. 
Takemoto, T. Ibuka, J. Org. Chem. 2001, 66, 4904-4914. 
[15] (a) I. Marek, P. Mangeney, A. Alexakis, J. F. Normant, Tetrahedron Lett. 1986, 27, 5499-5502; (b) A. Alexakis, I. 
Marek, P. Mangeney, J. F. Normant, J. Am. Chem. Soc. 1990, 112, 8042-8047; (c) I. Marek, A. Alexakis, P. Mangeney, J. F. 
Normant, Bull. Soc. Chim. Fr. 1992, 129, 171-190. 
[16] (a) D. J. Burton, G. A. Hartgraves, J. Hsu, Tetrahedron Lett. 1990, 31, 3699-3702; (b) M. H. Hung, Tetrahedron Lett. 
1990, 31, 3703-3706; (c) M. Yus, J. Gomis, Eur. J. Org. Chem. 2003, 2043-2048. 
[17] (a) H. Ohno, A. Toda, Y. Miwa, T. Taga, N. Fujii, T. Ibuka, Tetrahedron Lett. 1999, 40, 349-352; (b) H. Ohno, A. Toda, 
N. Fujii, Y. Takemoto, T. Tanaka, T. Ibuka, Tetrahedron 2000, 56, 2811-2820. 
[18] (a) J. F. Daeuble, C. McGettigan, J. M. Stryker, Tetrahedron Lett. 1990, 31, 2397-2400; (b) K. M. Brummond, J. Lu, J. 
Am. Chem. Soc. 1999, 121, 5087-5088. 
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In 2007, the CuH-catalyzed SN2'-reduction of propargyl oxiranes with N-heterocyclic carbene 
(NHC) ligands has been developed by Deutsch and Krause.
[19]
 The SN2'-reduction of 
propargyl oxiranes 1.22 with (NHC)CuH formed from 3 mol% of CuCl, 3 mol% of NHC 
ligand and 0.1 equivalent of sodium tert-butoxide in the presence of 2 equivalents of 
polymethylhydridosiloxane (PMHS) as the stoichiometric hydride source gave α-
hydroxyallene 1.23 with excellent center-to-axis chirality transfer and excellent anti-
stereoselectivity (Scheme 1.7).

 
 
Additionally, a mechanism of the (NHC) CuH-catalyzed SN2'-reduction of propargyl oxiranes 
was also proposed by Deutsch and Krause.
[19]
 The vinylcopper intermediate 1.25 is first 
formed by syn addition of the copper hydride to the triple bond of propargyl oxirane 1.24 and 
the α-alkoxyallene 1.27 is obtained by an anti-selective β-elimination. Then, transmetalation 
of 1.27 with the stoichiometric hydride source PHMS provides the silyl ether 1.29 and 
releases the catalyst LCuH. Fluoride-mediated hydrolytic workup of 1.29 affords the final α-
hydroxyallene. If an alcohol is present in the reaction system, the vinyloxirane 1.26 can be 
isolated by a hydrocupration-protodemetalation. An alternative way is that the α-alkoxyallene 
1.27 can be obtained from the π-complex 1.28 by reductive elimination. The isolation of 1.26 
                                                          
[19] C. Deutsch, B. H. Lipshutz, N. Krause, Angew. Chem. Int. Ed. 2007, 46, 1650 -1653. 
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makes the first path plausible, while the second approach better explains the observed high 
anti-selectivity and cannot be ruled out (Scheme 1.8). 
 
Two years later, the (NHC)CuH-catalyzed SN2'-reduction of propargyl carbonates was also 
reported by Deutsch and Krause,
[20]
 which shows that this method is an efficient route to 
functionalized allenes with high reactivity and stereoselectivity (Scheme 1.9).  
 
The following mechanism was proposed for the (NHC)CuH-catalyzed SN2'-reduction of 
propargyl carbonates.
[20]
 The π-complex 1.33 is first formed from the catalyst LCuH and 
propargyl carbonate 1.32. Then 1.33 is converted into σ-copper(III) species 1.34 which can 
be transformed to the product allene 1.35 and copper salt 1.36 by reductive elimination. 
                                                          
[20] C. Deutsch, B. H. Lipshutz, N. Krause, Org. Lett. 2009, 11, 5010-5012. 
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Transmetalation of 1.36 with PMHS regenerates the catalyst LCuH and the rate of this 
transmetalation step depends on the basicity of the copper salt (Scheme 1.10). 
 
1.2  Gold-catalyzed cycloisomerization of functionalized allenes and their 
application in total synthesis of natural products 
Allenes play a highly important role in synthetic organic chemistry because of their 
characteristics for undergoing various transformations.
[1,21]
 After activation of the cumulated 
double bonds by a Brønsted or Lewis acid, it allows a nucleophilic attack, which provides a 
new C-C or C-heteroatom bond in an inter- or intramolecular reaction. Furthermore, 
functionalized allenes can be utilized for asymmetric synthesis because their axial chirality 
can be transferred to the product.  
Gold catalysis is one of the fast growing sectors of modern chemistry.
[22]
 Homogenous gold 
catalysed transformations are often effective with excellent atom economy, great functional 
                                                          
[21] (a) S. Ma, Chem. Rev. 2005, 105, 2829-2871. (b) Cumulenes and Allenes, Science of Synthesis, Ed.: N. Krause, Thieme: 
Stuttgart, 2007. (c) N. Krause, C. Winter, Chem. Rev. 2011, 111, 1994-2009. 
[22] (a) A. S. K. Hashmi, G. J. Hutchings, Angew. Chem. Int. Ed. 2006, 45, 7896-7936; (b) D. J. Gorin, F. D. Toste, Nature, 
2007, 446, 395-403; (c) A. S. K. Hashmi, Chem. Rev. 2007, 107, 3180-3211; (d) Z. Li, C. Brouwer, C. He, Chem. Rev. 2008, 
108, 3239-3265; (e) A. Corma, A. Leyva-Pérez, M. J. Sabater, Chem. Rev. 2011, 111, 1657-1712; (f) D. Pflästerer, A. S. K. 
Hashmi, Chem. Soc. Rev. 2016, 45, 1331-1367. 
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group tolerance and sometimes tremendously increased molecular complexity.
[23]
 Because of 
the unique ability of gold catalysts to act as soft carbophilic Lewis acids towards C-C double 
and triple bonds, they are quite suitable for the selective activation of functionalized 
allenes.
[21c,24]
 
Recently, the Krause group has developed the gold-catalyzed cycloisomerization of 
functionalized allenes bearing a hydroxy,
[11a,25]
 amino,
[25c,26]
 or thiol group
[27]
 in α-/β-position 
to the corresponding 5- and 6-membered heterocycles with high reactivity and excellent axis-
to-center chirality transfer (Scheme 1.11). 
 
The mechanism of the gold-catalyzed cycloisomerization of functionalized allenes has not yet 
been clearly elucidated. According to Hoffmann-Röder and Krause,
[1a,11b,21c,28]
 the mechanism 
is proposed as follows (Scheme 1.12). The carbophilic gold catalyst is coordinated to the 
distal double bond of the allene 1.37 to form the π-complex 1.39, which undergoes a 
cyclization to afford zwitterionic σ-gold species 1.40. After protodeauration of 1.40, the 
heterocyclic compound 1.38 is formed and the catalyst is regenerated.  
                                                          
[23] (a) A. S. K. Hashmi, Acc. Chem. Res. 2014, 47, 864-876; (b) D.-H. Zhang, X.-Y. Tang, M. Shi, Acc. Chem. Res. 2014, 
47, 913-924; (c) B. Alcaide, P. Almendros, Acc. Chem. Res. 2014, 47, 939-952; (d) L. Fensterbank, M. Malacria, Acc. Chem. 
Res. 2014, 47, 953-965. 
[24] (a) H. C. Shen, Tetrahedron 2008, 64, 3885-3903; (b) P. Belmont, E. Parker, Eur. J. Org. Chem. 2009, 6075-6.89; (c) N. 
Krause, V. Belting, C. Deutsch, J. Erdsack, H.-T. Fan, B. Gockel, A. Hoffmann-Röder, N. Morita, F. Volz, Pure Appl. Chem. 
2008, 80, 1063-1069; (d) N. Krause, Ö. Aksin-Artok, V. Breker, C. Deutsch, B. Gockel, M. Poonoth, Y. Sawama, Y. 
Sawama, T. Sun, C. Winter, Pure Appl. Chem. 2010, 82, 1529-1536. 
[25] (a) A. Hoffmann-Röder, N. Krause, Org. Lett. 2001, 3, 2537-2538; (b) C. Deutsch, B. Gockel, A. Hoffmann-Röder, N. 
Krause, Synlett 2007, 11, 1790-1794; (c) B. Gockel, N. Krause, Org. Lett. 2006, 8, 4485-4488. 
[26] (a) N. Morita, N. Krause, Org. Lett., 2004, 6, 4121-4123; (b) N. Morita, N. Krause, Eur. J. Org. Chem. 2006, 4634-
4641. 
[27] N. Morita, N. Krause, Angew. Chem. Int. Ed. 2006, 45, 1897-1899. 
[28] W. Yang, A. S. K. Hashmi, chem. Soc. Rev. 2014, 43, 2941-2955. 
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Owing to the reliability, the gold-catalyzed cycloisomerization of functionalized allenes is 
successfully applied to the synthesis of natural products, natural product derivatives and 
interesting ring systems. As shown in Figure 1.1, there are nine examples with dihydro- or 
tetrahydrofuran ring 1.41-1.49
[11a,29-35]
 which are synthesized by the gold-catalyzed 
cycloisomerization of α-hydroxyallenes. The first and only application of the gold-catalyzed 
cycloisomerization of β-hydroxyallenes is to afford (R,R,R)-Bejarol 1.50.[36] 
                                                          
[29] J. A. Marshall, K. G. Pinney, J. Org. Chem. 1993, 58, 7180-7184. 
[30] F. Volz, N. Krause, Org. Biomol. Chem. 2007, 5, 1519-1521. 
[31] T. Sun, C. Deutsch, N. Krause, Org. Biomol. Chem. 2012, 10, 5965-5970. 
[32] J. Erdsack, N. Krause, Synthesis 2007, 23, 3741-3750. 
[33] F. Volz, S. H. Wadman, A. Hoffmann-Röder, N. Krause, Tetrahedron 2009, 65, 1902-1910. 
[34] V. M. Schmiedel, S. Stefani, H.-U. Reissig, Beilstein J. Org. Chem. 2013, 9, 2564-2569. 
[35] (a) B. D. Sherry, F. D. Toste, J. Am. Chem. Soc. 2004, 126, 15978-15979; (b) O. F. Jeker, E. M. Carreira, Angew. Chem. 
Int. Ed. 2012, 51, 3474-3477. 
[36] Y. Sawama, Y. Sawama, N. Krause, Org. Biomol. Chem. 2008, 6, 3573-3579. 
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As shown in Figure 1.2, swainsonine 1.51
[37]
 was obtained through a gold-catalyzed 6-exo-
cycloisomerization to provide the piperidine. Azafuranomycin analogues 1.52 and 1.53 were 
synthesized by the means of the gold-catalyzed endo-cycloisomerization of α-
aminoallenes.
[38]
 The first example of the gold-catalyzed endo-cycloisomerization of a β-
aminoallene to prepare a tetrahydropyridine derivative 1.54 was reported by Gockel and 
Krause in 2006
[25c]
 and several further tetrahydropyridine derivatives 1.55 were prepared by 
them later.
[39]
 
                                                          
[37] (a) R. W. Bates, M. R. Dewey, Org. Lett. 2009, 11, 3706-3708; (b) C. W. G. Au, S. G. Pyne, J. Org. Chem. 2006, 71, 
7097-7099.  
[38] J. Erdsack, N. Krause, Beilstein J. Org. Chem. 2013, 9, 1936-1942. 
[39] B. Gockel, PhD Thesis, TU Dortmund, 2009. 
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1.3 Objectives 
Owing to the interesting ability of allenes, which can be obtained successfully by copper-
catalyzed nucleophilic substitution, to undergo gold-catalyzed cycloisomerization, it is 
interesting to obtain different heterocyclic rings and use them for the synthesis of natural 
products, natural product derivatives and interesting ring systems. However, both the O-
heterocyclic 6-membered rings and N-heterocyclic 6-membered rings were rarely synthesized 
by these methods so far, which makes this a very interesting and challenging goal. 
The aim of the first project is the total synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-
agerafastin 1.56 by using the copper-mediated SN2'-substitution and the gold-catalyzed 
cycloisomerization as key steps to build the core ring system (Figure 1.3). 
 
The aim of the second project is the total synthesis of 3-O-Feruloylcassine 1.57 by using the 
CuH-catalyzed SN2'-reduction and the gold-catalyzed cycloisomerization as key steps to build 
the core ring system (Figure 1.4). 
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Not only the total synthesis is not reported so far, but also the absolute configuration of these 
two natural products is unknown. Therefore, the enantioselective synthesis of the target 
molecules is an important objective of this work. 
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2.1 Introduction 
The 9α,10β-Bisangeloyloxy agerafastins (2.1-2.3)[40] were first isolated by Robinson et al. 
from Brickellia vernicosa in 1985 and its structure was deduced from 
1
H NMR spectroscopy, 
IR spectroscopy, UV spectroscopy and mass spectrometry (Figure 2.1). 
 
The core structure of agerafastin is substituted tetrahydropyran which is one of the important 
classes of heterocycles because this special structure is a common element in a variety of 
natural products and pharmaceuticals (Figure 2.2). The (-)-neodysiherbaine A 2.4,
[41]
 a potent 
convulsant and a highly selective agonist for kainate (KA) and α-amino-3-hydroxy-5-methyl-
4-isoxazole propionate (AMPA) glutamate receptors, was isolated from the marine sponge 
Dysidea herbacea by Sakai et al. The caespitol 2.5
[42]
 could be isolated from both Laurencia 
caespitosa and the sea hare Aplysia dactylomela. Biological studies have shown that 2.5 has 
activity in the brine shrimp lethality assay and exhibits nematicidal effects toward 
Caenorrhabditis elegans as well as shows weak cytotoxic activity against HeLa cells 
(cervical cancer). The thailanstatin A 2.6
[43]
 is potent pre-mRNA splicing inhibitor and 
antiproliferative agent from Burkholderia thailandensis MSMB43.  
                                                          
[40] R. N. Baruah, C. Zdero, F. Bohlmann, R. M. King, H. Robinson, Phytochemistry 1985, 24, 2641-2644. 
[41] (a) R. Sakai, T. Koike, M. Sasaki, K. Shimamoto, C. Oiwa, A. Yano, K. Suzuki, K. Tachibana, H. Kamiya, Org. Lett. 
2001, 3, 1479-1482; (b) T. J. Donohoe, P. C. M. Winship, M. R. Tatton, Peter Szeto, Angew. Chem. Int. Ed. 2011, 50, 7604-
7606. 
[42] (a) J. J. Sims, G. H. Y. Lin, R. M. Wing, Tetrahedron Lett. 1974, 39, 3487-3490; (b) M. Wessels, G. M. König, A. D. 
Wright, J. Nat. Prod. 2000, 63, 920-928; (c) I. Brito, T. Dias, A. R. Díaz-Marrero, J. Darias, M. Cueto, Tetrahedron 2006, 
62, 9655-9660. 
[43] (a) X. Liu, S. Biswas, M. G. Berg, C. M. Antapli, F. Xie, Q. Wang, M.-C. Tang, G.-L. Tang, L. Zhang, G. Dreyfuss, Y.-
Q. Cheng, J. Nat. Prod. 2013, 76, 685-693; (b) K. C. Nicolaou, D. Rhoades, S. M. Kumar, J. Am. Chem. Soc. 2018, 140, 
8303-8320. 
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To the best of our knowledge, the total synthesis and absolute configuration of agerafastin 
derivatives 2.1-2.3 have not been reported. Based on our group’s previous works,[39] the gold-
catalyzed cycloisomerization of β-hydroxyallenes obtained by copper-mediated SN2'-
substitution is an effective and efficient method to synthesize dihydropyrans which can be 
easily changed to tetrahydropyrans. This method should be highly suitable for the synthesis 
of one of the displayed agerafastin derivatives 2.1-2.3 and to elucidate the absolute 
configuration during the total synthesis. 
2.2 Retrosynthetic analysis I 
We have chosen 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin 2.2 as the target for our total 
synthesis. According to the retrosynthetic analysis shown in Scheme 2.1, 2.2 could be 
obtained from tetrahydropyran 2.7 through a sequence of opening of epoxide/esterification/ 
oxidation/olefination. The key intermediate dihydropyran 2.8, which could be synthesized 
from 2.9 by gold-catalyzed cycloisomerization, could be transferred to 2.7 by means of 
epoxidation. The copper-mediated SN2'-substitution of 2.10 should provide the β-
hydroxyallene 2.9. 2.10 could be accessible from the propargyl alcohol 2.11 through 
asymmetric dihydroxylation. 
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2.3 Synthesis of 2-methylhept-1-en-5-yn-4-ol 2.11 
According to the retrosynthetic analysis I, we need to obtain rac-2.11 at the beginning. Firstly, 
as shown in Scheme 2.2, the synthesis of 2.15 was achieved from propargyl alcohol 2.12. The 
protected propargyl alcohol 2.13 was reacted with n-butyllithium and methyl iodide to 
provide 2.14 which can be converted into 2.15
[44]
 through deprotection with moderate yield 
of 36%. Taking the time and cost into consideration, we finally decided to buy the but-2-yn-
1-ol 2.15 directly. 
 
Then, the propargyl alcohol rac-2.11 should be accessible by a [2,3]-Wittig rearrangement
[45]
 
of 2.16 which can be obtained from commercially available alcohol 2.15 (Scheme 2.3). After 
deprotonation of the alcohol 2.15 with sodium hydride in a mixed solvent THF/DMF (1:1), 
methallyl chloride was added to provide the desired ether 2.16 with a good yield of 86%. The 
                                                          
[44] J. Rehbein, S. Leick, M. Hiersemann, J. Org. Chem. 2009, 74, 1531-1540. 
[45] (a) T. Nakai, K. Mikami, Chem. Rev. 1986, 86, 885-902; (b) K. Mikami, T. Nakai, Synthesis 1991, 594-604. 
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subsequent [2,3]-Wittig rearrangement of 2.16 by using n-butyllithium as a base was carried 
out at -80 °C to -70 °C for 1.5 h and the homoallylic alcohol rac-2.11 was obtained in 76% 
yield. 
 
With the desired starting materials rac-2.11 in hand, we tried to get the enantiomerically pure 
(R)-2.11 by kinetic resolution (KR)
[36,46]
 catalyzed by Lipase B from Candida antarctica 
(CAL-B) (Scheme 2.4). (R)-2.11 was efficiently obtained with 42% yield and up to 99% ee 
and the acetate (S)-2.17 with high selectivity (45% yield, 90% ee). 
 
Both(R)-2.11 and (S)-2.17 can be used in the following steps as substrates for a Sharpless 
dihydroxylation for obtaining diol intermediates with different selectivity. For obtaining 
enantiomerically pure (S)-2.17, a dynamic kinetic resolution (DKR)
[47]
 of rac-2.11 was 
examined, too. Firstly, the racemization catalyst ruthenium complex 2.20
[48] 
was synthesized 
from 2,3,4,5-tetraphenylcyclopentadienone 2.18 in two steps and the total yield was 21%.  
 
                                                          
[46] (a) V. S. Martin, S. S. Woodard, T. Katsuki, Y. Yamada, M. Ikeda, K. B. Sharpless, J. Am. Chem. Soc. 1981, 103, 6237-
6240; (b) Z.-M. Wang, W.-S. Zhou, Tetrahedron, 1987, 13, 2935-2944. 
[47] (a) O. Pàmies, J.-E. Bäckvall, Chem. Rev. 2003, 103, 3247-3261; (b) O. Verho J.-E. Bäckvall, J. Am. Chem. Soc. 2015, 
137, 3996-4009. 
[48] B. Martín-Matute, M. Edin, K. Bogár,† F. B. Kaynak, J.-E. Bäckvall, J. Am. Chem. Soc. 2005, 127, 8817-8825. 
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Then, the DKR of rac-2.11 was optimized. As shown in Table 1, the best ee of (S)-2.17 was 
94%, however, the yield was only 12% (Table 1, entry 8). When the reaction mixture was 
stirred at room temperature for 45 h without solvent, the highest yield was obtained with 36% 
yield and 92% ee (Table 1, entry 4). Through eight different reaction conditions were tested, 
unfortunately, the results of DKR were not better than KR. The DKR needs to be further 
optimized with different ruthenium catalysts, different acyl donors, different reaction 
temperatures and so on. 
Table 1: The dynamic kinetic resolution (DKR) of rac-2.11. 
 
Entry 2.20/mol% T/°C t/h Toluene/mL 
Acyl donor 
equiv. 
(S)-2.17 (R)-2.11 
Yield%
a
 Ee/%
b
 Yield/%
c
 Ee/%
d
 
1 8 50 68 1 1.5 13 91 87 24 
2 8 RT 68 1 1.5 26 91 74 66 
3 16 50 45 0 36 36 86 64 22 
4 16 RT 45 0 36 36 92 64 14 
5 16 50 45 1 20 17 91 83 18 
6 16 RT 45 1 20 24 93 76 9 
7 16 RT 45 1 1.5 19 92 81 51 
8 16 RT 64 1 1.5 12 94 88 8 
a
 Isolated yield of (S)-2.17. 
b
 Ee of (S)-2.17 was determined by chiral GC. 
c
 Recovered isolated yield of (R)-2.11. 
d
 Ee of (R)-2.11 was determined by chiral GC. 

 
                                                          
[49] (a) T. Y. S. But, P. H. Toy, Chem. Asian J. 2007, 2, 1340-1355; (b) K. C. K. Swamy, N. N. B. Kumar, E. Balaraman, K. 
V. P. P. Kumar, Chem. Rev. 2009, 109, 2551-2651; (c) D. Hirose, T. Taniguchi, H. Ishibashi, Angew. Chem. Int. Ed. 2013, 
52, 4613-4617. 
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At the same time, we also tried the Mitsunobu reaction
[49]
 to obtain (S)-2.17 with higher 
selectivity by using enantiomerically pure (R)-2.11 as a substrate. After optimization, the best 
result was 74% yield with 97 % ee (Scheme 2.6). 
 
2.4  Sharpless dihydroxylation of homoallylic alcohol derivatives 
Based on our group’s previous works,[39] a protective group of alcohol 2.11 was necessary to 
perform the Sharpless dihydroxylation.
[50]
 Otherwise, the yield of the Sharpless 
dihydroxylation was low because of the presence of the free hydroxyl group in β-position. 
First, (S)-2.17 was chosen as substrate for the Sharpless dihydroxylation. The 
dihydroxylation with AD-mix-α, additional ligand (DHQ)2PHAL
[51]
 and additional catalyst 
K2OsO2(OH)4 was disappointing with only 21% of (2S,4S)-2.21 isolated which means this 
substrate is unsuitable (Scheme 2.7).  
 
Then other protecting groups were tried. Firstly, The TBS-protected alcohol rac-2.22 could 
be obtained with a very good yield of 96% from propargyl alcohol rac-2.11. Subsequent 
Sharpless dihydroxylation proceeded with a mixture of AD-mix-α and AD-mix-β (1:1), AD-
mix-α or AD-mix-β easily with excellent yields of 97%, 96% and 99% respectively (Scheme 
2.8). The reason for using the mixture of AD-mix-α and AD-mix-β (1:1) is to obtain the 
racemate which will be utilized to determine the enantiomeric excess (ee) later. Both (S)- and 
                                                                                                                                                                                    
[50] (a) H. C. Kolb, M. S. VanNieuwenhze, K. B. Sharpless, Chem. Rev. 1994, 94, 2483-2547; (b) A. B. Zaitsev, H. 
Adolfsson, Synthesis 2006, 1725-1756; (c) J. K. Cha, N.-S. Kim, Chem. Rev. 1995, 95, 1761-1795; (d) C. Bolm, A. Gerlach, 
Eur. J. Org. Chem. 1998, 21-27. 
[51] D. J. Berrisford, C. Bolm, K. B. Sharpless, Angew. Chem. Int. Ed. 1995, 34, 1059-1070. 
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(R)-configured diol 2.23 are corresponding to the natural products 9α,10β-Bisangeloyloxy-
agerafastin 2.1-2.3 (see Figure 2.1). 
 
Secondly, started from enantiomerically pure propargyl alcohol (R)-2.11, (R)-2.22 was 
obtained with very high yield of 91%. Subsequent dihydroxylation was performed by using 
AD-mix-α or AD-mix-β (Scheme 2.9). Additionally, AD-mix-α and 2 mol% additional 
ligand (DHQ)2PHAL were utilized to optimize the reaction condition for getting higher 
stereoselectivity. However, unfortunately, the yield was lower with the same selectivity.

 
 
Thirdly, tert-butyl(chloro)diphenylsilane (TPSCl)
[52]
 was chosen as the protecting reagent for 
the free hydroxyl group of rac-2.11 because the TPS group is much larger than a TBS group 
which may lead to a higher stereoselectivity of Sharpless dihydroxylation. As shown in 
Scheme 2.10, The TPS-protected alcohol rac-2.24 was obtained with excellent yield (90%) 
                                                          
[52] H. Jullien, D. Brissy, P. Retailleau, A. Marinetti, Eur. J. Inorg. Chem. 2011, 5083-5086. 
 Chapter 2. The total synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin 
23 
 
from rac-2.11. The subsequent dihydroxylation proceeded with a mixture of AD-mix-α and 
AD-mix-β (1:1), AD-mix-α or AD-mix-β easily with excellent yields of 95%, 96% and 99%, 
respectively. 
 
Finally, 4-methoxyphenol
[53]
 was also chosen as protecting reagent because of a large steric 
hindrance and the product rac-2.26 is similar to known substrates of Sharpless 
dihydroxylation which generally give excellent ee. The product rac-2.26 was obtained with 
moderate yield of 58% by means of Mitsunobu reaction (Scheme 2.11). The dihydroxylation 
proceeded at 0 
o
C for 28 h to give a good yield of 76% by using AD-mix-α (Scheme 2.11). 
 
The absolute configuration of the diols can be predicted by means of the mnemonic device. 
Taking the double bond in a plane with the smallest group R
S
 to the left behind and the 
largest group R
L
 to the left front, as shown in Scheme 2.12, the dihydroxylation is performed 
with AD-mix-β preferably from above and with AD-mix-α preferably from underneath. 
                                                          
[53] (a) E. J. Corey, A. Guzman-Perez, M. C. Noe, J. Am. Chem. Soc. 1995, 117, 10805-10816; (b) L. F. Tietze, J. Görlitzer, 
Synthesis, 1998, 873-878. 
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With the racemate in hand, the determination of the ee of diols (2S, 4S)-2.21, (2S, 4R)-2.23, 
(2R, 4R)-2.23, (S)-2.23, (R)-2.23, (S)-2.25, (R)-2.25 and (S)-2.27 was examined. However, it 
is impossible to separate the four diastereomers and enantiomers by Chiral GC and HPLC. 
Therefore, the ee analysis had to be done at a later stage. 
2.5  Copper-mediated SN2'-substitution for synthesis of β-hydroxyallenes 
The intermediate rac-2.23 was selected to examine the following steps. The diol was reacted 
with acetone and p-toluenesulfonic acid hydrate, achieving two steps (protection of the diol 
and deprotection of the TBS ether), and the total yield over two steps was 71%. After 
esterification, the desired propargyl acetate rac-2.30 was obtained with a very good yield. 
This could be used for the copper-mediated SN2'-substitution to afford of β-hydroxyallenes 
(Scheme 2.13). However, neither rac-2.29 nor rac-2.30 could be analyzed by chiral GC and 
HPLC. Therefore, the ee analysis had to be tried at the next step. 
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Furthermore, starting from (S)-2.23, the (S)-2.30a was synthesized efficiently in the same 
route (Scheme 2.14). And the enantiomer (R)-2.30a was also synthesized in this way in the 
total yield of 57%. 
 
As shown in Scheme 2.15, (2S,4R)-2.30a and (2R,4R)-2.30 were provided with total yield of 
76% and 73%, respectively and with the same diastereomeric ratio (dr = 74:26). (2S,4R)-
2.30b was also provided from (2S,4R)-2.23b in this way.  
 
Then, through the sequence of protection/deprotection/protection, (S)-2.30b was obtained 
from (S)-2.25, the diol with bigger protecting group (Scheme 2.16). And the enantiomer (R)-
2.30b was also synthesized in this way. 
 
At the last, as shown in Scheme 2.17, the starting material (2S,4S)-2.21 was reacted with 
acetone to get (2S,4S)-2.30 with a moderate yield of 41%. (S)-2.27 was also reacted with 
acetone to get (S)-2.31 with a yield of 68%. Both of these two products could be used for the 
next step directly.  
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There are two ways to perform the copper-mediated SN2'-substitution (Scheme 2.18). In 
method A,
[36]
 the β-hydroxyallene rac-2.32 was obtained by SN2'-substitution of propargyl 
acetate rac-2.30 with the magnesium cuprate MeMgCl·CuI·LiBr. After being reacted for 24 h 
at room temperature, a very good yield 84% was obtained. In method B,
[30]
 the magnesium 
cuprate was formed from MeMgCl and CuCN in the presence of tri-n-butylphosphine. The 
yield was also 84% in 3 h at -40 °C. Both methods were strongly influenced by the reaction 
conditions, especially the temperature.  
 
Fortunately, the enantiomers of the allene rac-2.32 could be separated by both chiral GC and 
HPLC, which offered the opportunity to analyze the enantiomeric excess at this stage. The 
chirality center of the β-hydroxyallene derivatives was formed in the Sharpless 
dihydroxylation. So, according to the results of chiral GC and HPLC analysis of rac-2.32, we 
can conclude the optimal reaction condition for the asymmetric dihydroxylation. 
Then, the copper-mediated SN2'-substitution of propargyl acetates 2.30 was examined with 
method A or method B. Firstly, for the (S)-configuration, the (S)-2.30a was reacted with 
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method A in 48 h at room temperature to afford the desired allene (S)-2.32 with high yield of 
90% and moderate ee of 54% (Scheme 2.19). For the (R)-configuration, the allene (R)-2.32 
(85%, 63% ee) was synthesized from (R)-2.30a by method A, too. 
 
Secondly, for the (S)-configuration, the method B was optimized by using different ligands 
(Scheme 2.20). Obviously, the tri-n-butylphosphine is much better than triethyl phosphite. 
However, the ee value was not good enough and the Sharpless dihydroxylation step needs to 
be further optimized. For the (R)-configuration, the method A was used to provide (R)-2.32 
with 33% yield and 17% ee which means (2R,4R)-2.30 was not suitable for this copper-
mediated SN2'-substitution. 
 
After that, the SN2'-substitution of the propargyl acetate (S)-2.30b was carried out with 
method A to give (S)-2.32 with 66% yield and with higher ee of 67% (Scheme 2.21). The 
(R)-2.32 was also obtained higher ee of 58%. Therefore, the bigger protecting group for the 
homoallylic alcohol 2.11 is better but not good enough. 
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Finally, the reaction of (2S,4S)-2.30 was performed with method B to give (S)-2.32 with 40% 
yield and 37% ee (Scheme 2.22).  
 
All in all, the stereoselectivity was not improved by using protected propargyl alcohols, and 
the method B for copper-mediated SN2'-substitution is more suitable and reliable. All of these 
ee values were not good enough and the Sharpless dihydroxylation needs to be further 
optimized. 
With allenes rac-2.32 and (S)-2.32 the next step in the total synthesis of agerafastin was 
studied. Deprotection with a mixture of water, THF and acetic acid gave the β,γ-
dihydroxyallene rac-2.33 with a good yield 64% and the β,γ-dihydroxyallene (S)-2.33 with a 
very good yield of 89% (Scheme 2.23). 
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2.6 Gold-catalyzed cycloisomerization 
Based on our group’s previous works,[39] the gold-catalyzed cycloisomerization of 
unprotected β,γ-dihydroxyallenes affords tetrahydrofurans instead of the desired 
dihydropyrans because the γ-hydroxy group attacks the activated allene at the C-4.[54]  
To prevent this undesired reaction, the primary alcohol needed to be protected. The TBS 
group is a very good protecting group for primary alcohols in the presence of a secondary 
alcohol and can easily be removed. Successfully, the β-hydroxyallene rac-2.34 was produced 
with good yield 75% (Scheme 2.24). 
 
Fortunately, the key step, gold-catalyzed cycloisomerization of β-hydroxyallene rac-2.34, 
was performed with 2.5 mol% of Ph3PAuBF4 in toluene after just eight hours with a very 
good yield of 84% to get the desired dihydropyran rac-2.35 in gram scale efficiently (Scheme 
2.24). 
2.7  Epoxidation of dihydropyran for synthesis of tetrahydropyran 
The epoxidation of dihydropyran rac-2.35 was performed with 2 equivalents of mCPBA and 
Na2HPO4 for 41 hours at room temperature to give the product tetrahydropyran rac-2.36 in 
good yield of 82%. However, the diastereomeric ratio (dr) was only 1:1 (analyzed by NMR 
spectroscopy) (Scheme 2.25).  
 
                                                          
[54] (a) Z. Zhang, C. Liu, R. E. Kinder, X. Han, H. Qian, R. A. Widenhoefer, J. Am. Chem. Soc. 2006, 128, 9066-9073; (b) 
Z. Zhang, R. A. Widenhoefer, Angew. Chem. Int. Ed. 2007, 46, 283-285; c) G. L. Hamilton, E. J. Kang, M. Mba, F. D. Toste, 
Science 2007, 317, 496-499. 
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The free hydroxyl group should have a positive effect in the epoxidation selectivity because 
of hydroxyl group directivity.
[55]
 Therefore, the TBS protecting group was removed by using 
tetrabutylammonium fluoride trihydrate to afford rac-2.37 with excellent yield of 92%. By 
epoxidation, the tetrahydropyran rac-2.38 was formed with good yield of 73% and good dr 
(4:1) (Scheme 2.26). The amount of mCPBA and temperature were optimized as well as the 
additive Na2HPO4. In the end, 2 equivalents of mCPBA and Na2HPO4 were the best. The 
epoxidation with VO(acac)2 and TBHP
[56]
 was also tried but was very slow. 
 
2.8 Ring opening of epoxide

 
With the tetrahydropyran rac-2.38 in hand, opening the epoxide ring was studied. At the 
beginning, different acids and bases
[57-61] 
in water were tested to synthesize rac-2.39. 
Unfortunately, all attempts were failed (Scheme 2.27). It is possible that the epoxide bearing 
the free hydroxyl group forms a hydrogen bond which makes the molecule very stable. 
 
                                                          
[55] W. Adam, T. Wirth, Acc. Chem. Res. 1999, 32, 703-710. 
[56] G. Torres, W. Torres, J. A. Prieto, Tetrahedron 2004, 60, 10245-10251. 
[57] G. Mehta, S. Sen, S. S. Ramesh, Eur. J. Org. Chem. 2007, 423-436. 
[58] A. Guaragna, D. D’Alonzo, C. Paolella, C. Napolitano, G. Palumbo, J. Org. Chem. 2010, 75, 3558-3568. 
[59] C. J. Bartlett, D. P. Day, Y. Chan, S. M. Allin, M. J. McKenzie, A. M. Z. Slawin, P. C. B. Page, J. Org. Chem. 2012, 77, 
772-774. 
[60] B. Schmidt, J. Chem. Soc., Perkin Trans. 1999, 1, 2627-2637. 
[61] P. C. B. Page, L. F. Appleby, D. Day, Y. Chan, B. R. Buckley, S. M. Allin, M. J. McKenzie, Org. Lett. 2009, 9, 1991-
1993. 
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Next, epoxide rac-2.36 with a TBS protecting group was treated with different acids and 
bases. The starting material rac-2.36 was decomposed without formation of the desired 
product rac-2.40 (Scheme 2.28). Using acids or bases to open the epoxide ring is impossible 
because the epoxide ring is very stable. Therefore, much harsher reaction conditions were 
tested.  
 
After optimization, a protection of the free hydroxy group of the tetrahydropyran rac-2.38 
was performed with NaH and BnBr in THF/DMF (3:1)
[62-65]
 at room temperature for 4 hours 
to give rac-2.41 in good yield of 82%. Next, a SN2-substitution was carried out with allyl 
alcohol and 5 equivalents of HClO4
[66]
 to give rac-2.42 with good yield of 70% (Scheme 
2.29). Interestingly, the allyl alcohol only reacted with the major diastereomer so that it is 
possible to obtain diastero- and enantiomerically pure tetrahydropyran 2.42 later.

Only one 
regioisomer was obtained, probably by SN2-substitution at the sterically less hinded position 
of epoxide rac-2.41. 
 
With such a positive result in hand, the deprotection of the allyl and benzyl ether could be 
done in a stepwise way. First, the cleavage of the allyl ether with PdCl2 in MeOH/CH2Cl2 
(3:2) was performed at room temperature for 40 minutes without further purification and the 
                                                          
[62] B. M. Trost,.D. B. Horne, M. J. Woltering, Angew. Chem. Int. Ed. 2003, 42, 5987-5990. 
[63] N. Berezina, V. Alphand, R. Furstoss, Tetrahedron: Asymmetry 2002, 13, 1953-1955. 
[64] H. Onoue, T. Baba, K. Konoki, K. Torikai, M. Ebine, T. Oishi, Chem. Lett. 2014, 43, 1904-1906. 
[65] M. Hirama, T. Oishi, H. Uehara, M. Inoue, M. Maruyama, H. Oguri, M. Satake, Science 2001, 294, 1904-1907. 
[66] C. M. Ko1nig, K. Harms, U. Koert, Org. Lett. 2007, 23, 4777-4779. 
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product was used directly in the next step. Second, hydrogenolysis of the benzyl ether gave 
the target molecule rac-2.39 in 58% yield over two steps
[66]
 (Scheme 2.30). 
 
2.9 Synthesis of the side chain 
After opening the epoxide ring successfully, the total synthesis of 9α,10β-Bisangeloyloxy-7-
epi-3E-agerafastin 2.2 was nearly reached the final stage. Next, sulfone (E)-2.46 was 
synthesized to introduce the side chain of the target molecule through modified Julia 
olefination.

 
 
The dienol (E)-2.44 was obtained by partial hydrogenation of the enynol (E)-2.43 with 
molecular hydrogen and Lindlar catalyst (Pd/CaCO3, Pd(OCOCH3)2)
[67]
 with a good yield of 
68%. To prevent over-reduction, the reaction was monitored by gas chromatography. After 
                                                          
[67] K. A. Parker, I. A. Katsoulis, Org. Lett. 2004, 9, 1413-1416. 
 Chapter 2. The total synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin 
33 
 
complete reduction of the triple bond, the reaction was terminated by removing the catalyst 
through filtration. Subsequent Mitsunobu reaction produced (E)-2.45 with excellent yield of 
95% and an E/Z-ratio of 95:5. The desired sulfone (E)-2.45 was oxidized with 
ammoniummolybdate and hydrogen peroxide as co-oxidant to provide (E)-2.46 with a good 
yield of 71% (Scheme 2.31). Interestingly, the product was obtained with E/Z-ratio of 83:17, 
which indicates a partial E/Z-isomerization during the oxidation. 
2.10 Synthesis of racemic 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin 
With the positive results obtained through the journey, there were different ways to reach the 
racemic target molecules. If starting from rac-2.39, there would be two possible routes for the 
synthesis of rac-2.2.  
In route 1, the strategy is first to perform a selective oxidation of primary alcohol to provide 
rac-2.47 with esterification and Julia olefination following to achieve the final molecule rac-
2.2 (Scheme 2.32). However, the first problem is the selective oxidation of the primary 
alcohol to provide rac-2.47, which is not easy to realize because it may be necessary to 
protect the secondary hydroxy groups first. Then, the second problem for this route was the 
esterification. Possibly, the aldehyde group has to be protected to prevent it from interfering 
the esterification. Then, the protecting group needs to be removed later. The route appears to 
be very time-consuming.  
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In route 2, the first step was the same to the route 1, the selective oxidation of the primary 
alcohol to provide rac-2.47. Then the Julia olefination could be performed with (E)-2.46 to 
provide rac-2.49 with esterification following to afford rac-2.2. However, besides the same 
problem like in the route 1 for the oxidation, the another problem could be the final 
esterification because of a strong steric hindrance of the side chain (Scheme 2.33). 
 
Overall, triol rac-2.39 appears to be unsuitable for an efficient synthesis of the natural 
product. 
Consequently, rac-2.42 was chosen as a starting material for the next stage. The allyl group 
of rac-2.42 was removed while keeping the benzyl ether intact. After optimization, the best 
reaction conditions for the cleavage of the allyl ether was using 0.1 equivalents of PdCl2 in 
MeOH/CH2Cl2 (1:1) to give the diol rac-2.50 in a good yield of 71% after two hours at room 
temperature (Scheme 2.34).

 
 
                                                          
[68] (a) K. S. Feldman, M. D. Lawlor, J. Am. Chem. Soc. 2000, 122, 7396-7397; (b) T. Wakabayashi, K. Mori, S. Kobayashi, 
J. Am. Chem. Soc. 2001, 123, 1372-1375. 
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After that, the ester rac-2.51 was formed by Steglich esterification
[68] 
with 4 equivalents of 
angelic acid and DCC as well as 2 equivalents of DMAP at reflux for 48 hours with good 
yield of 72% and good Z/E ratio (4:1). Since the Z-configured angelic acid can isomerize to 
the E-configured tiglic acid easily during the reaction, it is hard to obtain pure Z-configured 
ester rac-2.51. It may be possible to make the reaction time shorter for getting higher Z/E 
ratio (Scheme 2.35).

 
 
Next, the benzyl ether needed to be removed for the final stage of the total synthesis of rac-
2.2. Firstly, the hydrogenolysis of the benzyl ether rac-2.51 was examined with Pd(OH)2 
under hydrogen atmosphere. Instead of the desired product, the over-reduced
[69]
 product rac-
2.52 was obtained with moderate yield of 64% (Scheme 2.36). 
 
Secondly, for the deprotection of the benzyl group, boron trichloride (BCl3)
[70]
 (1 M in 
CH2Cl2) was utilized to provide the desired product rac-2.53 with moderate yield of 63% 
(Scheme 2.37). However, this method was not easy to handle because the BCl3 is very 
moisture sensitive and active so that the reaction can easily fail. At the same time, DDQ
[71]
 
was selected to try this reaction, too. With the optimized reaction condition, DDQ in the 
mixed solvent DCM/H2O (9:1) gave rac-2.53 with a better yield of 80% and a good Z/E ratio 
                                                          
[69] A. Fürstner, F. Jeanjean, P. Razon, Angew. Chem. Int. Ed. 2002, 41, 2097-2101. 
[70] D. L. Sloman, J. W. Bacon, J. A. Porco, J. Am. Chem. Soc. 2011, 133, 9952-9955. 
[71] (a) S. Baek, H. Jo, H. Kim, H. Kim, S. Kim, D. Kim, Org. Lett. 2005, 1, 75-77; (b) D. Crich, O. Vinogradova, J. Org. 
Chem. 2007, 72, 3581-3584. 
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(4:1) (Scheme 2.37). The E/Z-isomers could be separated by column chromatography. 
However, for the racemic synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin, the 
mixture was used for the next step directly. They would be separated for the enantioselective 
synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin later. 
 
After synthesizing rac-2.53 successfully, the oxidation proceeded efficiently by using Dess-
Martin periodinane (DMP)
[72]
 in DCM for one hour at room temperature to give the desired 
aldehyde rac-2.54 with a good yield of 78% (Scheme 2.38). 
 
Finally, the last step of the racemic synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin, 
the Julia olefination, was reached. Although the modified Julia olefination
[73]
 is very 
promising for the implementation of the reaction of conjugated diene (E)-2.46 with the 
natural product precursor rac-2.54, a test reaction was carried out with the sulfone (E)-2.46 
and benzaldehyde 2.55. The procedure was as follows. At first, the sulfone (E)-2.46 and 
benzaldehyde 2.55 were mixed together. Then, sodium bis(trimethylsilyl)amide (NaHMDS) 
was added to deprotonate the sulfone (E)-2.46 at -80 °C (Scheme 2.39). After warming up to 
                                                          
[72] K. C. Nicolaou, C. J. N. Mathison, Angew. Chem. Int. Ed. 2005, 44, 5992-5997. 
[73] (a) A. B. Charette, H. Lebel, J. Am. Chem. Soc. 1996, 118, 10327-10328; (b) S. Das, D. Paul, R. K. Goswami, Org. Lett. 
2016, 18, 1908-1911. 
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-19 °C for 1.5 hours, the desired triene 2.56 was isolated (75%). However, the analysis of 
E/Z-isomer ratio by 
1
H-NMR spectroscopy could not be achieved. 
 
Since the reaction was successful, an analogous reaction with the aldehyde rac-2.54 was 
performed. After using the similar procedure like the test reaction, only 21% of the desired 
product was obtained, so the reaction needs further optimization. A new procedure was that 
the sulfone (E)-2.46 was deprotonated with NaHMDS at -80 °C for 30 minutes before the 
aldehyde rac-2.54 was added (Scheme 2.40). After warming to -20 
o
C for 4 hours, the desired 
product rac-2.2 was obtained with a much higher yield of 53%. However the E/Z-isomer ratio 
could not be determined because the aldehyde rac-2.54 was used as 4:1-mixture of 
diasteroisomers and the sulfone (E)-2.46 as E/Z-mixture (83:17). 
 
With the racemic target rac-2.2 in hand, the synthesis route starting from 2.15 proved to be 
suitable. However, the longest linear route is 19 steps which is very long journey. 
Based on previous works,
[39]
 triene rac-2.57 could be synthesized from the tetrahydropyran 
rac-2.38 through oxidation and Julia olefination. However, it was impossible to open the 
epoxide ring of the triene rac-2.57 by using a variety of acids and bases to produce diol rac-
2.49. Rather, an efficient method for the stereo- and regioselective epoxide opening with allyl 
alcohol was applied to open the epoxide rac-2.41. If this method could be also used for rac-
2.57 to obtain rac-2.58, a shorter synthesis route would be possible. As shown in Scheme 
2.41, after synthesizing rac-2.58, the diol rac-2.49 should be available by removing the allyl 
group. With the esterification following, the final target rac-2.2 could be obtained. And the 
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longest linear route is 17 steps in this synthesis route which is two steps shorter than the 
previous successful synthetic route. 
 
Therefore, this synthesis route was tested. Starting from epoxide rac-2.38, the oxidation 
proceeded with DMP to give aldehyde rac-2.59 (71%). By adding rac-2.59 and (E)-2.46 with 
NaHMDS, the desired product triens rac-2.57 was obtained with moderate yield (36%) 
(Scheme 2.42).  
 
After synthesizing rac-2.57 successfully, the stereo- and regioselective epoxide opening with 
allyl alcohol was tried (Scheme 2.43). The SN2-substitution was carried out with allyl alcohol 
and 2 equivalents of HClO4. Unfortunately, this time a low conversion was observed and the 
starting material was completely decomposed in one day. As a result, this synthesis route was 
not working so that the 19 linear steps synthesis route is the best way to obtain racemic 
9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin. 
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2.11 Retrosynthetic analysis II 
There are three chiral carbon centers in the natural product 9α,10β-Bisangeloyloxy-7-epi-3E-
agerafastin. Chirality centers at C-9 and C-10 were fixed in the diastereoselective epoxidation 
which is controlled by the free side hydroxy group. The third chirality center at C-7 was 
controlled by the Sharpless dihydroxylation.  
If a similar synthetic route to the racemic version were chosen for the enantioselective 
synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin 2.2, the epoxidation would proceed 
with a good yield 73% and good dr (4:1). For the Sharpless dihydroxylation, different 
protecting groups and reaction conditions were optimized. Unfortunately, the best ee value of 
(S)-2.32-5 obtained from the dihydroxylation was only 67% ((S)-configuration). Therefore, a 
new substrate needs to be selected to perform the Sharpless dihydroxylation.  
As shown in scheme 2.44, a new retrosynthesis was designed. Again, 9α,10β-
Bisangeloyloxy-7-epi-3E-agerafastin 2.2 was selected as the target for our total synthesis. 
The key steps were similar to retrosynthesis I, such as opening of epoxide, esterification, 
olefination, gold-catalyzed cycloisomerization and copper-mediated SN2'-substitution. The 
different part is the synthesis of propargyl acetate 2.10 by Sharpless dihydroxylation starting 
from homoallyl alcohol 2.60. 
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2.12 Enantioselective synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-
agerafastin 
Our approach to enantiomerically pure 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin 2.2 
started with the formation of the protected homoallylic alcohol 2.61
[53]
 by Mitsunobu reaction 
of the homoallyl alcohol 2.60 with 4-methoxyphenol, triphenylphosphine and DIAD, which 
afforded 2.61 with excellent yield of 98% in ten-gram scale. Next, the Sharpless 
dihydroxylation was performed with respective addition of reagents from AD-mix-α to 
provide diol (S)-2.62 with excellent yield 95% and 95% ee (rac-2.62: 89%). After a single 
recrystallization, enantiomerically pure diol (S)-2.62 was obtained with high yield (Scheme 
2.45). 
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The enantiomerically pure diol (S)-2.62 was converted into alcohol (S)-2.64 by ketalization 
with cyclohexanone and oxidative cleavage of the protecting group with very high yield of 97% 
in two steps
[36,74]
 (rac-2.64: 79%) (Scheme 2.46). Oxidation of (S)-2.64 with Dess-Martin 
periodinane (DMP) produced the aldehyde (S)-2.65 in high yield of 88% in one hour (rac-
2.65: 73%) (Scheme 2.46). 
 
The significant step for preparing the propargyl alcohol (S)-2.66, an important intermediate 
for this synthesis plan, followed. Propyne (1.0 M in THF ) was deprotonated with n-BuLi at -
80 
o
C under argon for 30 min before the aldehyde (S)-2.65 was added to give the propargyl 
alcohol (S)-2.66 in 82% yield
[75]
 (rac-2.66: 64%) (Scheme 2.47). 
 
The propargyl alcohol (S)-2.66 was converted in excellent yield (96%) into the propargyl 
acetate (S)-2.67 by acetylation with Ac2O (rac-2.67: 82%). Then, the allene (S)-2.68 was 
                                                          
[74] M. Shimizu, M. Kimura, T. Watanabe, Y. Tamaru, Org. Lett. 2005, 4, 637-640. 
[75] D. E. Frantz, R. Fässler, C. S. Tomooka, E. M. Carreira, Acc. Chem. Res. 2000, 33, 373-381. 
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synthesized by means of the copper-mediated SN2'-substitution of propargyl acetate (S)-2.67 
with a magnesium cuprate formed from MeMgCl and CuCN in the presence of tri-n-
butylphosphine to afford a good yield of 81% (rac-2.68: 97%) (Scheme 2.48). The racemic 
allene 2.68 could not be separated by chiral GC or HPLC. 
 
Instead of a mixture of water, THF and acetic acid, p-toluenesulfonic acid hydrate was used 
in methanol for the acetal cleavage to give diol (S)-2.33 with high yield of 90% (rac-2.33: 
76%) (Scheme 2.49). 
 
It was necessary to protect the primary alcohol of (S)-2.33 before synthesizing the desired 
dihydropyran (S)-2.35 because otherwise undesired the tetrahydrofuran would be produced. 
The β-hydroxyallene (S)-2.34 was obtained by using TBS as protecting group with high yield 
of 87%. Subsequent gold-catalyzed cycloisomerization of β-hydroxyallene (S)-2.34 was 
performed with 2.5 mol% Ph3PAuBF4 in toluene to give the desired dihydropyran (S)-2.35 in 
good yield of 84% in grams scale (Scheme 2.50). Fortunately, rac-2.35 could be separated by 
chiral GC so that the ee value of (S)-2.35 was measured. This was over 99% so that there was 
no loss of enantiomeric excess through the steps from (S)-2.62.  
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The TBS protecting group was removed by using tetrabutylammonium fluoride trihydrate so 
that the free hydroxyl group would direct the epoxidation. The following deprotection 
provided enantiomerically pure (S)-2.37 with excellent yield of 95%. With the epoxidation 
the tetrahydropyran (S,S,S)-2.38 was obtained with good yield of 78% and good selectivity 
(dr = 6.3:1.0) (Scheme 2.51). However, the two isomers could not be separated by column 
chromatography, and the relative configuration of the major isomer could not be assigned at 
this stage.  
 
Next, (2S,4S,5S)-2.38 was oxidized with Dess-Martin periodinane to give (2S,4S,5S)-2.59 in 
an isolated yield of 45% and (2S,4R,5R)-2.59 in an isolated yield of 6% (Scheme 2.52).  
 
Since the two diastereoisomers of 2.59 could be separated by column chromatography, the 
relative configuration could be determined by NOESY (Figure 2.3). In the NOESY spectrum 
of the main diastereoisomer (2S,4S,5S)-2.59, the aldehyde proton signal (δ = 9.60) correlated 
with the Me
e
 protons signal (δ = 1.43), and the Mef protons signal (δ = 1.34) correlated with 
the H
a
 signal (δ = 2.99), respectively. This proves that the carbonyl group and the epoxide are 
on the same side of the six-membered ring and also proved that the free hydroxy group of the 
main diastereoisomer of (2S,4S,5S)-2.38 was also on the same side with the epoxide. 
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Combining this information with the configuration predicted by the Sharpless 
dihydroxylation, the absolute configuration of the intermediate 2.38 was determined to be 
(2S,4S,5S). Then, protected tetrahydropyran (2S,4S,5S)-2.41 was synthesized with excellent 
yield of 90% and a good diastereoisomer ratio of 4.5:1.0. Subsequent ring opening of epoxide 
(2S,4S,5S)-2.41 proceeded by using allyl alcohol and 5 equivalents of HClO4 to afford 
enantiomerically and diastereomerically pure tetrahydropyran (2S,4R,5S)-2.42 with good 
yield because the allyl alcohol only reacted with the major isomer of (2S,4S,5S)-2.41 
(Scheme 2.53). 
 
The nucleophile allyl alcohol should preferably attack the less hindered carbon (C-4), so that 
the relative configuration of the tetrahydropyran (2S,4R,5S)-2.42 accorded with the natural 
product 2.2. The 2D NMR spectrum of the enantiomerically pure tetrahydropyran 
(2S,4R,5S)-2.42 was measured. In the HMBC spectrum of (2S,4R,5S)-2.42 (Figure 2.4), both 
protons e signals (δ = 3.92 and δ = 4.10) correlated with the carbon h signal (δ = 75.7), while 
proton h signal (δ = 3.52) correlated with carbon e signal (δ = 69.9). This illustrates that the 
allyl alcohol attacked the C-4 position and the desired (2S,4R,5S)-2.42 was obtained. This 
result suggests that the absolute configuration can be expected to be (2S,4R,5S) as shown in 
Figure 2.4. 
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To confirm the absolute configuration of the tetrahydropyran (2S,4R,5S)-2.42, X-ray analysis 
of the single crystal should be the first choice. Since the (2S,4R,5S)-2.42 was an oil, solid 
derivatives were needed to be prepared by coupling the free hydroxy group of (2S,4R,5S)-
2.42 with various groups, and those derivatives could be used to prepare single crystal as 
follows.  
As shown in Scheme 2.54, rac-2.42 was used as the starting material to prepare the solid 
product at the beginning. At first, 3,5-dinitrobenzoyl chloride 2.69 was selected as the 
coupling reagent. Fortunately, the white solid product rac-2.70 was obtained in high yield of 
90%.  
 
It is better to introduce heavy atoms to the molecule so that the absolute configuration could 
be determined more clearly. Thus, the 4-bromobenzoyl chloride 2.71, 4-iodobenzoyl chloride 
2.73 and ferrocenecarboxylic acid 2.75 were reacted with rac-2.42, but no solid products 
were produced. Finally the enantiomerically pure tetrahydropyran (2S,4R,5S)-2.42 was 
reacted with 3,5-dinitrobenzoyl chloride 2.69 in pyridine to afford the white solid product 
(2S,4R,5S)-2.70 with an excellent yield of 99%. However, this solid product did not afford 
any single crystals. 
Next, the deprotection of the allyl group of (2S,4R,5S)-2.42 was performed with 0.1 
equivalent of PdCl2 in the mixed solvent of MeOH/CH2Cl2 (1:1) to afford the diol 
(2S,4R,5S)-2.50 with good yield of 72% as a singer diastereomer (Scheme 2.55).  
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To couple the free hydroxy groups in (2S,4R,5S)-2.50, 3,5-dinitrobenzoyl chloride 2.69 was 
also used in pyridine to provide product (2S,4R,5S)-2.77 with an excellent yield of 99% 
(Scheme 2.56). Unfortunately, the product (2S,4R,5S)-2.77 was oil, and it was impossible to 
produce single crystals. 
 
After that, the ester (2S,4R,5S)-2.51 was synthesized by the Steglich esterification with 4 
equivalents of angelic acid and DCC as well as 2 equivalents of DMAP under reflux for 48 
hours in good yield of 80% with good Z/E ratio (4.7:1.0) (Scheme 2.57). 
 
Deprotection of benzyl group of (2S,4R,5S)-2.51 with DDQ in the mixed solvent DCM/H2O 
(9:1) was performed at 40 °C at a shorter reaction time 24 hours to obtain a larger amount of 
major Z-isomer (Scheme 2.58). Separated by column chromatography, the pure Z-isomer of 
(2S,4R,5S)-2.53 was achieved in a moderate yield of 50% and a 1:1-mixture of Z-isomer and 
E-isomer of (2S,4R,5S)-2.53 was afforded in 19% yield. 
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The pure Z-isomer of (2S,4R,5S)-2.53 was utilized for the next step. The oxidation was 
performed with DMP to provide the pure Z-isomer of aldehyde (2S,4R,5S)-2.54 in good yield 
of 77% in one hour at room temperature (Scheme 2.59). 
 
With the enantiomerically pure aldehyde (2S,4R,5S)-2.54 in hand, the final step, the modified 
Julia olefination was carried out with the sulfone (E)-2.46 and NaHMDS to give the desired 
product 2.2 in a moderate yield of 55% with a good E/Z ratio of 83:17 (Scheme 2.60). 
Unfortunately, it was impossible to separate these two E/Z isomers. However, the product 
was the mixture of the natural products of 2.2 and 2.3 in a ratio of 83:17.  
 
The specific rotation of the synthesized product is [𝛼]𝐷
20  = -20.1 (c = 0.50, CHCl3). The 
reported  specific rotation for the isolated natural product is [𝛼]𝐷
20 = +103 (c = 0.10, CHCl3). 
This indicates that the absolute configuration of the natural product is (7R,9S,10R). 
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2.13 Summary 
In this chapter, both of racemic and enantiomerically pure synthesis of 9α,10β-
Bisangeloyloxy-7-epi-3E-agerafastins 2.2 were successfully completed.  
In the synthesis route to the racemic product, the longest linear route included 19 steps. The 
first key step was the copper-mediated SN2'-substitution of propargyl acetate rac-2.30 to 
provide the desired β-hydroxyallene rac-2.32. Then, the gold-catalyzed cycloisomerization of 
rac-2.32 followed to afford the dihydropyran rac-2.35 efficiently which provided the 
structural core of the agerafastin. After epoxidation of rac-2.35, the regio- and stereoselective 
opening of the epoxide by allyl alcohol and HClO4 was another key step to give rac-2.42 
with a good yield of 70%. Subsequently, after combining the Steglich esterification and 
selective deprotection of the benzyl group to give alcohol rac-2.53, the final product rac-2.2 
was obtained by oxidation and Julia olefination. 
In the enantioselective synthesis route, Sharpless dihydroxylation of homoallylic alcohol 2.11 
was optimized many times with unsatisfactory results at the beginning. Then, the synthesis 
strategy was changed to use the homoallyl alcohol 2.60 as a starting material. The 
enantiomerically pure diol (S)-2.62 was obtained with high yield by Sharpless 
dihydroxylation. Based on the racemic synthesis, the key steps, the copper-mediated SN2'-
substitution of propargyl acetate (S)-2.67 and the gold-catalyzed cycloisomerization of β-
hydroxyallene (S)-2.34, were performed to afford the desired dihydropyran (S)-2.35 with 
good yield of 84% in gram scale. Then, the following steps were similar to the racemic 
synthesis. After the 19 steps, the natural product of 2.2 was obtained as a mixture with 2.3. 
In conclusion, the first enantioselective total synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-
agerafastin was achieved by using methods developed by our group, i.e. the gold-catalyzed 
cycloisomerization of β-hydroxyallenes, as well as the copper-mediated SN2'-substitution, as 
key steps. 
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2.14 Experimental Part 
2.14.1 General Information 
Solvents and reagents: 
All reactions with air- or moisture-sensitive chemicals were carried out under an inert 
atmosphere of argon. All glassware for reactions were baked under reduced pressure and 
cooled under argon before use carefully. The reagents were added either in an argon 
countercurrent or by injection through a septum. Tetrahydrofuran (THF), dichloromethane 
(DCM), diethyl ether (Et2O), toluene and dimethylformamide (DMF) were dried before use 
with the solvent cleaning system MB-SPS 800 from M. Braun. Acetone was dried with 
magnesium sulfate. Commercial reagents were purchased from ABCR, Acros Organics, 
Sigma Aldrich, Fluorochem, Fisher scientific and TCI and used without purification, unless 
otherwise noted. 
The content determinations of the n-butyllithium and methylmagnesium chloride solution 
used were carried out by titration in each case against salicylaldehyde phenylhydrazone.
[76]
 
Chromatography: 
Flash column chromatography was carried out using silica gel 60 M (0.040-0.063) from 
Macherey-Nagel. Thin layer chromatography (TLC) was performed on TLC plates 
ALUGRAM Xtra SIL G UV254 from Macherey-Nagel.  
Nuclear magnetic resonance (NMR) spectra: 
1
H-NMR and 
13
C-NMR were recorded on a Bruker DRX400 (400 MHz), Bruker DRX500 
(500 MHz), INOVA500 (500 MHz) and Bruker DRX700 using CD2Cl2, CDCl3, benzene-d6 or 
methanol-d4 as solvent. Data are reported in the following order: chemical shift (δ) values are 
reported in ppm with the solvent resonance as internal standard (CD2Cl2: δ = 5.32 for 
1H, δ = 
54.00 for 
13
C; CDCl3: δ = 7.26 for 
1H, δ = 77.16 for 13C; benzene-d6: δ = 7.16 for 
1H, δ = 
128.06 for 
13
C; methanol-d4: δ = 4.87 for 
1H, δ = 49.00 for 13C); coupling constants (J) are 
given in Hertz (Hz). Observed multiplicities are described by the following abbreviations: 
                                                          
[76] B.E. Love, E. G. Jones, J. Org. Chem. 1999, 64, 3755-3756. 
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s (singlet)            d (doublet)             t (triplet) 
q (quartet)           qi (quintet)             sx (sextet) 
m (multiplet)         dd (doublet of doublet)   td (triplet of doublet) 
dt (doublet of triplet)   br (broad)       p (pseudo) 
Mass spectrocopy: 
Mass spectra were recorded using the following spectrometers: 
LC-ESI-LRMS: Thermo TSQ 
HPLC-ESI-HRMS: Thermo LTQ Orbitrap with enclosed Hypersil gold column (50 mm × 1 
mm ID, grain size 1.9 μm) 
Analytical GC and HPLC: 
Gas chromatography (GC) analyses were carried out on a gas chromatograph GC 8000 TOP 
from CE Instruments using helium as carrier gas (80 kPa) and the capillary column CP-SIL-
5CB (30 m, 0.32 mm ID, DF 0.25 μm). Chiral measurements were carried out on a gas 
chromatograph GC 8000 TOP from CE Instruments with hydrogen as the carrier gas (60 kPa) 
and the capillary column hydrodex-beta-3P (25 m, 0.25 mm ID, DF 0.25 μm). 
High performance liquid chromatography (HPLC) analyses were carried out on an HPLC 
system from Agilent Technologies and columns from Chiral Technologies Europe 
(precolumn: Chiralpak® IA 1 cm × 0.4 cm ID, main column: Chiralpak® IA 25 cm × 0.46 
cm ID). 
Infrared Spectroscopy: 
The IR spectroscopy was measured by FT-IR spectrometer TENSOR 27 from Bruker using 
the thin-film technique. The signal intensities have been characterized by the following 
abbreviations: s = strong, m = medium, w = weak, br = broad signal. 
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Polarimeter: 
The rotation of optically active compounds was measured with an automatic Polarimeter 
P8000-T from A. Krüss Optronic and is given as specific rotation [𝛼]𝐷
20. 
2.14.2 General procedures 
AAV 1: General procedure for dynamic kinetic resolution (DKR) of a propargyl 
alcohol
[47]
 
To a 10 mL Schlenk flask, 0.1 eq. of t-BuOK, CAL-B (40 mg/mmol), 0.1 eq. of Na2CO3 and 
8 %mol Ru-catalyst were quickly added. The Schlenk flask was evacuated and filled with 
argon. Dry toluene (2 mL/mmol) was added, and the mixture was stirred for 6 min. Then 1.0 
eq. of the substrate was added. After stirring for 4 min, 1.5 eq. of isopropenyl acetate was 
added. After being stirred for 24 h at room temperature, the reaction mixture was filtered and 
concentrated. The crude product is purified by flash column chromatography on silica gel. 
AAV 2: General procedure for Mitsunobu reaction of an alcohol
[49]
 
To a solution of 1 eq. of alcohol in dry toluene (8 mL/mmol) was added 1.2 eq. of acetic acid, 
1.2 eq. of triphenylphosphine at room temperature. After being stirred for 5 minutes at room 
temperature and then cooled to 0 °C , 1.2 eq. of DEAD or DIAD was added dropwise and the 
solution was stirred for 3 h at room temperature. The reaction mixture was quenched with 
water and extracted three times with DCM. The organic layer was washed with brine, dried 
with MgSO4, and concentrated under vacuum. The crude product is purified by flash column 
chromatography on silica gel. 
AAV3: General procedure for silylation of primary alcohols with tert-butyldimethylsilyl 
chloride (TBSCl) 
To a solution of 1 eq. of the alcohol in dry DCM (1 ml/mmol), 0.1 eq. of N, N-
dimethylaminopyridine (DMAP), 5 eq. of Triethylamine and 1.5 eq. of tert-
butyldimethylsilyl chloride (TBSCl) were added and the solution was stirred overnight at 
room temperature. The reaction mixture was quenched with sat. aq. NaHCO3 and extracted 
three times with DCM. The organic layer was washed with brine, dried with MgSO4, and 
concentrated under vacuum. The crude product is purified by flash column chromatography 
on silica gel. 
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AAV 4: General Procedure for the Sharpless dihydroxylation
[50]
 
Method A: To a suspension of AD-mix-α/β (1.4 g/mmol) in n-butanol/H2O (1 : 1, 10 
mL/mmol), 1 eq. of the substrate was added at 0 °C. After being stirred overnight at 0 °C, 
Na2SO3 sodium sulfite (1.5 g/mmol) was added and stirred for 30 min. The mixture was 
extracted three times with DCM. The organic layer was washed with brine, dried with 
MgSO4, and concentrated under vacuum. The crude product is purified by flash column 
chromatography on silica gel. 
Method B: To a suspension of 1 mol% (DHQ)2PHAL, 3 eq. of K3Fe(CN)6, 3 eq. of K2CO3 
and 0.4 mol% K2OsO2(OH)4 in n-butanol/H2O (1 : 1, 10 mL/mmol) was added 1 eq. of the 
substrate at 0 °C. After being stirred 17 hours at this temperature, Na2SO3 sodium sulfite (1.5 
g/mmol) was added and then warmed to room temperature and stirred for 30 min. The 
mixture was extracted three times with DCM. The organic layer was washed with brine, dried 
with MgSO4, and concentrated under vacuum. The crude product is purified by flash column 
chromatography on silica gel. 
AAV 5: General procedure for the esterification of secondary alcohols with acetic 
anhydride  
To a solution of 1 eq. of the alcohol in DCM (15 mL/mmol) was added 2 eq. of Ac2O, 2 eq. 
of Et3N and 0.2 eq. of DMAP at 0 °C. After being stirred for 30 min at this temperature, the 
reaction mixture was quenched with sat. aq. NH4Cl and extracted with DCM. The organic 
layer was washed with brine, dried with MgSO4, and concentrated under vacuum. The crude 
product is purified by flash column chromatography on silica gel. 
AAV 6: General procedure for the copper-mediated SN2'-substitution of propargyl 
acetates
[30,36]
 
Method A: To a flask 10 eq. of LiBr were added and heated under vacuum at about 300 
o
C 
for 5 minutes and cooled under argon to room temperature. Then, 10 eq. of copper (I) iodide 
and dry THF (20 mL/mmol) was added at room temperature and cooled at ice bath. 10 eq. of 
Methylmagnesium chloride (3 M in THF) was slowly added dropwise at 0 °C. It was stirred 
at this temperature for 30 minutes. To the yellow suspension, a solution of 1 eq. of the 
substrate in dry THF (4 mL/mmol) was added dropwise. After being stirred for 24 h at room 
temperature, saturated aqueous NH4Cl solution was added and the mixture was hydrolyzed 
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and stirred for another 15 minutes. Subsequent filtration through celite, drying with MgSO4, 
and concentrated under vacuum, the crude product is purified by flash column 
chromatography on silica gel. 
Method B: To a suspension of 10 eq. of CuCN in dry THF (20 mL/mmol) was added 
dropwise 10 eq. of n-Bu3P. The mixture was stirred at room temperature until the solution 
was homogeneous and then cooled to -40 
o
C. 10 eq. of MeMgCl (3 M in THF) was added 
dropwise, the mixture was stirred for a further 30 min during -40 
o
C to -30 
o
C. A solution of 1 
eq. of the substrate in dry THF (4 mL/mmol) was added dropwise and the reaction mixture 
was stirred at this temperature for 2.5 h. sat. aq. NH4Cl solution was added and the mixture 
was hydrolyzed and stirred for another 15 minutes while warming to room temperature. 
Subsequent filtration through celite, drying with MgSO4, and concentrated under vacuum, the 
crude product is purified by flash column chromatography on silica gel. 
AAV 7: General procedure for the gold-catalyzed cycloisomerization of β-
hydroxyallenes 
To a solution of 1 eq. of β-hydroxyallenes in dry toluene (16 mL/mmol) was added 2.5 mol% 
Triphenylphosphingold (I) chloride, 2.5 mol% silver tetrafluoroborate at room temperature 
under argon. After being stirred for 6 h, the reaction mixture was filtrated through Celite and 
the filtrate was concentrated under vacuum. The crude product is purified by flash column 
chromatography on silica gel. 
AAV 8: General procedure for the epoxidation of dihydropyrans with mCPBA
 
To a solution of 1 eq. of dihydropyrans in dry DCM (10 ml/mmol) was added 2 eq. of 
disodium hydrogen phosphate (677 mg, 4.77 mmol) and 2 eq. of mCPBA (70%-75% in water) 
at 0 °C. After being stirred for 48 h at room temperature, the reaction mixture was quenched 
with sat. aq. Na2CO3 (10 mL/mmol) and extracted three times with DCM. The organic layer 
was washed with brine, dried with MgSO4, and concentrated under vacuum. The crude 
product is purified by flash column chromatography on silica gel. 
AAV 9: General procedure for the oxidation of primary alcohols
[72]
 
To a solution of 1 eq. of the substrate in DCM (10 ml/mmol) was added 1.2 eq. of Dess-
Martin periodinane at room temperature. After being stirred for 1 h at room temperature, the 
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reaction mixture was quenched with sat. aq. NaHCO3 and extracted three times with DCM. 
The organic layer was washed with brine, dried with MgSO4, and concentrated under vacuum. 
The crude product is purified by flash column chromatography on silica gel. 
AAV 10: General procedure for the benzylation of primary alcohols
[62-65]
 
To a solution of 1 eq. of the substrate in the mixture of THF/DMF (3 : 1, 10 ml/mmol) was 
added 2.2 eq. of NaH was added and stirred for 30 min at 0 
o
C. 2.1 eq. of BnBr was added 
dropwise to the solution. After being stirred for 6 h at room temperature, the reaction mixture 
was quenched with water carefully and the aqueous phase was extracted five times with ethyl 
acetate. The organic layers were dried with MgSO4, the solvent was removed. Toluene (3 x 
20 mL/mmol) was added and removed in vacuum to remove traces of DMF. The crude 
product is purified by flash column chromatography on silica gel. 
2.14.3 The total synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin 
2-(Prop-2-yn-1-yloxy)tetrahydro-2H-pyran (2.13)
[44]
 
V2.1 
(ZY-65) 
To a solution of propargyl alcohol (1.0 g, 17.9 mmol) in 40 mL Et2O 3, 4-dihydro-2H-pyran 
(6.0 g, 71.6 mmol) and p-toluenesulfonic acid hydrate (26.6 mg, 0.14 mmol) were added. 
After being stirred for 5 h, the mixture was hydrolyzed with water and extracted three times 
with diethyl ether. The organic layer was washed with brine, dried with MgSO4, and 
concentrated under vacuum. The residue was purified by column chromatography using 
cyclohexane-ethyl acetate (20 : 1) to give 2.13 (1.2 g, 8.6 mmol, 48%). 
1
H NMR (400 MHz, CDCl3): δ = 4.81 (t, J = 3.3 Hz, 1H), 4.30-4.20 (m, 2H), 3.85-3.80 (m, 
1H), 3.54-3.51 (m, 1H), 2.40 (t, J = 2.4 Hz, 1H), 1.86-1.77 (m, 1H), 1.76-1.69 (m, 1H), 1.65-
1.50 (m, 4H). 
13
C NMR (100 MHz, CDCl3): δ = 96.9, 79.9, 74.1, 62.1, 54.1, 30.3, 25.4, 19.1. 
The NMR data are consistent with the literature data.
[44]
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2-(But-2-yn-1-yloxy)tetrahydro-2H-pyran (2.14)
[44]
 
V2.2 
(ZY-68) 
To a solution of 2.13 (600 mg, 4.28 mmol) in 15 ml dry THF was added n-butyllithium (1.8 
mL, 4.5 mmol, 2.5 M in hexane) was added dropwise at -80 
o
C. After being stirred 30 
minutes at this temperature, methyl iodide (0.53 mL, 8.56 mmol) was added dropwise and the 
reaction was stirred overnight at room temperature. The mixture was hydrolyzed with water 
and extracted three times with diethyl ether. The organic layer was washed with brine, dried 
with MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using cyclohexane-ethyl acetate (20:1) to give 2.14 (461 mg, 2.99 mmol, 
70%) as light yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 4.79 (t, J = 3.3 Hz, 1H), 4.28-4.13 (m, 2H), 3.85-3.80 (m, 
1H), 3.53-3.50 (m, 1H), 1.85-1.80 (m, 4H), 1.75-1.69 (m, 1H), 1.64-1.50 (m, 4H). 
13
C NMR (100 MHz, CDCl3): δ = 96.9, 82.3, 75.1, 62.1, 54.8, 30.4, 25.5, 19.2, 3.8. 
The NMR data are consistent with the literature data.
[44]
 
 
But-2-yn-1-ol (2.15)
[44]
 
V2.3 
(ZY-76) 
To a solution of 2.14 (1.0 g, 6.5 mmol) in 10 mL methanol p-toluenesulfonic acid hydrate 
(124 mg, 0.65 mmol) was added at room temperature. After being stirred overnight, K2CO3 
(90 mg, 0.65 mmol) was added and the reaction solution was filtered through Celite. The 
solvent was concentrated under vacuum and the residue was purified by column 
chromatography using cyclohexane-ethyl acetate (4:1) to give 2.15 (510 mg, 32% in Et2O, 
2.3 mmol, 36%) as light yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 4.23 (q, J = 2.3 Hz, 2H), 1.86 (t, J = 2.4 Hz, 3H), 1.67 (bs, 
1H). 
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13
C NMR (100 MHz, CDCl3): δ = 82.2, 77.6, 51.5, 3.7. 
The NMR data are consistent with the literature data.
[44]
 
 
1-((2-Methylallyl)oxy)but-2-yne (2.16) 
V2.4 
(ZY-528) 
To a suspension of sodium hydride (60% in mineral oil, 1.26 g, 31.4 mmol) in dry DMF (29 
mL) was added 2.15 (2.0 g, 28.6 mmol) in dry THF (29 mL) dropwise at 0 
o
C. After being 
stirred for 1 h at this temperature, methallyl chloride (3.09 mL, 31.4 mmol) was added and 
stirred for an additional four hours at room temperature. Then, the reaction mixture was 
quenched with water and extracted three times with Et2O. The organic layer was washed with 
brine, dried with MgSO4, and concentrated under vacuum. The residue was purified by 
column chromatography using pentane-Et2O (10:1) to give 2.16 (3.58 g, 85% in Et2O, 24.5 
mmol, 86%) as light yellow oil.  
1
H NMR (400 MHz, CDCl3): δ = 4.98 (s, 1H), 4.91 (s, 1H), 4.08-1.07 (m, 2H), 3.94 (s, 2H), 
1.86-1.85 (m, 3H), 1.74 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 141.8, 112.8, 82.4, 75.3, 73.6, 57.7, 19.7, 3.7. 
The NMR data are consistent with the literature data.
[39]
 
 
2-Methylhept-1-en-5-yn-4-ol (rac-2.11) 
V2.5 
(ZY-529) 
To a solution of 2.16 (3.0 g, 24.17 mmol) in dry THF (120 mL) was added n-BuLi (2.5 M in 
hexane, 14.5 mL, 36.26 mmol) was added dropwise at -80 
o
C. After being stirred for 1.5 h 
from -80 
o
C to -70 
o
C, the reaction mixture was quenched with sat. aq. NaCl, warmed up to 
room temperature and the aqueous phase extracted three times with diethyl ether. The organic 
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layer was washed with brine, dried with MgSO4, and concentrated under vacuum. The 
residue was purified by column chromatography using pentane-Et2O (4:1) to give rac-2.11 
(2.85 g, 80% in Et2O, 18.37 mmol, 76%) as light yellow oil.  
1
H NMR (400 MHz, CDCl3): δ = 4.90 (s, 1H), 4.83 (s, 1H), 4.48-4.44 (m, 1H), 2.40 (d, J = 
6.6 Hz, 2H), 1.90 (bs, 1H), 1.84 (d, J = 2.1 Hz, 3H), 1.78 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 141.4, 114.2, 81.2, 80.1, 60.6, 46.6, 22.7, 3.7. 
The NMR data are consistent with the literature data.
[39]
 
 
(R)-2-Methylhept-1-en-5-yn-4-ol ((R)-2.11)
[36,46]
 
V2.6 
(ZY-532) 
To a solution of rac-2.11 (2.0 g, 16.12 mmol) in vinyl acetate (18 mL) was added CAL-B (1.0 
g) at room temperature under air. After being stirred for 65 h, the reaction mixture was 
filtered. The residue was concentrated under vacuum and purified by column chromatography 
using pentane-Et2O (4:1) to give (R)-2.11 (990 mg, 85% in Et2O, 6.78 mmol, 42%) as light 
yellow oil.  
The ee was determined by chiral GC: start temperature, 40 oC; flow rate, 0.5 oC min-1 to 80 
oC; retention time, (R)-6 64.4 min, (S)-6 68.6 min. 
ee = >99%. 
[𝛼]𝐷
20 = -28.8 (c = 1.28, CHCl3). 
Spectroscopic data of the alcohol (R)-2.11: see experiment V 2.5. 
 
(S)-2-Methylhept-1-en-5-yn-4-yl acetate ((S)-2.17) 
V2.7 
(ZY-532) 
Chapter 2. The total synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin 
 
58 
 
To a solution of rac-2.11 (2.0 g, 16.12 mmol) in vinyl acetate (18 mL) was added CAL-B 
(1.0 g) at room temperature under air. After being stirred for 65 h, the reaction mixture was 
filtered. The residue was concentrated under vacuum and purified by column chromatography 
using pentane-Et2O (4:1) to give (S)-2.17 (1.2 g, 7.22 mmol, 45%) as light yellow oil.  
The ee was determined by chiral GC: start temperature, 40 oC; flow rate, 0.5 oC min-1 to 80 
oC; retention time, (S)-2.17 54.3 min, (R)-2.17 55.5 min. 
1
H NMR (400 MHz, CDCl3): δ = 5.51-5.46 (m, 1H), 4.84 (s, 1H), 4.79 (s, 1H), 2.51-2.39 (m, 
2H), 2.06 (s, 3H), 1.84 (d, J = 2.1 Hz, 3H), 1.76 (s, 3H). 
ee = 90%. 
The NMR data are consistent with the literature data.
[39]
 
 
V2.8  
(ZY-697) 
Based on AAV 1, to a 10 mL Schlenk flask, t-BuOK (5.6 mg, 50 umol), CAL-B (20 mg), 
Na2CO3 (53 mg, 0.5 mmol) and Ru-catalyst 2.20 (25 mg, 40 umol) were quickly added. The 
Schlenk flask was evacuated and filled with argon. Toluene (1 mL) was added, and the 
mixture was stirred for 6 min. Then rac-2.11 (62 mg, 0.5 mmol) was added, and after 4 min, 
isopropenyl acetate (83 µL, 0.75 mmol) was added. After being stirred for 68 h at 50 oC, the 
reaction mixture was filtered and concentrated. Purification by column chromatography 
pentane-diethyl ether (4:1) afforded (S)-2.17 (11 mg, 13%, 91% ee) and (R)-2.11 (54 mg, 
87%, 24% ee) as light yellow oil. 
Spectroscopic data of the alcohol (S)-2.17: see experiment V 2.7; Spectroscopic data of the 
alcohol (R)-2.11: see experiment V 2.5. 
 
V2.9  
(ZY-698) 
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Based on AAV 1, to a 10 mL Schlenk flask, t-BuOK (5.6 mg, 50 umol), CAL-B (20 mg), 
Na2CO3 (53 mg, 0.5 mmol) and Ru-catalyst 2.20 (25 mg, 40 umol) were quickly added. The 
Schlenk flask was evacuated and filled with argon. Toluene (1 mL) was added, and the 
mixture was stirred for 6 min. Then rac-2.11 (62 mg, 0.5 mmol) was added, and after 4 min, 
isopropenyl acetate (83 µL, 0.75 mmol) was added. After being stirred for 68 h at room 
temperature, the reaction mixture was filtered and concentrated. Purification by column 
chromatography pentane-diethyl ether (4:1) afforded (S)-2.17 (22 mg, 26%, 91% ee) and (R)-
2.11 (46 mg, 74%, 66% ee) as light yellow oil. 
Spectroscopic data of the alcohol (S)-2.17: see experiment V 2.7; Spectroscopic data of the 
alcohol (R)-2.11: see experiment V 2.5. 
 
V2.10  
(ZY-670) 
Based on AAV 1, to a 10 mL Schlenk flask, t-BuOK (5.6 mg, 50 umol), CAL-B (20 mg), 
Na2CO3 (53 mg, 0.5 mmol) and Ru-catalyst 2.20 (25 mg, 40 umol) were quickly added. The 
Schlenk flask was evacuated and filled with argon. Then rac-2.11 (31 mg, 0.25 mmol) and 
isopropenyl acetate (1 mL, 9.0 mmol) was added. After being stirred for 45 h at 50 oC, the 
reaction mixture was filtered and concentrated. Purification by column chromatography 
pentane-diethyl ether (4:1) afforded (S)-2.17 (15 mg, 36%, 86% ee) and (R)-2.11 (19.8 mg, 
64%, 22% ee) as light yellow oil. 
Spectroscopic data of the alcohol (S)-2.17: see experiment V 2.7; Spectroscopic data of the 
alcohol (R)-2.11: see experiment V 2.5. 
 
V2.11  
(ZY-671) 
Based on AAV 1, to a 10 mL Schlenk flask, 0.1 eq. t-BuOK (5.6 mg, 50 umol), CAL-B (20 
mg), Na2CO3 (53 mg, 0.5 mmol) and Ru-catalyst 2.20 (25 mg, 40 umol) were quickly added. 
The Schlenk flask was evacuated and filled with argon. Then rac-2.11 (31 mg, 0.25 mmol) 
and isopropenyl acetate (1 mL, 9.0 mmol) was added. After being stirred for 45 h at room 
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temperature, the reaction mixture was filtered and concentrated. Purification by column 
chromatography pentane-diethyl ether (4:1) afforded (S)-2.17 (15 mg, 36%, 92% ee) and (R)-
2.11 (19.8 mg, 64%, 14% ee) as light yellow oil. 
Spectroscopic data of the alcohol (S)-2.17: see experiment V 2.7; Spectroscopic data of the 
alcohol (R)-2.11: see experiment V 2.5. 
 
V2.12  
(ZY-674) 
Based on AAV 1, to a 10 mL Schlenk flask, t-BuOK (5.6 mg, 50 umol), CAL-B (20 mg), 
Na2CO3 (53 mg, 0.5 mmol) and Ru-catalyst 2.20 (25 mg, 40 umol) were quickly added. The 
Schlenk flask was evacuated and filled with argon. Toluene (1 mL) was added, and the 
mixture was stirred for 6 min. Then rac-2.11 (31 mg, 0.25 mmol) was added, and after 4 min, 
isopropenyl acetate (553 µL, 5.0 mmol) was added. After being stirred for 45 h at 50 oC, the 
reaction mixture was filtered and concentrated. Purification by column chromatography 
pentane-diethyl ether (4:1) afforded (S)-2.17 (7 mg, 17%, 91% ee) and (R)-2.11 (25.7 mg, 
83%, 18% ee) as light yellow oil. 
Spectroscopic data of the alcohol (S)-2.17: see experiment V 2.7; Spectroscopic data of the 
alcohol (R)-2.11: see experiment V 2.5. 
 
V2.13  
(ZY-675) 
Based on AAV 1, to a 10 mL Schlenk flask, t-BuOK (5.6 mg, 50 umol), CAL-B (20 mg), 
Na2CO3 (53 mg, 0.5 mmol) and Ru-catalyst 2.20 (25 mg, 40 umol) were quickly added. The 
Schlenk flask was evacuated and filled with argon. Toluene (1 mL) was added, and the 
mixture was stirred for 6 min. Then rac-2.11 (31 mg, 0.25 mmol) was added, and after 4 min, 
isopropenyl acetate (553 µL, 5.0 mmol) was added. After being stirred for 45 h at room 
temperature, the reaction mixture was filtered and concentrated. Purification by column 
chromatography pentane-diethyl ether (4:1) afforded (S)-2.17 (10 mg, 24%, 93% ee) and (R)-
2.11 (23.6 mg, 76%, 9% ee) as light yellow oil. 
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Spectroscopic data of the alcohol (S)-2.17: see experiment V 2.7; Spectroscopic data of the 
alcohol (R)-2.11: see experiment V 2.5. 
 
V2.14 
(ZY-676) 
Based on AAV 1, to a 10 mL Schlenk flask, t-BuOK (5.6 mg, 50 umol), CAL-B (20 mg), 
Na2CO3 (53 mg, 0.5 mmol) and Ru-catalyst 2.20 (25 mg, 40 umol) were quickly added. The 
Schlenk flask was evacuated and filled with argon. Toluene (1 mL) was added, and the 
mixture was stirred for 6 min. Then rac-2.11 (31 mg, 0.25 mmol) was added, and after 4 min, 
isopropenyl acetate (42 µL, 0.38 mmol) was added. After being stirred for 45 h at room 
temperature, the reaction mixture was filtered and concentrated. Purification by column 
chromatography pentane-diethyl ether (4:1) afforded (S)-2.17 (8 mg, 19%, 92% ee) and (R)-
2.11 (25.1 mg, 81%, 51% ee) as light yellow oil. 
Spectroscopic data of the alcohol (S)-2.17: see experiment V 2.7; Spectroscopic data of the 
alcohol (R)-2.11: see experiment V 2.5. 
 
V2.15 
(ZY-677) 
Based on AAV 1, to a 10 mL Schlenk flask, t-BuOK (5.6 mg, 50 umol), CAL-B (20 mg), 
Na2CO3 (53 mg, 0.5 mmol) and Ru-catalyst 2.20 (25 mg, 40 umol) were quickly added. The 
Schlenk flask was evacuated and filled with argon. Toluene (1 mL) was added, and the 
mixture was stirred for 6 min. Then rac-2.11 (31 mg, 0.25 mmol) was added, and after 4 min, 
isopropenyl acetate (42 µL, 0.38 mmol) was added. After being stirred for 64 h at room 
temperature, the reaction mixture was filtered and concentrated. Purification by column 
chromatography pentane-diethyl ether (4:1) afforded (S)-2.17 (5 mg, 12%, 94% ee) and (R)-
2.11 (27.3 mg, 88%, 8% ee) as light yellow oil. 
Spectroscopic data of the alcohol (S)-2.17: see experiment V 2.7; Spectroscopic data of the 
alcohol (R)-2.11: see experiment V 2.5. 
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V2.16  
(ZY-699) 
Based on AAV2, to a solution of (R)-2.11 (32 mg, 0.26 mmol) in toluene (2 mL) was added 
acetic acid (18 uL, 0.31 mmol), triphenylphosphine (81 mg, 0.31 mmol) at room temperature. 
After being stirred for 5 minutes at room temperature and then cooled to -20 °C, DEAD (0.14 
mL, 0.31 mmol) was added dropwise and the solution was stirred at this temperature for 1.5 h 
and another 16.5 h at room temperature. The reaction mixture was quenched with water and 
extracted three times with DCM. The organic layer was washed with brine, dried with 
MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (4:1) to give (S)-2.17 (32 mg, 74%, 97% ee) as light 
yellow oil. 
Spectroscopic data of the alcohol (S)-2.17: see experiment V 2.7. 
 
V2.17  
(ZY-673) 
Based on AAV2, to a solution of (R)-2.11 (32 mg, 0.26 mmol) in toluene (2 mL) was added 
acetic acid (18 uL, 0.31 mmol), triphenylphosphine (81 mg, 0.31 mmol) at room temperature. 
After being stirred for 5 minutes at room temperature and then cooled to -20 °C, DEAD (0.14 
mL, 0.31 mmol) was added dropwise and the solution was stirred at this temperature for 6 h 
and another 10 h at room temperature. The reaction mixture was quenched with water and 
extracted three times with DCM. The organic layer was washed with brine, dried with 
MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (4:1) to give (S)-2.17 (27 mg, 63%, 98% ee) as light 
yellow oil. 
Spectroscopic data of the alcohol (S)-2.17: see experiment V 2.7. 
 
V2.18  
(ZY-678) 
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Based on AAV2, to a solution of (R)-2.11 (32 mg, 0.26 mmol) in toluene (2 mL) was added 
acetic acid (18 uL, 0.31 mmol), triphenylphosphine (81 mg, 0.31 mmol) at room temperature. 
After being stirred for 5 minutes at room temperature and then cooled to 0 °C, DIAD (65 uL, 
0.31 mmol) was added dropwise and the solution was stirred at this temperature for 1 h and 
another 23 h at room temperature. The reaction mixture was quenched with water and 
extracted three times with DCM. The organic layer was washed with brine, dried with 
MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (4:1) to give (S)-2.17 (20 mg, 46%, 98% ee) as light 
yellow oil. 
Spectroscopic data of the alcohol (S)-2.17: see experiment V 2.7. 
 
V2.19  
(ZY-679) 
Based on AAV2, to a solution of (R)-2.11 (32 mg, 0.26 mmol) in THF (2 mL) was added 
acetic acid (18 uL, 0.31 mmol), triphenylphosphine (81 mg, 0.31 mmol) at room temperature. 
After being stirred for 5 minutes at room temperature and then cooled to 0 °C, DIAD (65 uL, 
0.31 mmol) was added dropwise and the solution was stirred at this temperature for 1 h and 
another 23 h at room temperature. The reaction mixture was quenched with water and 
extracted three times with DCM. The organic layer was washed with brine, dried with 
MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (4:1) to give (S)-2.17 (19 mg, 44%, 98% ee) as light 
yellow oil. 
Spectroscopic data of the alcohol (S)-2.17: see experiment V 2.7. 
 
Cyclopenta-1, 3-diene-1, 2, 3, 4, 5-pentaylpentabenzene (2.19)
[48]
 
V2.20 
(ZY-241) 
To a suspension of Mg turnings (100 mg, 4 mmol) in THF (1 mL) a solution of PhBr (736 mg, 
4.7 mmol) in dry THF (4 mL) was added dropwise at room temperature. After being stirred 1 
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h, 2, 3, 4, 5-tetraphenylcyclopentadienone (1 g, 2.6 mmol) was added with 4 mL dry THF. 
After being stirred 2 h, LiAlH4 (250 mg, 6.5 mmol) was added in portions. The mixture was 
quenched after 2 h with an aqueous saturated solution of NH4Cl and extracted with hot DCM, 
and dried over MgSO4. After evaporation, the product was obtained as a white solid (515 mg, 
1.15 mmol, 44%). 
1
H NMR (400 MHz, CDCl3): δ = 7.22-6.94 (m, 25H), 5.08 (s, 1H). 
13
C NMR (100 MHz, CDCl3): δ = 146.7, 144.1, 138.2, 136.3, 135.9, 130.2, 129.1, 128.7, 
128.6, 128.0, 127.8, 126.8, 126.7, 126.5, 62.8. 
The NMR data are consistent with the literature data.
[48]
 
 
Ruthenium complexes (η5-Ph5Cp)Ru(CO)2Cl (2.20)
[48]
 
V2.21 
(ZY-254) 
To a suspension of 2.19 (400 mg, 0.88 mmol) and [Ru3(CO)12] (188 mg, 0.29 mmol) in 
decane (4 mL) and toluene (2 mL) was heated at 160 oC in a 20 mL sealed tube for 64 h. 
After cooling the mixture to room temperature, CHCl3 (0.5 mL) was added and the mixture 
was heated at 160 oC for 1 h. After cooling down to room temperature, pentane was added 
and the resulting yellow powder was filtered off. After purification by column 
chromatography pentane-DCM (3:1) to give complex 2.20 (270 mg, 0.42 mmol, 48%) as a 
yellow solid. 
1
H NMR (400 MHz, CDCl3): δ = 7.20 (t, J = 7.3 Hz, 5H), 7.10 (t, J = 7.7 Hz, 10H), 7.04-7.02 
(m, 10H). 
13
C NMR (101 MHz, CDCl3): δ = 197.0, 132.3, 129.7, 128.5, 128.0, 106.6. 
The NMR data are consistent with the literature data.
[48]
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(R)-tert-Butyldimethyl((2-methylhept-1-en-5-yn-4-yl)oxy)silane ((R)-2.22) 
V2.22 
(ZY-550) 
Based on AAV3, to a solution of (R)-2.11 (1.6 g, 12.9 mmol) in dry DCM (13 mL) was 
added N,N-dimethylaminopyridine (DMAP) (156 mg, 1.29 mmol), triethylamine (8.8 mL, 
64.5 mmol) and t-butyldimethylsilyl chloride (TBSCl) (2912 mg, 19.4 mmol) at room 
temperature. After being stirred for 15 h at 40 
o
C, the reaction mixture was quenched with sat. 
aq. NaHCO3 and extracted three times with DCM. The organic layer was washed with brine, 
dried with MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (10:1) to give (R)-2.22 (2.8 g, 11.75 mmol, 91%) as 
light yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 4.82-4.81 (m, 1H), 4.77-4.76 (m, 1H), 4.44-4.41 (m, 1H), 
2.39-2.31 (m, 2H), 1.82 (d, J = 2.1 Hz, 3H), 1.76 (s, 3H), 0.89 (s, 9H), 0.12 (s, 3H), 0.09 (s, 
3H). 
13
C NMR (100 MHz, CDCl3): δ = 141.9, 113.4, 81.0, 80.4, 62.4, 47.4, 26.0, 23.1, 18.4, 3.7, -
4.4, -4.9. 
The NMR data are consistent with the literature data.
[39]
 
 
tert-Butyldimethyl((2-methylhept-1-en-5-yn-4-yl)oxy)silane (rac-2.22)  
V2.23 
(ZY-109) 
Based on AAV3, to a solution of rac-2.11 (800 mg, 6.44 mmol) in dry DCM (6.4 mL) was 
added N,N-dimethylaminopyridine (DMAP) (78 mg, 0.64 mmol), triethylamine (4.4 mL, 
32.2 mmol) and t-butyldimethylsilyl chloride (TBSCl) (1456 mg, 9.66 mmol) at room 
temperature. After being stirred overnight at this temperature, the reaction was heated to 40 
o
C for additional 5 h. After cooled down to room temperature, the mixture was quenched with 
sat. aq. NaHCO3 and extracted three times with DCM. The organic layer was washed with 
brine, dried with MgSO4, and concentrated under vacuum. The residue was purified by 
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column chromatography using cyclohexane-ethyl acetate (10:1) to give rac-2.22 (1470 mg, 
6.17 mmol, 96%) as light yellow oil. 
Spectroscopic data of the alcohol rac-2.22: see experiment V 2.22. 
 
tert-Butyl((2-methylhept-1-en-5-yn-4-yl)oxy)diphenylsilane (rac-2.24) 
V2.24 
(ZY-146) 
Based on AAV3, to a solution of rac-2.11 (800 mg, 6.45 mmol) in dry DCM (10 mL) was 
added N,N-dimethylaminopyridine (DMAP) (82 mg, 0.65 mmol), triethylamine (4.4 mL, 
32.3 mmol) and t-butyldiphenylsilyl chloride (TPSCl) (2.6 mL, 9.68 mmol) at room 
temperature. After being stirred for 22 h at this temperature, the reaction mixture was 
quenched with sat. aq. NaHCO3 and extracted three times with DCM. The organic layer was 
washed with brine, dried with MgSO4, and concentrated under vacuum. The residue was 
purified by column chromatography using cyclohexane-ethyl acetate (10:1) to give rac-2.24 
(2.1 g, 5.8 mmol, 90%) as light yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.77-7.69 (m, 4H), 7.44-7.35 (m, 6H), 4.74 (d, J = 22.6 Hz, 
2H), 4.44-4.39 (m, 1H), 2.36 (dd, J = 6.6, 2.9 Hz, 2H), 1.66 (d, J = 2.1 Hz, 3H), 1.59 (s, 3H), 
1.07 (s, 9H). 
13
C NMR (100 MHz, CDCl3): δ = 141.6, 136.3, 136.1, 134.1, 134.0, 129.8, 129.6, 127.6, 
127.4, 113.6, 81.4, 80.7, 63.2, 47.2, 27.1, 22.8, 19.4, 3.6. 
HRMS: calc’d for [M+H]+: 363.2139, found: 363.2135; calc’d for [M+Na]+: 385.1958, found: 
385.1954. 
 
1-Methoxy-4-((2-methylhept-1-en-5-yn-4-yl)oxy)benzene (rac-2.26) 
 
V2.25 
(ZY-566) 
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Based on AAV3, to a solution of rac-2.11 (380 mg, 3.06 mmol) in DCM (31 mL) was added 
4-methoxyphenol (760 mg, 6.12 mmol), triphenylphosphine (1605 mg, 6.12 mmol) at room 
temperature. After being stirred for 5 minutes at room temperature and then cooled to 0 °C, 
DIAD (1316 mg, 6.12 mmol) was added dropwise and the solution was stirred at room 
temperature for 24 h. The reaction mixture was quenched with water and extracted three 
times with DCM. The organic layer was washed with brine, dried with MgSO4, and 
concentrated under vacuum. The residue was purified by column chromatography using 
pentane-Et2O (20:1) to give rac-2.26 (411 mg, 1.79 mmol, 58%) as light yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 6.98-6.94 (m, 2H), 6.85-6.81 (m, 2H), 4.88-4.85 (m, 2H), 
4.75-4.69 (m, 1H), 3.77 (s, 3H), 2.69-2.52 (m, 2H), 1.82 (d, J = 7.8 Hz, 6H). 
13
C NMR (100 MHz, CDCl3):δ = 154.4, 152.0, 141.3, 117.2, 114.6, 113.5, 82.8, 77.9, 68.3, 
55.8, 44.4, 23.1, 3.8, 1.2. 
HRMS: calc’d for [M+H]+: 231.1380, found: 231.1391; calc’d for [M+Na]+: 253.1199, found: 
253.1212. 
 
(2S,4S)-6, 7-Dihydroxy-6-methylhept-2-yn-4-yl acetate ((2S,4S)-2.21) 
V2.26 
(ZY-563) 
Based on AAV4, to a suspension of AD-mix-α (4.2 g) in n-butanol/H2O (1:1, 30 mL) (S)-
2.17 (500 mg, 3.0 mmol, 90% ee) was added at 0 °C. After being stirred overnight at 0 °C, 
(DHQ)2PHAL (23.4 mg, 30 umol) was added and stirred for another 10 h. Then, 
Methanesulfonamide (571 mg, 6.0 mmol), (DHQ)2PHAL (46.8 mg, 60 umol), and 
K2OsO2(OH)4 (11 mg, 30 umol) were added and continued to stir 23 h at 0 °C. Na2SO3 
sodium sulfite (4.5 g) was added and stirred for 50 min. The mixture was extracted three 
times with DCM. The organic layer was washed with brine, dried with MgSO4, and 
concentrated under vacuum. The residue was purified by column chromatography using 
cyclohexane-ethyl acetate (1:1) to give (2S,4S)-2.21 (124 mg, 0.62 mmol, 21%, dr = 61:39) 
as light yellow oil. And (S)-2.17 (110 mg, 22%) recovered as light yellow oil. 
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1
H NMR (400 MHz, CDCl3): δ = 4.76-4.72 (m, 0.39H), 4.69-4.65 (m, 0.61H), 4.08-3.99 (m, 
2H), 2.93 (d, J = 13.5 Hz, 2H), 2.10 (d, J = 4.7 Hz, 3H), 2.07-1.93 (m, 2H), 1.83 (d, J = 2.1 
Hz, 3H), 1.28 (d, J = 9.5 Hz, 3H). 
13
C NMR (101 MHz, CDCl3): δ = 171.3/171.1, 81.8/81.6, 80.1/80.0, 72.1/71.6, 70.0, 
60.1/59.9, 45.2/44.6, 26.1/23.7, 21.0/21.0, 3.7. 
The NMR data are consistent with the literature data.
[39]
 
 
(2S,4R)-4-((tert-Butyldimethylsilyl)oxy)-2-methylhept-5-yne-1,2-diol((2S,4R)-2.23a) 
V2.27 
(ZY-551) 
Based on AAV4, to a suspension of AD-mix-α (15.26 g) in n-butanol/H2O (1:1, 109 mL) (R)-
2.22 (2.6 g, 10.9 mmol) was added at 0 °C. After being stirred overnight at 0 °C, Na2SO3 
sodium sulfite (16.35 g) was added and stirred for 30 min. The mixture was extracted three 
times with DCM. The organic layer was washed with brine, dried with MgSO4, and 
concentrated under vacuum. The residue was purified by column chromatography using 
pentane-Et2O (1:1) to give (2S,4R)-2.23a (2.53 g, 9.29 mmol, 85%, dr = 77:23) as light 
yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 4.75 (d, J = 9.6 Hz, 0.77H), 4.70 (s, 0.23H), 3.52-3.38 (m, 
2H), 3.05 (bs, 2H), 2.14 (dd, J = 14.7, 9.8 Hz, 1H), 1.83-1.71 (m, 3H), 1.70 (dd, J = 14.8, 3.3 
Hz, 1H), 1.20 (s, 3H), 0.91 (s, 9H), 0.20-0.15 (m, 6H). 
13
C NMR (100 MHz, CDCl3): δ = 82.5/82.1, 80.3/80.3, 72.6/72.6, 70.2/69.6, 61.4/61.3, 
45.9/45.0, 25.9/25.9, 25.5/23.7, 18.1/18.1, 3.6/3.6, -3.9/-4.1, -4.9/-5.0. 
The NMR data are consistent with the literature data.
[39]
 
 
(2S,4R)-4-((tert-Butyldimethylsilyl)oxy)-2-methylhept-5-yne-1,2-diol((2S,4R)-2.23b) 
V2.28 
(ZY-533) 
 Chapter 2. The total synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin 
69 
 
Based on AAV4, to a suspension of AD-mix-α (350 mg) and (DHQ)2PHAL (3.9 mg, 5 umol) 
in n-butanol/H2O (1:1, 3 mL) (R)-2.22 (60 mg, 0.25 mmol) was added at 0 °C. After being 
stirred overnight at 0 °C, Na2SO3 sodium sulfite (375 mg) was added and stirred for 30 min. 
The mixture was extracted three times with DCM. The organic layer was washed with brine, 
dried with MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (1:1) to give (2S,4R)-2.23b (52 mg, 191 umol, 76%, dr 
= 77:23) as light yellow oil. 
Spectroscopic data of (2S,4R)-2.23: see experiment V 2.27. 
 
(2R,4R)-4-((tert-Butyldimethylsilyl)oxy)-2-methylhept-5-yne-1,2-diol((2R,4R)-2.23) 
V2.29 
(ZY-213) 
Based on AAV4, to a suspension of AD-mix-β (1.46 g) in n-butanol/H2O (1:1, 10 mL) (R)-
2.22 (249 mg, 1.05 mmol) was added at 0 °C. After being stirred overnight at 0 °C, Na2SO3 
sodium sulfite (1.5 g) was added and stirred for 30 min. The mixture was extracted three 
times with DCM. The organic layer was washed with brine, dried with MgSO4, and 
concentrated under vacuum. The residue was purified by column chromatography using 
cyclohexane-ethyl acetate (1:1) to give (2R,4R)-2.23 (266 mg, 0.98 mmol, 93%, dr = 76:24) 
as light yellow oil. 
Spectroscopic data of (2S, 4R)-2.23: see experiment V 2.27. 
 
(2S)-4-((tert-Butyldimethylsilyl)oxy)-2-methylhept-5-yne-1,2-diol ((S)-2.23) 
V2.30 
(ZY-119) 
Based on AAV4, to a suspension of AD-mix-α (1.97 g) in n-butanol/H2O (1:1, 14 mL) rac-
2.22 (335 mg, 1.41 mmol) was added at 0 °C. After being stirred 18 h at 0 °C, Na2SO3 
sodium sulfite (5.22 g) was added and stirred for 30 min. The mixture was extracted three 
times with DCM. The organic layer was washed with brine, dried with MgSO4, and 
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concentrated under vacuum. The residue was purified by column chromatography using 
cyclohexane-ethyl acetate (1:1) to give (S)-2.23 (370 mg, 1.35 mmol, 96%, dr = 50:50) as 
light yellow oil. 
Spectroscopic data of (S)-2.23: see experiment V 2.27. 
 
(2R)-4-((tert-Butyldimethylsilyl)oxy)-2-methylhept-5-yne-1,2-diol ((R)-2.23) 
V2.31 
(ZY-115) 
Based on AAV4, to a suspension of AD-mix-β (1.97 g) in n-butanol/H2O (1:1, 14 mL) rac-
2.22 (335 mg, 1.41 mmol) was added at 0 °C. After being stirred 20 h at 0 °C, Na2SO3 
sodium sulfite (2.1 g) was added and stirred for 30 min. The mixture was extracted three 
times with DCM. The organic layer was washed with brine, dried with MgSO4, and 
concentrated under vacuum. The residue was purified by column chromatography using 
cyclohexane-ethyl acetate (1:1) to give (R)-2.23 (380 mg, 1.4 mmol, 99%, dr = 50:50) as 
light yellow oil. 
Spectroscopic data of (R)-2.23: see experiment V 2.27. 
 
4-((tert-Butyldimethylsilyl)oxy)-2-methylhept-5-yne-1,2-diol (rac-2.23) 
V2.32 
(ZY-232) 
Based on AAV4, to a suspension of AD-mix-α (9.1 g) and AD-mix-β (9.1 g) in n-
butanol/H2O (1:1, 130 mL) rac-2.22 (3.1 g, 13.01 mmol) was added at 0 °C. After being 
stirred 24 h at room temperature, Na2SO3 sodium sulfite (19.5 g) was added and stirred for 30 
min. The mixture was extracted three times with DCM. The organic layer was washed with 
brine, dried with MgSO4, and concentrated under vacuum. The residue was purified by 
column chromatography using cyclohexane-ethyl acetate (1:1) to give rac-2.23 (3.31 g, 12.16 
mmol, 93%, dr = 63:37) as light yellow oil. 
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Spectroscopic data of rac-2.23: see experiment V 2.27. 
 
(2S)-4-((tert-Butyldiphenylsilyl)oxy)-2-methylhept-5-yne-1,2-diol ((S)-2.25) 
V2.33 
(ZY-150) 
Based on AAV4, to a suspension of AD-mix-α (2.3 g) in n-butanol/H2O (1:1, 17 mL) rac-
2.24 (600 mg, 1.66 mmol) was added at 0 °C. After being stirred 30 h at 0 °C, Na2SO3 
sodium sulfite (2.49 g) was added and stirred for 30 min. The mixture was extracted three 
times with DCM. The organic layer was washed with brine, dried with MgSO4, and 
concentrated under vacuum. The residue was purified by column chromatography using 
cyclohexane-ethyl acetate (1:1) to give (S)-2.25 (630 mg, 1.59 mmol, 96%, dr = 50:50) as 
light yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.76-7.70 (m, 4H), 7.45-7.37 (m, 6H), 4.68-4.62 (m, 1H), 
3.51-3.43 (m, 2H), 2.16 (dd, J = 14.7, 8.2 Hz, 0.5H), 1.99 (dd, J = 14.7, 5.4 Hz, 0.5H), 1.88 
(dd, J = 14.7, 6.5 Hz, 0.5H), 1.77 (dd, J = 14.7, 4.5 Hz, 0.5H), 1.47 (dd, J = 59.5, 2.1 Hz, 3H), 
1.18 (d, J = 9.4 Hz, 3H), 1.07 (d, J = 2.7 Hz, 9H). 
13
C NMR (100 MHz, CDCl3): δ = 136.1, 135.9/135.9, 133.5/133.2, 132.8/132.8, 130.1/130.1, 
129.8/129.7, 127.9/127.8, 127.4, 127.3, 84.2/83.9, 80.1, 72.7/72.6, 70.5/70.0, 62.4/62.0, 
45.6/45.1, 27.0, 25.2/23.9, 19.2, 3.4/3.3. 
HRMS: calc’d for [M+H]+: 397.2194, found: 397.2216; calc’d for [M+Na]+: 419.2013, found: 
419.2038. 
 
(2R)-4-((tert-Butyldiphenylsilyl)oxy)-2-methylhept-5-yne-1,2-diol ((R)-2.25) 
V2.34 
(ZY-151) 
Based on AAV4, to a suspension of AD-mix-β (2.3 g) in n-butanol/H2O (1:1, 17 mL) rac-
2.24 (600 mg, 1.66 mmol) was added at 0 °C. After being stirred 30 h at 0 °C, Na2SO3 
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sodium sulfite (2.49 g) was added and stirred for 30 min. The mixture was extracted three 
times with DCM. The organic layer was washed with brine, dried with MgSO4, and 
concentrated under vacuum. The residue was purified by column chromatography using 
cyclohexane-ethyl acetate (1:1) to give (R)-2.25 (650 mg, 1.64 mmol, 99%, dr = 50:50) as 
light yellow oil. 
Spectroscopic data of (R)-2.25: see experiment V 2.33. 
 
4-((tert-Butyldiphenylsilyl)oxy)-2-methylhept-5-yne-1,2-diol (rac-2.25) 
V2.35 
(ZY-152) 
Based on AAV4, to a suspension of AD-mix-α (1.74 g) and AD-mix-β (1.74 g) in n-
butanol/H2O (1:1, 25 mL) rac-2.24 (900 mg, 2.48 mmol) was added at 0 °C. After being 
stirred 28 h at room temperature, Na2SO3 sodium sulfite (3.72 g) was added and stirred for 30 
min. The mixture was extracted three times with DCM. The organic layer was washed with 
brine, dried with MgSO4, and concentrated under vacuum. The residue was purified by 
column chromatography using cyclohexane-ethyl acetate (1:1) to give rac-2.25 (930 mg, 2.35 
mmol, 95%, dr = 50:50) as light yellow oil. 
Spectroscopic data of rac-2.25: see experiment V 2.33. 
 
(2S)-4-(4-methoxyphenoxy)-2-methylhept-5-yne-1,2-diol ((S)-2.27) 
 
V2.36 
(ZY-567) 
Based on AAV4, to a suspension of AD-mix-α (2.31 g) in n-butanol/H2O (1:1, 17 mL) rac-
2.26 (380 mg, 1.65 mmol) was added at 0 °C. After being stirred 28 h at 0 °C, Na2SO3 
sodium sulfite (2.5 g) was added and stirred for 30 min. The mixture was extracted three 
times with DCM. The organic layer was washed with brine, dried with MgSO4, and 
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concentrated under vacuum. The residue was purified by column chromatography using 
cyclohexane-ethyl acetate (1:1) to give (S)-2.27 (333 mg, 1.26 mmol, 76%, dr = 50:50) as 
light yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 6.93-6.88 (m, 2H), 6.79-6.77 (m, 2H), 4.90-4.83 (m, 1H), 
3.71 (d, J = 2.1 Hz, 3H), 3.43-3.39 (m, 2H), 2.38 (bs, 2H), 2.33-1.90 (m, 2H), 1.75 (dd, J = 
5.0, 2.0 Hz, 3H), 1.19 (d, J = 11.1 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 154.9/154.8, 151.0/150.8, 117.5/117.2, 114.7, 83.7/83.6, 
77.8/77.6, 72.3, 70.3/70.0, 66.8/66.7, 66.0, 55.8, 44.7/44.4, 24.7/24.5, 15.4/14.3, 3.8/3.8. 
HRMS: calc’d for [M+Na]+: 287.1254, found: 287.1251. 
 
(R)-1-((S)-2,2,4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-ol ((2S,4R)-2.29a) 
V2.37 
(ZY-552) 
To a solution of (2S,4R)-2.23a (2.4 g, 8.82 mmol) in dry acetone (22 mL) was added p-
toluenesulfonic acid hydrate (336 mg, 1.76 mmol). After being stirred 16.5 h at room 
temperature, the reaction mixture was quenched with sat. aq. NaHCO3 and extracted three 
times with ethyl acetate. The organic layer was washed with brine, dried with MgSO4, and 
concentrated under vacuum. The residue was purified by column chromatography using 
pentane-Et2O (4:1) to give (2S,4R)-2.29a (1.47 g, 7.42 mmol, 84%, dr = 74:26) as colorless 
oil. 
1
H NMR (400 MHz, CDCl3): δ = 4.76-4.69 (m, 0.74H), 4.58-4.55 (m, 0.26H), 3.89 (dd, J = 
18.1, 8.6 Hz, 1H), 3.77 (dd, J = 18.6, 8.6 Hz, 1H), 3.24 (bs, 1H), 2.10-1.85 (m, 2H), 1.83-1.82 
(m, 3H), 1.42 (d, J = 3.5 Hz, 3H), 1.39 (s, 3H), 1.36 (d, J = 4.7 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 110.2/109.4, 81.1/81.0, 80.9/80.7, 80.3/80.0, 75.3/74.2, 
60.0/59.8, 46.8/46.6, 27.5/27.0/26.9/26.9, 26.1/24.4, 3.7/3.7. 
The NMR data are consistent with the literature data.
[39]
 
 
Chapter 2. The total synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin 
 
74 
 
(R)-1-((S)-2, 2, 4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-ol ((2S,4R)-2.29b) 
V2.38 
(ZY-540) 
To a solution of (2S,4R)-2.23b (52 mg, 191 umol) in dry acetone (0.5 mL) was added p-
toluenesulfonic acid hydrate (8.0 mg, 38.2 umol). After being stirred 16.5 h at room 
temperature, the reaction mixture was quenched with sat. aq. NaHCO3 and extracted three 
times with ethyl acetate. The organic layer was washed with brine, dried with MgSO4, and 
concentrated under vacuum. The residue was purified by column chromatography using 
pentane-Et2O (4:1) to give (2S,4R)-2.29b (19 mg, 95.9 umol, 50%, dr = 74:26) as colorless 
oil. 
Spectroscopic data of (2S,4R)-2.29b: see experiment V 2.37. 
 
(R)-1-((R)-2,2,4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-ol ((2R,4R)-2.29) 
V2.39 
(ZY-217) 
To a solution of (2R,4R)-2.23 (255 mg, 0.94 mmol) in dry acetone (2.4 mL) was added p-
toluenesulfonic acid hydrate (0.19 mmol, 36 mg). After being stirred 22.5 h at room 
temperature, the reaction mixture was quenched with sat. aq. NaHCO3 and extracted three 
times with ethyl acetate. The organic layer was washed with brine, dried with MgSO4, and 
concentrated under vacuum. The residue was purified by column chromatography using 
cyclohexane-ethyl acetate (4:1) to give (2R,4R)-2.29 (146 mg, 0.74 mmol, 78%, dr = 74:26) 
as colorless oil. 
Spectroscopic data of (2R,4R)-2.29: see experiment V 2.37. 
 
1-((S)-2,2,4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-ol ((S)-2.29a) 
V2.40 
(ZY-116) 
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To a solution of (S)-2.23 (335 mg, 0.97 mmol) in dry acetone (3.0 mL) was added p-
toluenesulfonic acid hydrate (47.5 mg, 0.25 mmol). After being stirred 18 h at room 
temperature, the reaction mixture was quenched with sat. aq. NaHCO3 and extracted three 
times with ethyl acetate. The organic layer was washed with brine, dried with MgSO4, and 
concentrated under vacuum. The residue was purified by column chromatography using 
cyclohexane-ethyl acetate (4:1) to give (S)-2.29a (236 mg, 1.19 mmol, 97%, dr = 50:50) as 
colorless oil. 
Spectroscopic data of (S)-2.29a: see experiment V 2.37. 
 
1-((R)-2,2,4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-ol ((R)-2.29a) 
V2.41 
(ZY-118) 
To a solution of (R)-2.23 (360 mg, 1.32 mmol) in dry acetone (3.2 mL) was added p-
toluenesulfonic acid hydrate (50.3 mg, 0.26 mmol). After being stirred 17.5 h at room 
temperature, the reaction mixture was quenched with sat. aq. NaHCO3 and extracted three 
times with ethyl acetate. The organic layer was washed with brine, dried with MgSO4, and 
concentrated under vacuum. The residue was purified by column chromatography using 
cyclohexane-ethyl acetate (4:1) to give (R)-2.29a (172 mg, 0.87 mmol, 66%, dr = 50:50) as 
colorless oil. 
Spectroscopic data of (R)-2.29a: see experiment V 2.37. 
 
1-(2,2,4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-ol (rac-2.29a) 
V2.42 
(ZY-231) 
To a solution of rac-2.23 (3.05 g, 11.2 mmol) in dry acetone (28 mL) was added p-
toluenesulfonic acid hydrate (469 mg, 2.47 mmol). After being stirred 14.5 h at room 
temperature, another p-toluenesulfonic acid hydrate (469 mg, 2.47 mmol) was added again. 
After being stirred another 24 h at room temperature, the reaction mixture was quenched with 
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sat. aq. NaHCO3 and extracted three times with ethyl acetate. The organic layer was washed 
with brine, dried with MgSO4, and concentrated under vacuum. The residue was purified by 
column chromatography using cyclohexane-ethyl acetate (4:1) to give rac-2.29a (1.58 g, 8.0 
mmol, 71%, dr = 63:37) as colorless oil. 
Spectroscopic data of rac-2.29a: see experiment V 2.37. 
 
1-((S)-2,2,4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-ol ((S)-2.29b) 
V2.43 
(ZY-154) 
To a solution of (S)-2.25 (290 mg, 0.73 mmol) in dry acetone (2 mL) was added p-
toluenesulfonic acid hydrate (55.5 mg, 0.29 mmol). After being stirred 15 h at room 
temperature, another p-toluenesulfonic acid hydrate (55.5 mg, 0.29 mmol) was added and 
continued to stir 72.5 h. The reaction mixture was quenched with sat. aq. NaHCO3 and 
extracted three times with ethyl acetate. The organic layer was washed with brine, dried with 
MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using cyclohexane-ethyl acetate (4:1) to give (S)-2.29b (75 mg, 0.38 mmol, 
52%, dr = 50:50) as colorless oil. 
Spectroscopic data of (S)-2.29b: see experiment V 2.37. 
 
1-((R)-2,2,4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-ol ((R)-2.29b) 
V2.44 
(ZY-155) 
To a solution of (R)-2.25 (290 mg, 0.73 mmol) in dry acetone (2 mL) was added p-
toluenesulfonic acid hydrate (55.5 mg, 0.29 mmol). After being stirred 15 h at room 
temperature, another p-toluenesulfonic acid hydrate (55.5 mg, 0.29 mmol) was added and 
continued to stir 72.5 h. The reaction mixture was quenched with sat. aq. NaHCO3 and 
extracted three times with ethyl acetate. The organic layer was washed with brine, dried with 
MgSO4, and concentrated under vacuum. The residue was purified by column 
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chromatography using cyclohexane-ethyl acetate (4:1) to give (R)-2.29b (80 mg, 0.40 mmol, 
55%, dr = 50:50) as colorless oil. 
Spectroscopic data of (R)-2.29b: see experiment V 2.37. 
 
1-(2,2,4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-ol (rac-2.29b) 
V2.45 
(ZY-156) 
To a solution of rac-2.25 (290 mg, 0.73 mmol) in dry acetone (2 mL) was added p-
toluenesulfonic acid hydrate (61.1 mg, 0.32 mmol). After being stirred 15.5 h at room 
temperature, another p-toluenesulfonic acid hydrate (61.1 mg, 0.32 mmol) was added and 
continued to stir 72.5 h. The reaction mixture was quenched with sat. aq. NaHCO3 and 
extracted three times with ethyl acetate. The organic layer was washed with brine, dried with 
MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using cyclohexane-ethyl acetate (4:1) to give rac-2.29b (78 mg, 0.39 mmol, 
53%, dr = 50:50) as colorless oil. 
Spectroscopic data of rac -2.29b: see experiment V 2.37. 
 
(4S)-4-(2-(4-Methoxyphenoxy)pent-3-yn-1-yl)-2,2,4-trimethyl-1,3-dioxolane ((S)-2.31) 
 
V2.46 
(ZY-570) 
To a solution of (S)-2.27 (150 mg, 0.57 mmol) in dry acetone (1.3 mL) was added p-
toluenesulfonic acid hydrate (22 mg, 114 umol). After being stirred 24 h at room temperature, 
the reaction mixture was quenched with sat. aq. NaHCO3 and extracted three times with ethyl 
acetate. The organic layer was washed with brine, dried with MgSO4, and concentrated under 
vacuum. The residue was purified by column chromatography using cyclohexane-ethyl 
acetate (4:1) to give (S)-2.31 (118 mg, 0.39 mmol, 68%, dr = 50:50) as colorless oil. 
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1
H NMR (400 MHz, CDCl3): δ = 6.95-6.93 (m, 2H), 6.84-6.82 (m, 2H), 4.82-4.74 (m, 1H), 
4.05 (dd, J = 25.8, 8.6 Hz, 1H), 3.77 (d, J = 1.4 Hz, 3H), 3.76-3.72 (m, 1H), 2.32-2.27 (m, 
1H), 2.19-2.15 (m, 1H), 1.81-1.81 (m, 3H), 1.40-1.38 (m, 6H), 1.30 (d, J = 5.7 Hz, 3H). 
13
C NMR (151 MHz, CDCl3): δ = 154.4/154.3, 151.6/151.5, 117.0/116.7, 114.7/114.7/114.6, 
83.1/82.7, 80.1/79.8, 78.3/78.1, 75.1, 73.7/72.3, 65.9/65.8, 55.8/55.8, 46.5/45.7, 31.1, 
27.4/27.4, 27.2/27.0, 26.2, 24.5/24.5, 3.8. 
HRMS: calc’d for [M+Na]+: 327.1567, found: 327.1570; calc’d for [M+K]+: 343.1306, found: 
343.1304. 
 
(R)-1-((S)-2,2,4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-yl acetate ((2S,4R)-2.30a) 
V2.47 
(ZY-553) 
Based on AVV 5, to a solution of (2S,4R)-2.29a (1.4 g, 7.07 mmol) in DCM (110 mL) was 
added Ac2O (1.33 mL, 14.14 mmol), Et3N (2.0 mL, 14.14 mmol) and DMAP (172 mg, 1.41 
mmol) at 0 
o
C. After being stirred for 22 h at room temperature, the reaction mixture was 
quenched with sat. aq. NH4Cl and extracted with DCM. The organic layer was washed with 
brine, dried with MgSO4, and concentrated under vacuum. The residue was purified by 
column chromatography using pentane-Et2O (10:1) to give (2S,4R)-2.30a (1.52 g, 6.33 mmol, 
90%, dr = 74:26) as light yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 5.49-5.46 (m, 0.74H), 5.43-5.40 (m, 0.26H), 3.98-3.96 (m, 
0.76H), 3.92-3.90 (m, 0.24H), 3.72-3.66 (m, 1H), 2.16-1.98 (m, 5H), 1.85-1.82 (m, 3H), 
1.37-1.24 (m, 9H). 
13
C NMR (100 MHz, CDCl3): δ = 170.0/169.9, 109.3/109.2, 82.3/81.9, 79.6/79.4, 77.3/77.2, 
74.5/74.0, 61.6/61.5, 45.1/44.8, 27.3/27.0, 27.1/27.0, 25.4/24.8, 21.3/21.3, 3.8/1.2. 
The NMR data are consistent with the literature data.
[39]
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(R)-1-((S)-2,2,4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-yl acetate ((2S,4R)-2.30b) 
V2.48 
(ZY-544) 
Based on AVV 5, to a solution of (2S,4R)-2.29b (19 mg, 95.9 umol) in DCM (1.5 mL) was 
added Ac2O (18 uL, 191.8 umol), Et3N (26.5 uL, 191.8 umol) and DMAP (2.3 mg, 19.18 
umol) at 0 
o
C. After being stirred for 22 h at room temperature, the reaction mixture was 
quenched with sat. aq. NH4Cl and extracted with DCM. The organic layer was washed with 
brine, dried with MgSO4, and concentrated under vacuum. The residue was purified by 
column chromatography using pentane-Et2O (10:1) to give (2S,4R)-2.30b (10 mg, 41.6 umol, 
43%, dr = 74:26) as light yellow oil. 
Spectroscopic data of (2S,4R)-2.30b: see experiment V 2.47. 
 
(R)-1-((R)-2,2,4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-yl acetate ((2R,4R)-2.30) 
V2.49 
(ZY-221) 
Based on AVV 5, to a solution of (2R,4R)-2.29 (140 mg, 0.7 mmol) in DCM (11 mL) was 
added Ac2O (131 uL, 1.4 mmol), Et3N (193 uL, 1.4 mmol) and DMAP (17 mg, 0.14 mmol) 
at 0 
o
C. After being stirred for 22 h at room temperature, the reaction mixture was quenched 
with sat. aq. NH4Cl and extracted with DCM. The organic layer was washed with brine, dried 
with MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using cyclohexane-ethyl acetate (10:1) to give (2R,4R)-2.30 (156 mg, 0.65 
mmol, 93%, dr = 74:26) as light yellow oil. 
Spectroscopic data of (2R,4R)-2.30: see experiment V 2.47. 
 
1-((S)-2,2,4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-yl acetate ((S)-2.30a) 
V2.50 
(ZY-123) 
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Based on AVV 5, to a solution of (S)-2.29a (236 mg, 1.19 mmol) in DCM (20 mL) was 
added Ac2O (223 uL, 2.38 mmol), Et3N (330 uL, 2.38 mmol) and DMAP (29.3 mg, 0.24 
mmol) at 0 
o
C. After being stirred for 17 h at room temperature, the reaction mixture was 
quenched with sat. aq. NH4Cl and extracted with DCM. The organic layer was washed with 
brine, dried with MgSO4, and concentrated under vacuum. The residue was purified by 
column chromatography using cyclohexane-ethyl acetate (10:1) to give (S)-2.30a (247 mg, 
1.03 mmol, 86%, dr = 50:50) as light yellow oil. 
Spectroscopic data of (S)-2.30a: see experiment V 2.47. 
 
1-((R)-2,2,4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-yl acetate ((R)-2.30a) 
V2.51 
(ZY-122) 
Based on AVV 5, to a solution of (R)-2.29a (172 mg, 0.87 mmol) in DCM (20 mL) was 
added Ac2O (163 uL, 1.74 mmol), Et3N (240 uL, 1.74 mmol) and DMAP (21.3 mg, 0.17 
mmol) at 0 
o
C. After being stirred for 17 h at room temperature, the reaction mixture was 
quenched with sat. aq. NH4Cl and extracted with DCM. The organic layer was washed with 
brine, dried with MgSO4, and concentrated under vacuum. The residue was purified by 
column chromatography using cyclohexane-ethyl acetate (10:1) to give (R)-2.30a (182 mg, 
0.76 mmol, 87%, dr = 50:50) as light yellow oil. 
Spectroscopic data of (R)-2.30a: see experiment V 2.47. 
 
1-(2,2,4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-yl acetate (rac-2.30a) 
V2.52 
(ZY-233) 
Based on AVV 5, to a solution of rac-2.29a (1.58 g, 8 mmol) in DCM (150 mL) was added 
Ac2O (1.9 mL, 20 mmol), Et3N (3.0 mL, 20 mmol) and DMAP (243 mg, 2 mmol) at 0 
o
C. 
After being stirred for 24 h at room temperature, the reaction mixture was quenched with sat. 
aq. NH4Cl and extracted with DCM. The organic layer was washed with brine, dried with 
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MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using cyclohexane-ethyl acetate (10:1) to give rac-2.30a (1.68 g, 7 mmol, 
87%, dr = 63:37) as light yellow oil. 
Spectroscopic data of rac-2.30a: see experiment V 2.47. 
 
1-((S)-2,2,4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-yl acetate ((S)-2.30b) 
V2.53 
(ZY-160) 
Based on AVV 5, to a solution of (S)-2.29b (75 mg, 0.38 mmol) in DCM (10 mL) was added 
Ac2O (75 uL, 0.76 mmol), Et3N (110 uL, 0.76 mmol) and DMAP (10 mg, 0.08 mmol) at 0 
o
C. 
After being stirred for 20 h at room temperature, the reaction mixture was quenched with sat. 
aq. NH4Cl and extracted with DCM. The organic layer was washed with brine, dried with 
MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using cyclohexane-ethyl acetate (10:1) to give (S)-2.30b (71 mg, 0.3 mmol, 
78%, dr = 50:50) as light yellow oil. 
Spectroscopic data of (S)-2.30b: see experiment V 2.47. 
 
1-((R)-2,2,4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-yl acetate ((R)-2.30b) 
V2.54 
(ZY-161) 
Based on AVV 5, to a solution of (R)-2.29b (80 mg, 0.4 mmol) in DCM (10 mL) was added 
Ac2O (75 uL, 0.8 mmol), Et3N (110 uL, 0.8 mmol) and DMAP (10 mg, 0.08 mmol) at 0 
o
C. 
After being stirred for 20 h at room temperature, the reaction mixture was quenched with sat. 
aq. NH4Cl and extracted with DCM. The organic layer was washed with brine, dried with 
MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using cyclohexane-ethyl acetate (10:1) to give (R)-2.30b (70 mg, 0.29 mmol, 
73%, dr = 50:50) as light yellow oil. 
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Spectroscopic data of (R)-2.30b: see experiment V 2.47. 
 
1-(2,2,4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-yl acetate (rac-2.30b) 
V2.55 
(ZY-162) 
Based on AVV 5, to a solution of rac-2.29b (78 mg, 0.39 mmol) in DCM (10 mL) was added 
Ac2O (95 uL, 1.0 mmol), Et3N (140 uL, 1.0 mmol) and DMAP (12 mg, 0.1 mmol) at 0 
o
C. 
After being stirred for 20 h at room temperature, the reaction mixture was quenched with sat. 
aq. NH4Cl and extracted with DCM. The organic layer was washed with brine, dried with 
MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using cyclohexane-ethyl acetate (10:1) to give rac-2.30b (86 mg, 0.36 mmol, 
92%, dr = 50:50) as light yellow oil. 
Spectroscopic data of rac-2.30b: see experiment V 2.47. 
 
(S)-1-((S)-2, 2,4-Trimethyl-1,3-dioxolan-4-yl)pent-3-yn-2-yl acetate ((2S,4S)-2.30) 
V2.56 
(ZY-564) 
Based on AVV 5, to a solution of (2S,4S)-2.21 (108 mg, 0.54 mmol) in dry acetone (1.2 mL) 
was added p-toluenesulfonic acid hydrate (20.5 mg, 108 umol). After being stirred 23 h at 
room temperature, the reaction mixture was quenched with sat. aq. NaHCO3 and extracted 
three times with ethyl acetate. The organic layer was washed with brine, dried with MgSO4, 
and concentrated under vacuum. The residue was purified by column chromatography using 
cyclohexane-ethyl acetate (4:1) to give (2S,4S)-2.30 (54 mg, 0.22 mmol, 41%, dr = 61:39) as 
light yellow oil. 
Spectroscopic data of (2S,4S)-2.30: see experiment V 2.47. 
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(S)-2,2,4-Trimethyl-4-(4-methylpenta-2,3-dien-1-yl)-1,3-dioxolane ((S)-2.32) 
V2.57 
(ZY-579) 
Based on AVV 6, to a suspension of CuCN (4.78 g, 52.9 mmol) in dry THF (130 mL) was 
added dropwise n-Bu3P (13.2 mL, 52.9 mmol). The mixture was stirred at room temperature 
until the solution was homogeneous and then cooled to -40 
o
C. MeMgCl (17.8 mL, 52.9 
mmol, 3 M in THF) was added dropwise, the mixture was stirred for a further 30 min during -
40 
o
C to -30 
o
C. A solution of (2S,4R)-2.30a (1.27 g, 5.29 mmol) in 20 mL dry THF was 
added dropwise and the reaction mixture was stirred at this temperature for 2.5 h. Saturated 
aqueous NH4Cl solution was added and the mixture was hydrolyzed and stirred for another 
15 minutes while warming to room temperature. Subsequent filtration through celite, drying 
with MgSO4, and concentrated under vacuum, The residue was purified by column 
chromatography using pentane-Et2O (20:1) to give (S)-2.32 (830 mg, 4.23 mmol, 80%) as 
light yellow oil. 
The ee was determined by chiral GC: start temperature, 40 oC; flow rate, 0.5 oC min-1 to 80 
oC; retention time, (R)-6 70.5 min, (S)-6 72.6 min. 
1
H NMR (400 MHz, CDCl3): δ = 4.94-4.90 (m, 1H), 3.87 (d, J = 8.3 Hz, 1H), 3.69 (d, J = 8.3 
Hz, 1H), 2.21 (d, J = 7.6 Hz, 2H), 1.67 (d, J = 2.9 Hz, 6H), 1.42 (s, 3H), 1.40 (s, 3H), 1.30 (s, 
3H). 
13
C NMR (100 MHz, CDCl3): δ = 203.8, 109.3, 94.6, 84.3, 81.3, 73.4, 40.4, 27.3, 27.1, 24.8, 
20.7, 20.6. 
ee = 55%. 
The NMR data are consistent with the literature data.
[39]
 
 
V2.58 
(ZY-556) 
Based on AVV 6, to a suspension of CuCN (188 mg, 2.1 mmol) in dry THF (6 mL) was 
added dropwise (EtO)3P (370 uL, 2.1 mmol). The mixture was stirred at room temperature 
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until the solution was homogeneous and then cooled to -40 
o
C. MeMgCl (0.7 mL, 2.1 mmol, 
3 M in THF) was added dropwise, the mixture was stirred for a further 30 min during -40 
o
C 
to -30 
o
C. A solution of (2S,4R)-2.30a (50 mg, 0.21 mmol) in 2 mL dry THF was added 
dropwise and the reaction mixture was stirred at this temperature for 2.5 h. Saturated aqueous 
NH4Cl solution was added and the mixture was hydrolyzed and stirred for another 15 minutes 
while warming to room temperature. Subsequent filtration through celite, drying with MgSO4, 
and concentrated under vacuum, The residue was purified by column chromatography using 
pentane-Et2O (20:1) to give (S)-2.32 (10 mg, 51 umol, 24%, 42% ee) as light yellow oil. 
The ee was determined by chiral GC: see experiment V 2.57. 
ee = 42%. 
Spectroscopic data of (S)-2.32: see experiment V 2.57. 
 
V2.59 
(ZY-580) 
Based on AVV 6, to a suspension of CuCN (37.6 mg, 416 umol) in dry THF (3 mL) was 
added dropwise n-Bu3P (104 uL, 416 umol). The mixture was stirred at room temperature 
until the solution was homogeneous and then cooled to -40 
o
C. MeMgCl (140 uL, 416 umol, 
3 M in THF) was added dropwise, the mixture was stirred for a further 30 min during -40 
o
C 
to -30 
o
C. A solution of (2S,4R)-2.30b (10 mg, 41.6 umol) in 20 mL dry THF was added 
dropwise and the reaction mixture was stirred at this temperature for 2.5 h. Saturated aqueous 
NH4Cl solution was added and the mixture was hydrolyzed and stirred for another 15 minutes 
while warming to room temperature. Subsequent filtration through celite, drying with MgSO4, 
and concentrated under vacuum, The residue was purified by column chromatography using 
pentane-Et2O (20:1) to give (S)-2.32 (3 mg, 15.3 umol, 37%) as light yellow oil. 
The ee was determined by chiral GC: see experiment V 2.57. 
ee = 52%. 
Spectroscopic data of (S)-2.32: see experiment V 2.57. 
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V2.60 
(ZY-134) 
Based on AVV 6, to a flask LiBr (285 mg, 3.3 mmol) were added and heated under vacuum 
at about 300 
o
C for 5 minutes and cooled under argon to room temperature. Then, copper (I) 
iodide (623 mg, 3.3 mmol) and dry THF (10 mL) was added at room temperature and cooled 
at ice bath. Methyl magnesium chloride (1.1 mL, 3.3 mmol, 3 M in THF) was slowly added 
dropwise at 0 °C. It was stirred at this temperature for 30 minutes. To the yellow solution (S)-
2.30a (80 mg, 0.33 mmol) in 3 mL dry THF was added dropwise. After being stirred for 48 h 
at room temperature, saturated aqueous NH4Cl solution was added and the mixture was 
hydrolyzed and stirred for another 15 minutes. Subsequent filtration through celite, drying 
with MgSO4, and concentrated under vacuum, The residue was purified by column 
chromatography using pentane-Et2O (20:1) to give (S)-2.32 (58 mg, 0.3 mmol, 90%) as light 
yellow oil. 
The ee was determined by chiral GC: see experiment V 2.57. 
ee = 54%. 
Spectroscopic data of (S)-2.32: see experiment V 2.57. 
 
V2.61 
(ZY-215) 
Based on AVV 6, to a flask LiBr (145 mg, 1.7 mmol) were added and heated under vacuum 
at about 300 
o
C for 5 minutes and cooled under argon to room temperature. Then, copper (I) 
iodide (323 mg, 1.7 mmol) and dry THF (6 mL) was added at room temperature and cooled 
at ice bath. Methyl magnesium chloride (0.85 mL, 1.7 mmol, 2 M in THF) was slowly added 
dropwise at 0 °C. It was stirred at this temperature for 30 minutes. To the yellow solution (S)-
2.30b (40 mg, 0.17 mmol) in 2 mL dry THF was added dropwise. After being stirred for 48 h 
at room temperature, saturated aqueous NH4Cl solution was added and the mixture was 
hydrolyzed and stirred for another 15 minutes. Subsequent filtration through celite, drying 
with MgSO4, and concentrated under vacuum, The residue was purified by column 
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chromatography using pentane-Et2O (20:1) to give (S)-2.32 (22 mg, 0.11 mmol, 66%) as 
light yellow oil. 
The ee was determined by HPLC: see experiment V 2.60. 
ee = 67%. 
Spectroscopic data of (S)-2.32: see experiment V 2.57. 
 
V2.62 
(ZY-578) 
Based on AVV 6, to a suspension of CuCN (94 mg, 1.0 mmol) in dry THF (6 mL) was added 
dropwise n-Bu3P (260 uL, 1.0 mmol). The mixture was stirred at room temperature until the 
solution was homogeneous and then cooled to -40 
o
C. MeMgCl (0.35 mL, 1.0 mmol, 3 M in 
THF) was added dropwise, the mixture was stirred for a further 30 min during -40 
o
C to -30 
o
C. A solution of (2S,4S)-2.30 (25 mg, 0.1 mmol) in 1 mL dry THF was added dropwise and 
the reaction mixture was stirred at this temperature for 2.5 h. Saturated aqueous NH4Cl 
solution was added and the mixture was hydrolyzed and stirred for another 15 minutes while 
warming to room temperature. Subsequent filtration through celite, drying with MgSO4, and 
concentrated under vacuum, The residue was purified by column chromatography using 
pentane-Et2O (20:1) to give (S)-2.32 (10 mg, 0.04 mmol, 40%) as light yellow oil. 
The ee was determined by chiral GC: see experiment V 2.57. 
ee = 37%. 
Spectroscopic data of (S)-2.32: see experiment V 2.57. 
 
V2.63 
(ZY-571) 
Based on AVV 6, to a suspension of CuCN (94 mg, 1.0 mmol) in dry THF (6 mL) was added 
dropwise n-Bu3P (260 uL, 1.0 mmol). The mixture was stirred at room temperature until the 
solution was homogeneous and then cooled to -40 
o
C. MeMgCl (0.34 mL, 1.0 mmol, 3 M in 
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THF) was added dropwise, the mixture was stirred for a further 30 min during -40 
o
C to -30 
o
C. A solution of (S)-2.31 (31 mg, 0.1 mmol) in 1 mL dry THF was added dropwise and the 
reaction mixture was stirred at this temperature for 0.5 h. Then it was warmed up to -10 
o
C in 
1 h. It was still no reaction and ended with saturated aqueous NH4Cl solution. 
 
(R)-2,2,4-Trimethyl-4-(4-methylpenta-2,3-dien-1-yl)-1,3-dioxolane ((R)-2.32) 
V2.64 
(ZY-225) 
Based on AVV 6, to a flask LiBr (145 mg, 1.7 mmol) were added and heated under vacuum 
at about 300 
o
C for 5 minutes and cooled under argon to room temperature. Then, copper (I) 
iodide (323 mg, 1.7 mmol) and dry THF (6 mL) was added at room temperature and cooled 
at ice bath. Methyl magnesium chloride (0.85 mL, 1.7 mmol, 2 M in THF) was slowly added 
dropwise at 0 °C. It was stirred at this temperature for 30 minutes. To the yellow solution 
(2R,4R)-2.30 (40 mg, 0.17 mmol) in 2 mL dry THF was added dropwise. After being stirred 
for 52 h at room temperature, saturated aqueous NH4Cl solution was added and the mixture 
was hydrolyzed and stirred for another 15 minutes. Subsequent filtration through celite, 
drying with MgSO4, and concentrated under vacuum, The residue was purified by column 
chromatography using pentane-Et2O (20:1) to give (R)-2.32 (11 mg, 0.06 mmol, 33%) as 
light yellow oil. 
The ee was determined by chiral HPLC: i-PrOH : n-heptane = 3 : 97; flow rate, 0.3 mL min
−1
; 
25 °C; retention time, (S)-2.32 11.2 min, (R)-2.32 12.3 min.  
ee = 17%. 
Spectroscopic data of (R)-2.32: see experiment V 2.57. 
 
V2.65 
(ZY-138) 
Based on AVV 6, to a flask LiBr (345 mg, 4 mmol) were added and heated under vacuum at 
about 300 
o
C for 5 minutes and cooled under argon to room temperature. Then, copper (I) 
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iodide (755 mg, 4 mmol) and dry THF (12 mL) was added at room temperature and cooled at 
ice bath. Methyl magnesium chloride (1.3 mL, 4 mmol, 3 M in THF) was slowly added 
dropwise at 0 °C. It was stirred at this temperature for 30 minutes. To the yellow solution 
(R)-2.30a (96 mg, 0.4 mmol) in 4 mL dry THF was added dropwise. After being stirred for 
48 h at room temperature, saturated aqueous NH4Cl solution was added and the mixture was 
hydrolyzed and stirred for another 15 minutes. Subsequent filtration through celite, drying 
with MgSO4, and concentrated under vacuum, The residue was purified by column 
chromatography using pentane-Et2O (20:1) to give (R)-2.32 (67 mg, 0.34 mmol, 85%) as 
light yellow oil. 
The ee was determined by HPLC: see experiment V 2.60. 
ee = 63%. 
Spectroscopic data of (R)-2.32: see experiment V 2.57. 
 
V2.66 
(ZY-200) 
Based on AVV 6, to a flask LiBr (243 mg, 2.8 mmol) were added and heated under vacuum 
at about 300 
o
C for 5 minutes and cooled under argon to room temperature. Then, copper (I) 
iodide (532 mg, 2.8 mmol) and dry THF (10 mL) was added at room temperature and cooled 
at ice bath. Methyl magnesium chloride (1.1 mL, 2.8 mmol, 2.5 M in THF) was slowly added 
dropwise at 0 °C. It was stirred at this temperature for 30 minutes. To the yellow solution 
(R)-2.30b (68 mg, 0.28 mmol) in 3 mL dry THF was added dropwise. After being stirred for 
46 h at room temperature, saturated aqueous NH4Cl solution was added and the mixture was 
hydrolyzed and stirred for another 15 minutes. Subsequent filtration through celite, drying 
with MgSO4, and concentrated under vacuum, The residue was purified by column 
chromatography using pentane-Et2O (20:1) to give (R)-2.32 (30 mg, 0.15 mmol, 55%) as 
light yellow oil. 
The ee was determined by HPLC: see experiment V 2.60. 
ee = 58%. 
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Spectroscopic data of (R)-2.32: see experiment V 2.57. 
 
2,2,4-Trimethyl-4-(4-methylpenta-2,3-dien-1-yl)-1,3-dioxolane (rac-2.32) 
V2.67 
(ZY-424) 
Based on AVV 6, to a suspension of CuCN (3.76 g, 41.6 mmol) in dry THF (130 mL) was 
added dropwise n-Bu3P (10.4 mL, 41.6 mmol). The mixture was stirred at room temperature 
until the solution was homogeneous and then cooled to -40 
o
C. MeMgCl (14 mL, 41.6 mmol, 
3 M in THF) was added dropwise, the mixture was stirred for a further 30 min during -40 
o
C 
to -30 
o
C. A solution of rac-2.30a (1.0 g, 4.16 mmol) in 20 mL dry THF was added dropwise 
and the reaction mixture was stirred at this temperature for 2.5 h. Saturated aqueous NH4Cl 
solution was added and the mixture was hydrolyzed and stirred for another 15 minutes while 
warming to room temperature. Subsequent filtration through celite, drying with MgSO4, and 
concentrated under vacuum, The residue was purified by column chromatography using 
pentane-Et2O (20:1) to give rac-2.32 (620 mg, 3.16 mmol, 76%) as light yellow oil. 
Spectroscopic data of rac-2.32: see experiment V 2.57. 
 
V2.68 
(ZY-234) 
Based on AVV 6, to a flask LiBr (3.61 g, 41.6 mmol) were added and heated under vacuum 
at about 300 
o
C for 5 minutes and cooled under argon to room temperature. Then, copper (I) 
iodide (7.93 g, 41.6 mmol) and dry THF (125 mL) was added at room temperature and 
cooled at ice bath. Methyl magnesium chloride (13.9 mL, 41.6 mmol, 3 M in THF) was 
slowly added dropwise at 0 °C. It was stirred at this temperature for 30 minutes. To the 
yellow solution rac-2.30a (1.0 g, 4.16 mmol) in 21 mL dry THF was added dropwise. After 
being stirred for 24 h at room temperature, saturated aqueous NH4Cl solution was added and 
the mixture was hydrolyzed and stirred for another 15 minutes. Subsequent filtration through 
celite, drying with MgSO4, and concentrated under vacuum, The residue was purified by 
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column chromatography using pentane-Et2O (20:1) to give rac-2.32 (624 mg, 3.18 mmol, 
76%) as light yellow oil. 
Spectroscopic data of rac-2.32: see experiment V 2.57. 
 
V2.69 
(ZY-168) 
Based on AVV 6, to a flask LiBr (310 mg, 3.6 mmol) were added and heated under vacuum 
at about 300 
o
C for 5 minutes and cooled under argon to room temperature. Then, copper (I) 
iodide (680 mg, 3.6 mmol) and dry THF (11 mL) was added at room temperature and cooled 
at ice bath. Methyl magnesium chloride (1.2 mL, 3.6 mmol, 3 M in THF) was slowly added 
dropwise at 0 °C. It was stirred at this temperature for 30 minutes. To the yellow solution 
rac-2.30b (86 mg, 0.36 mmol) in 3 mL dry THF was added dropwise. After being stirred for 
24 h at room temperature, saturated aqueous NH4Cl solution was added and the mixture was 
hydrolyzed and stirred for another 15 minutes. Subsequent filtration through celite, drying 
with MgSO4, and concentrated under vacuum, The residue was purified by column 
chromatography using pentane-Et2O (20:1) to give rac-2.32 (30 mg, 0.15 mmol, 42%) as 
light yellow oil. 
Spectroscopic data of rac-2.32: see experiment V 2.57. 
 
1-Methoxy-4-((3-methylbut-3-en-1-yl)oxy)benzene (2.61) 
V2.70 
(ZY-581) 
Based on AVV2, to a solution of 3-methyl-3-buten-1-ol 2.60 (4.31 g, 50.0 mmol) in DCM 
(500 mL) was added 4-methoxyphenol (19.24 g, 155.0 mmol), triphenylphosphine (18.00 g, 
68.5 mmol) at room temperature. After being stirred for 5 minutes at room temperature and 
then cooled to 0 °C, DIAD (14.74 g, 68.5 mmol) was added dropwise and the solution was 
stirred at room temperature for three hours. The reaction mixture was quenched with water 
and extracted three times with DCM. The organic layer was washed with brine, dried with 
 Chapter 2. The total synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin 
91 
 
MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (10:1) to give 2.61 (9.41 g, 49.0 mmol, 98%) as 
colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 6.88-6.80 (m, 4H), 4.84 (s, 1H), 4.80 (s, 1H), 4.03 (t, J = 
6.9 Hz, 2H), 3.77 (s, 3H), 2.48 (t, J = 6.9 Hz, 2H), 1.81 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 153.9, 153.2, 142.5, 115.7, 114.7, 112.0, 67.3, 55.9, 37.5, 
23.0. 
The NMR data are consistent with the literature data.
[53]
 
 
(S)-4-(4-Methoxyphenoxy)-2-methylbutane-1,2-diol ((S)-2.62) 
 
V2.71 
(ZY-600) 
Based on AVV4, to a suspension of (DHQ)2PHAL (299 mg, 0.38 mmol), K3Fe(CN)6 (37.92 
g, 114.9 mmol), K2CO3 (16.10 g, 114.9 mmol) and K2OsO2(OH)4 (54 mg, 153.2 umol) in n-
butanol/H2O (1:1, 384 mL) was added 2.61 (7.35 g, 38.3 mmol) at 0 °C. After being stirred 
17 hours at this temperature, Na2SO3 sodium sulfite (57.45 g) was added and then warmed to 
room temperature and stirred for 30 min. The mixture was extracted three times with DCM. 
The organic layer was washed with brine, dried with MgSO4, and concentrated under vacuum. 
The residue was purified by column chromatography using pentane-Et2O (1:1) to give (S)-
2.62 (8.26 g, 36.5 mmol, 95%, 95% ee). After recrystallization from cyclohexane-AcOEt, 
enantiomerically pure (S)-2.62 (7.11 g, 31.4 mmol, 86%) was obtained as colorless solid. 
The ee was determined by chiral HPLC: i-PrOH : n-heptane = 10:90; flow rate, 1.2 mL min
−1
; 
room temperature; retention time, (S)-2.62 16.0 min, (R)-2.62 17.1 min.  
1
H NMR (400 MHz, CDCl3): δ = 6.87-6.82 (m, 4H), 4.20-4.07 (m, 2H), 3.77 (s, 3H), 3.54 (d, 
J = 11.1 Hz, 1H), 3.47 (d, J = 11.1 Hz, 1H), 2.55 (brs, 2H), 2.15-2.05 (m, 1H), 1.97-1.86 (m, 
1H), 1.25 (s, 3H). 
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13
C NMR (100 MHz, CDCl3): δ = 154.4, 152.4, 115.7, 114.8, 72.5, 70.2, 65.6, 55.9, 37.7, 
24.3. 
ee = >99%. 
[𝛼]𝐷
20 = +11.8 (c = 2.00, CHCl3). 
The NMR data are consistent with the literature data.
[36]
 
 
4-(4-Methoxyphenoxy)-2-methylbutane-1,2-diol (rac-2.62) 
 
V2.72 
(ZY-576) 
Based on AVV4, to a suspension of AD-mix-α (2.8 g) and AD-mix-β (2.8 g) in n-
butanol/H2O (1:1, 40 mL) 2.61 (768 mg, 4.0 mmol) was added at 0 °C. After being stirred 
overnight at room temperature, Na2SO3 sodium sulfite (6.0 g) was added and stirred for 30 
min. The mixture was extracted three times with DCM. The organic layer was washed with 
brine, dried with MgSO4, and concentrated under vacuum. The residue was purified by 
column chromatography using pentane-Et2O (1:1) to give rac-2.62 (801 mg, 3.54 mmol, 89%) 
as colorless solid.  
Spectroscopic data of rac-2.62: see experiment V 2.71. 
 
(S)-2-(2-Methyl-1,4-dioxaspiro[4.5]decan-2-yl)ethanol ((S)-2.64) 
V2.73 
(ZY-607) 
To a solution of (S)-2.62 (4.00 g, 17.7 mmol) in cyclohexanone (50 mL) was added p-
TsOH·H2O (673 mg, 3.54 mmol) at room temperature under argon. After being stirred for 30 
min, the reaction mixture was quenched with sat. aq. NaHCO3 and extracted with AcOEt. 
The organic layer was washed with brine, dried with MgSO4, and concentrated under vacuum 
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to give the crude cyclohexylidene ketal. This was dissolved in a 4 : 1-mixture of CH3CN and 
H2O (175 mL) and CAN (19.4 g, 35.4 mmol) was added at 0 
o
C under air. After being stirred 
for 1 hour, the reaction mixture was quenched with sat. aq. NaHCO3 and extracted with Et2O. 
The organic layer was washed with brine, dried with MgSO4, and concentrated under vacuum. 
The residue was purified by column chromatography using pentane-Et2O (1:1) to give (S)-
2.64 (3.42 g, 17.1 mmol, 97%) as yellow oil.  
1
H NMR (400 MHz, CDCl3): δ = 3.94-3.87 (m, 1H), 3.83 (d, J = 8.4 Hz, 1H), 3.79-3.73 (m, 
2H), 2.60 (brs, 1H), 1.96-1.85 (m, 1H), 1.78-1.69 (m, 1H), 1.63 (dd, J = 21.8, 14.7 Hz, 8H), 
1.45-1.36 (m, 2H), 1.34 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 110.5, 81.2, 74.5, 59.7, 41.1, 36.8, 36.5, 25.4, 25.2, 24.1, 
24.0. 
[𝛼]𝐷
20 = -12.6 (c = 1.40, CHCl3). 
The NMR data are consistent with the literature data.
[36]
 
 
2-(2-Methyl-1,4-dioxaspiro[4.5]decan-2-yl)ethanol (rac-2.64) 
V2.74 
(ZY-582) 
To a solution of rac-2.62 (786 mg, 3.48 mmol) in cyclohexanone (9.8 mL) was added p-
TsOH·H2O (132.4 mg, 0.7 mmol) at room temperature under argon. After being stirred for 5 
min, the reaction mixture was quenched with sat. aq. NaHCO3 and extracted with AcOEt. 
The organic layer was washed with brine, dried with MgSO4, and concentrated under vacuum 
to give the crude cyclohexylidene ketal. This was dissolved in a 4 : 1-mixture of CH3CN and 
H2O (35 mL) and CAN (3.81 g, 6.96 mmol) was added at 0 
o
C under air. After being stirred 
for 5 min, the reaction mixture was quenched with sat. aq. NaHCO3 and extracted with Et2O. 
The organic layer was washed with brine, dried with MgSO4, and concentrated under vacuum. 
The residue was purified by column chromatography using pentane-Et2O (1:1) to give rac-
2.64 (550 mg, 2.75 mmol, 79%) as yellow oil. 
Spectroscopic data of rac-2.64: see experiment V 2.73. 
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(S)-2-(2-Methyl-1,4-dioxaspiro[4.5]decan-2-yl)acetaldehyde ((S)-2.65) 
V2.75 
(ZY-609) 
Based on AVV9, to a solution of (S)-2.64 (2.20 g, 11.0 mmol) in DCM (100 mL) was added 
Dess–Martin periodinane (5.60 g, 13.2 mmol) at room temperature under air, and the reaction 
mixture was heated up to 40 
o
C for 1 h. After cooling to room temperature, the reaction 
mixture was quenched with sat. aq. NaHCO3 and extracted with DCM The organic layer was 
washed with brine, dried with MgSO4, and concentrated under vacuum. The residue was 
purified by column chromatography using pentane-Et2O (4:1) to give (S)-2.65 (1.92 g, 9.65 
mmol, 88%) as yellow oil.  
1
H NMR (400 MHz, CDCl3): δ = 9.81 (t, J = 2.4 Hz, 1H), 3.87 (d, J = 8.8 Hz, 1H), 3.81 (d, J 
= 8.8 Hz, 1H), 2.73 (dd, J = 15.6, 2.2 Hz, 1H), 2.59 (dd, J = 15.6, 2.6 Hz, 1H), 1.66-1.56 (m, 
8H), 1.47-1.40 (m, 1H), 1.39 (s, 3H), 1.35 (dd, J = 11.7, 5.5 Hz, 1H). 
13
C NMR (100 MHz, CDCl3): δ = 201.6, 110.5, 78.4, 73.8, 53.6, 36.8, 36.5, 25.9, 25.2, 24.0, 
24.0. 
[𝛼]𝐷
20 = -34.6 (c = 1.10, CHCl3). 
The NMR data are consistent with the literature data.
[36]
 
 
2-(2-Methyl-1,4-dioxaspiro[4.5]decan-2-yl)acetaldehyde (rac-2.65) 
V2.76 
(ZY-585) 
Based on AVV9, to a solution of rac-2.64 (250 mg, 1.25 mmol) in DCM (12 mL) was added 
Dess–Martin periodinane (636 mg, 1.5 mmol) at room temperature under air, and the reaction 
mixture was heated up to 40 
o
C for 1 h. After cooling to room temperature, the reaction 
mixture was quenched with sat. aq. NaHCO3 and extracted with DCM. The organic layer was 
washed with brine, dried with MgSO4, and concentrated under vacuum. The residue was 
purified by column chromatography using pentane-Et2O (4:1) to give rac-2.65 (180 mg, 0.91 
mmol, 73%) as yellow oil. 
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Spectroscopic data of rac-2.65: see experiment V 2.75. 
 
1-((S)-2-Methyl-1, 4-dioxaspiro[4.5]decan-2-yl)pent-3-yn-2-ol ((S)-2.66) 
V2.77 
(ZY-611) 
To a solution of propyne (1.0 M in THF; 12.1 mL, 12.12 mmol) in dry THF (60 mL) was 
added n-BuLi (2.5 M in hexane; 5.7 mL, 14.14 mmol) at -80 
o
C under argon. After being 
stirred for 30 min at -80 
o
C, to reaction mixture was added the solution of (S)-2.65 (2.00 g, 
10.10 mmol) in dry THF (40 mL) at -80 
o
C under argon. After warming up to -40 
o
C for 1 h, 
the reaction mixture was quenched with H2O and extracted with Et2O. The organic layer was 
washed with brine, dried with MgSO4, and concentrated under vacuum. The residue was 
purified by column chromatography using pentane-Et2O (10:1) to give (S)-2.66 (1.97 g, 8.27 
mmol, 82%, dr = 62:38) as yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 4.78-4.53 (m, 1H), 3.87 (dd, J = 18.5, 8.6 Hz, 1H), 3.76 
(ddd, J = 22.3, 8.6, 1.2 Hz, 1H), 2.94 (brs, 1H), 2.14-1.91 (m, 2H), 1.87-1.80 (m, 3H), 1.62 
(ddt, J = 23.9, 18.4, 8.8 Hz, 8H), 1.46-1.30 (m, 5H). 
13
C NMR (100 MHz, CDCl3): δ = 110.9, 110.2, 81.0, 80.6, 80.5, 80.3, 80.1, 75.0, 73.7, 60.0, 
59.9, 46.9, 46.4, 37.0, 36.4, 36.4, 26.6, 25.2, 24.5, 24.1, 24.1, 24.0, 23.9, 3.7. 
IR (v cm
-1
): 3441, 2933, 2861, 2360, 2342. 
HRMS: calc’d for [M+H]+: 239.1642, found: 239.1643. 
 
1-(2-Methyl-1,4-dioxaspiro[4.5]decan-2-yl)pent-3-yn-2-ol (rac-2.66) 
V2.78 
(ZY-590) 
To a solution of propyne (1.0 M in THF; 0.46 mL, 0.46 mmol) in dry THF (4 mL) was added 
n-BuLi (2.5 M in hexane; 0.26 mL, 0.64 mmol) at -80 
o
C under argon. After being stirred for 
30 min at -80 
o
C, to reaction mixture was added the solution of rac-2.65 (100 mg, 0.5 mmol) 
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in dry THF (3 mL) at -80 
o
C under argon. After warming up to -40 
o
C for 2.5 h, the reaction 
mixture was quenched with H2O and extracted with Et2O. The organic layer was washed with 
brine, dried with MgSO4, and concentrated under vacuum. The residue was purified by 
column chromatography using pentane-Et2O (10:1) to give rac-2.66 (70 mg, 0.29 mmol, 64%, 
dr = 62:38) as yellow oil. 
Spectroscopic data of rac-2.66: see experiment V 2.77. 
 
1-((S)-2-Methyl-1,4-dioxaspiro[4.5]decan-2-yl)pent-3-yn-2-yl acetate ((S)-2.67) 
V2.79 
(ZY-613) 
Based on AVV 5, to a solution of (S)-2.66 (2.30 g, 9.66 mmol) in DCM (53 mL) was added 
Ac2O (1.84 mL, 19.32 mmol), Et3N (2.76 mL, 19.32 mmol) and DMAP (72.5 mg, 0.48 mmol) 
at 0 
o
C. After being stirred for 30 min at this temperature, the reaction mixture was quenched 
with sat. aq. NH4Cl and extracted with DCM. The organic layer was washed with brine, dried 
with MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (10:1) to give (S)-2.67 (2.60 g, 9.28 mmol, 96%, dr = 
62:38) as light yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 5.50-5.40 (m, 1H), 3.92 (dd, J = 30.5, 8.5 Hz, 1H), 3.67 (dd, 
J = 20.4, 8.5 Hz, 1H), 2.16-1.98 (m, 5H), 1.86-1.79 (m, 3H), 1.56-1.62 (m, 8H), 1.39-1.28 (m, 
5H). 
13
C NMR (100 MHz, CDCl3): δ = 170.0, 109.9, 109.8, 82.3, 81.9, 79.0, 78.9, 77.3, 74.2, 73.7, 
61.7, 61.6, 45.3, 45.1, 36.8, 36.7, 36.5, 25.7, 25.3, 25.2, 25.1, 24.1, 24.0, 21.3, 21.3, 3.8. 
IR (v cm
-1
): 2934, 2862, 2248, 1740. 
HRMS: calc’d for [M+H]+: 281.1747, found: 281.1747. 
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1-(2-Methyl-1,4-dioxaspiro[4.5]decan-2-yl)pent-3-yn-2-yl acetate (rac-2.67) 
V2.80 
(ZY-596) 
To a solution of rac-2.66 (130 mg, 0.55 mmol) in DCM (3 mL) was added Ac2O (63 uL, 0.66 
mmol), Et3N (100 uL, 0.72 mmol) and DMAP (4.1 mg, 0.03 mmol) at 0 
o
C. After being 
stirred for 30 min at this temperature, the reaction mixture was quenched with sat. aq. NH4Cl 
and extracted with DCM. The organic layer was washed with brine, dried with MgSO4, and 
concentrated under vacuum. The residue was purified by column chromatography using 
pentane-Et2O (10:1) to give rac-2.67 (127 mg, 0.45 mmol, 82%, dr = 62:38) as light yellow 
oil. 
Spectroscopic data of rac-2.67: see experiment V 2.79. 
 
(S)-2-Methyl-2-(4-methylpenta-2, 3-dien-1-yl)-1,4-dioxaspiro[4.5]decane ((S)-2.68) 
V2.81 
(ZY-615) 
Based on AVV 6, to a suspension of CuCN (6.40 g, 71.4 mmol) in dry THF (200 mL) was 
added dropwise n-Bu3P (17.8 mL, 71.4 mmol). The mixture was stirred at room temperature 
until the solution was homogeneous and then cooled to -40 
o
C. MeMgCl (23.8 mL, 71.4 
mmol, 3 M in THF) was added dropwise, the mixture was stirred for a further 30 min during -
40 
o
C to -30 
o
C. A solution of (S)-2.67 (2.00 g, 7.14 mmol) in 40 Ml dry THF was added 
dropwise and the reaction mixture was stirred at this temperature for two hours. Saturated 
aqueous NH4Cl solution was added and the mixture was hydrolyzed and stirred for another 
15 minutes while warming to room temperature. Subsequent filtration through celite, drying 
with MgSO4, and concentrated under vacuum, the residue was purified by column 
chromatography using pentane-Et2O (20:1) to give (S)-2.68 (1.37 g, 5.80 mmol, 81%) as 
light yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 4.93 (dddd, J = 10.4, 7.6, 5.8, 2.9 Hz, 1H), 3.85 (d, J = 8.3 
Hz, 1H), 3.67 (d, J = 8.3 Hz, 1H), 2.21 (d, J = 7.5 Hz, 2H), 1.67 (d, J = 2.9 Hz, 6H), 1.64-
1.33 (m, 10H), 1.30 (s, 3H). 
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13
C NMR (100 MHz, CDCl3): δ = 203.7, 109.9, 94.6, 84.4, 80.8, 73.0, 40.6, 36.9, 25.3, 25.1, 
24.1, 20.7, 20.6. 
IR (v cm
-1
): 2976, 2933, 2861, 1969. 
HRMS: calc’d for [M+H]+: 237.1849, found: 237.1849. 
[𝛼]𝐷
20 = +5.5 (c = 2.10, CHCl3). 
 
2-Methyl-2-(4-methylpenta-2,3-dien-1-yl)-1,4-dioxaspiro[4.5]decane (rac-2.68) 
V2.82 
(ZY-597) 
Based on AVV 6, to a suspension of CuCN (225 mg, 2.5 mmol) in dry THF (10 mL) was 
added dropwise n-Bu3P (0.62 mL, 2.5 mmol). The mixture was stirred at room temperature 
until the solution was homogeneous and then cooled to -40 
o
C. MeMgCl (0.84 mL, 2.5 mmol, 
3 M in THF) was added dropwise, the mixture was stirred for a further 30 min during -40 
o
C 
to -30 
o
C. A solution of rac-2.67 (70 mg, 0.25 mmol) in dry THF (2 mL) was added dropwise 
and the reaction mixture was stirred at this temperature for two hours. Saturated aqueous 
NH4Cl solution was added and the mixture was hydrolyzed and stirred for another 15 minutes 
while warming to room temperature. Subsequent filtration through celite, drying with MgSO4, 
and concentrated under vacuum, the residue was purified by column chromatography using 
pentane-Et2O (20:1) to give rac-2.68 (57 mg, 241 umol, 97%) as light yellow oil. 
Spectroscopic data of rac-2.68: see experiment V 2.81. 
 
(S)-2,6-Dimethylhepta-4,5-diene-1,2-diol ((S)-2.33) 
V2.83 
(ZY-617) 
To a solution of (S)-2.68 (2.50 g, 10.58 mmol) in dry MeOH (250 mL) was added p-TsOH 
(2.01 g, 10.58 mmol) at room temperature under argon. After being stirred for 24 h, the 
reaction mixture was quenched with sat. aq. NaHCO3 and extracted with Et2O. The organic 
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layer was washed with brine, dried with MgSO4, and concentrated under vacuum. The 
residue was purified by column chromatography using pentane-Et2O (1:1) to give (S)-2.33 
(1.49 g, 9.55 mmol, 90%) as well as recovered starting material (S)-2.68 (130 mg, 0.55 mmol, 
5%) as light yellow oil. 
1
H NMR (400 MHz, C6D6) δ = 5.04 (tp, J = 8.6, 2.9 Hz, 1H), 3.35-3.21 (m, 2H), 2.22-2.04 
(m, 2H), 1.90 (brs, 1H), 1.75 (brs, 1H), 1.58 (dd, J = 2.8, 1.6 Hz, 6H), 1.07 (s, 3H). 
13
C NMR (100 MHz, C6D6) δ = 204.2, 94.4, 84.5, 72.7, 69.6, 39.3, 30.5, 23.5, 20.6. 
IR (v cm
-1
): 3363, 2976, 2933, 2873, 1968, 1721. 
HRMS: calc’d for [M+Na]+: 179.1043, found: 179.1043. 
[𝛼]𝐷
20 = -2.5 (c = 2.05, CHCl3). 
 
V2.84 
(ZY-584) 
To a solution of (S)-2.32 (830 mg, 4.23 mmol) in THF (8.2 mL) and H2O (82 mL) was added 
concentrated acetic acid (205 mL) at room temperature under air. After being stirred for 24 h, 
the solvent was removed in vacuum using toluene as entrainer. The residue was purified by 
column chromatography using cyclohexane-ethyl acetate (1:1) to give (S)-2.33 (590 mg, 3.78 
mmol, 89%) as light yellow oil. 
Spectroscopic data of (S)-2.33: see experiment V 2.83. 
 
2,6-Dimethylhepta-4,5-diene-1,2-diol (rac-2.33) 
V2.85 
(ZY-598) 
To a solution of rac-2.68 (30 mg, 127 umol) in dry MeOH (3.3 mL) was added p-TsOH·H2O 
(24 mg, 127 umol) at room temperature under argon. After being stirred for 24 h, the reaction 
mixture was quenched with sat. aq. NaHCO3 and extracted with Et2O. The organic layer was 
washed with brine, dried with MgSO4, and concentrated under vacuum. The residue was 
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purified by column chromatography using pentane-Et2O (1:1) to give rac-2.33 (15 mg, 96 
umol, 76 %) as light yellow oil.  
Spectroscopic data of rac-2.33: see experiment V 2.83. 
 
V2.86 
(ZY-429) 
To a solution of rac-2.32 (1 g, 5.1 mmol) in THF (10 mL) and H2O (100 mL) was added 
concentrated acetic acid (250 mL) at room temperature under air. After being stirred for 24 h, 
the solvent was removed in vacuum using toluene as entrainer. The residue was purified by 
column chromatography using cyclohexane-ethyl acetate (1:1) to give rac-2.33 (702 mg, 4.5 
mmol, 88%) as light yellow oil. 
Spectroscopic data of rac-2.33: see experiment V 2.83. 
 
(S)-1-((tert-Butyldimethylsilyl)oxy)-2,6-dimethylhepta-4,5-dien-2-ol ((S)-2.34) 
V2.87 
(ZY-618) 
Based on AVV3, to a solution of (S)-2.33 (1.60 g, 10.25 mmol) in 15 mL dry DCM was 
added N,N-dimethylaminopyridine (DMAP) (52 mg, 0.41 mmol), triethylamine (1.7 mL, 12.3 
mmol) and t-butyldimethylsilyl chloride (TBSCl) (1.62 g, 10.76 mmol) at room temperature. 
After being stirred for 14 h at this temperature, the reaction mixture was quenched with sat. 
aq. NaHCO3 and extracted three times with DCM. The organic layer was washed with brine, 
dried with MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (10:1) to give (S)-2.34 (2.42 g, 8.94 mmol, 87%) as 
light yellow oil.  
1
H NMR (400 MHz, CDCl3): δ = 4.97-4.89 (m, 1H), 3.48 (d, J = 9.4 Hz, 1H), 3.39 (d, J = 9.5 
Hz, 1H), 2.42 (s, 1H), 2.18-2.08 (m, 2H), 1.68 (d, J = 2.9 Hz, 6H), 1.14 (s, 3H), 0.91 (s, 9H), 
0.07 (s, 6H). 
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13
C NMR (100 MHz, CDCl3): δ = 203.8, 94.3, 84.2, 72.6, 69.6, 39.0, 26.0, 23.2, 20.8, 20.7, 
18.4, -5.3. 
IR (v cm
-1
): 3570, 3461, 2955, 2930, 2907, 2857, 2711, 1969. 
HRMS: calc’d for [M+H]+: 271.2088, found: 271.2088. 
[𝛼]𝐷
20 = -9.3 (c = 2.03, CHCl3). 
 
1-((tert-Butyldimethylsilyl)oxy)-2,6-dimethylhepta-4,5-dien-2-ol (rac-2.34) 
V2.88 
(ZY-432) 
Based on AVV3, to a solution of rac-2.33 (1000 mg, 6.4 mmol) in 10 mL dry DCM was 
added DMAP (32 mg, 0.26 mmol), triethylamine (1063 uL, 7.68 mmol) and TBSCl (1013 mg, 
6.72 mmol) at room temperature. After being stirred for 18 h at this temperature, the reaction 
mixture was quenched with sat. aq. NaHCO3 and extracted three times with DCM. The 
organic layer was washed with brine, dried with MgSO4, and concentrated under vacuum. 
The residue was purified by column chromatography using pentane-Et2O (10:1) to give rac-
2.34 (1405 mg, 5.2 mmol, 81%) as light yellow oil. 
Spectroscopic data of rac-2.34: see experiment V 2.87. 
 
(S)-tert-Butyldimethyl((2,6,6-trimethyl-3,6-dihydro-2H-pyran-2-yl)methoxy)silane ((S)-
2.35) 
V2.89 
(ZY-620) 
Based on AVV7, to a solution of (S)-2.34 (2.10 g, 7.77 mmol) in 125 mL dry toluene was 
added Triphenylphosphingold (I) chloride (96.1 mg, 194.3 umol), silver tetrafluoroborate 
(37.8 mg, 194.3 umol) at room temperature under argon. After being stirred for 6 h, the 
reaction mixture was filtrated through Celite and the filtrate was concentrated under vacuum. 
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The residue was purified by column chromatography using pentane-Et2O (20:1) to give (S)-
2.35 (1.77 g, 6.54 mmol, 84%) as colorless oil.  
The ee was determined by chiral GC: start temperature, 40 oC; flow rate, 0.5 oC min-1 to 80 
oC; retention time, (S)-2.35 65.5 min, (R)-2.35 69.2 min. 
1
H NMR (400 MHz, CDCl3): δ = 5.77-5.58 (m, 2H), 3.51 (d, J = 9.2 Hz, 1H), 3.34 (d, J = 9.2 
Hz, 1H), 2.10 (ddd, J = 17.2, 3.7, 1.4 Hz, 1H), 1.91-1.82 (m, 1H), 1.25 (s, 3H), 1.20 (d, J = 
2.9 Hz, 6H), 0.89 (s, 9H), 0.03 (d, J = 2.1 Hz, 6H). 
13
C NMR (100 MHz, CDCl3): δ = 134.2, 120.8, 73.5, 71.6, 69.8, 31.0, 31.0, 30.3, 26.1, 24.9, 
18.4, -5.3. 
IR (v cm
-1
): 3032, 2971, 2956, 2929, 2896, 2858, 2710, 1666. 
HRMS: calc’d for [M+H]+: 271.2088, found: 271.2088. 
ee = >99%. 
[𝛼]𝐷
20 = -3.3 (c = 2.27, CHCl3). 
 
tert-Butyldimethyl((2,6,6-trimethyl-3,6-dihydro-2H-pyran-2-yl)methoxy)silane (rac-2.35) 
V2.90 
(ZY-437) 
Based on AVV7, to a solution of rac-2.34 (1000 mg, 3.7 mmol) in 60 mL dry toluene was 
added Triphenylphosphingold (I) chloride (45.8 mg, 92.5 umol), silver tetrafluoroborate (18 
mg, 92.5 umol) at room temperature under argon. After being stirred for 8 h, the reaction 
mixture was filtrated through Celite and the filtrate was concentrated under vacuum. The 
residue was purified by column chromatography using pentane-Et2O (20:1) to give rac-2.35 
(842 mg, 3.1 mmol, 84%) as colorless oil. 
Spectroscopic data of rac-2.35: see experiment V 2.89. 
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(S)-(2,6,6-Trimethyl-3,6-dihydro-2H-pyran-2-yl)methanol ((S)-2.37) 
V2.91 
(ZY-623) 
To a solution of (S)-2.35 (1.00 g, 3.7 mmol) in 36 mL THF was added tetrabutylammonium 
fluoride trihydrate (2.34 g, 7.4 mmol) at room temperature. Then the solution was heated at 
reflux for 7.5 h. After cooled to room temperature, the reaction mixture was quenched with 
saturated aqueous NH4Cl solution, filtered through celite, and concentrated under vacuum. 
The residue was purified by column chromatography using pentane-Et2O (4:1) to give (S)-
2.37 (546 mg, 3.5 mmol, 95%) as light yellow oil. 
The ee was determined by chiral GC: start temperature, 40 oC; flow rate, 0.5 oC min-1 to 65 
oC; retention time, (R)-2.37 37.6 min, (S)-2.37 46.5 min. 
1
H NMR (400 MHz, CDCl3): δ = 5.74-5.64 (m, 2H), 3.44-3.34 (m, 2H), 2.29 (d, J = 16.9 Hz, 
1H), 2.10 (bs, 1H), 1.74 (dd, J = 16.9, 5.3 Hz, 1H), 1.28 (s, 3H), 1.23 (s, 3H), 1.19 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 133.6, 120.6, 72.8, 72.1, 69.9, 31.1, 30.0, 29.5, 24.3. 
IR (v cm
-1
): 3441, 3031, 2972, 2929, 1663. 
HRMS: calc’d for [M+H]+: 157.1223, found: 157.1223. 
ee = >99%. 
[𝛼]𝐷
20 = -11.8 (c = 1.27, CHCl3). 
 
(2,6,6-Trimethyl-3,6-dihydro-2H-pyran-2-yl)methanol (rac-2.37) 
V2.92 
(ZY-446) 
To a solution of rac-2.35 (1000 mg, 3.7 mmol) in 38 mL THF was added 
tetrabutylammonium fluoride trihydrate (2335 mg, 7.4 mmol) at room temperature. Then the 
solution was heated at reflux for 7.5 h. After cooled to room temperature, the reaction 
mixture was quenched with saturated aqueous NH4Cl solution, filtered through celite, and 
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concentrated under vacuum. The residue was purified by column chromatography using 
pentane-Et2O (4:1) to give rac-2.37 (531 mg, 3.4 mmol, 92%) as light yellow oil. 
Spectroscopic data of rac-2.37: see experiment V 2.91. 
 
tert-Butyldimethyl((2,2,4-trimethyl-3,7-dioxabicyclo[4.1.0]heptan-4-yl)methoxy)silane 
(rac-2.36) 
V2.93 
(ZY-530) 
Based on AVV8, to a solution of rac-2.35 (100 mg, 0.37 mmol) in 6 mL dry DCM was added 
disodium hydrogen phosphate (105 mg, 0.74 mmol) and m-CPBA (70%-75% in water, 182 
mg, 0.74 mmol,) at 0 °C. After being stirred for 41 h at room temperature, the reaction 
mixture was quenched with sat. aq. Na2CO3 and extracted three times with DCM. The 
organic layer was washed with brine, dried with MgSO4, and concentrated under vacuum. 
The residue was purified by column chromatography using pentane-Et2O (2:1) to give rac-
2.36 (87 mg, 0.3 mmol, 82%, dr = 1:1) as yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 3.56-3.33 (m, 1H), 3.41-3.40 (m, 0.5H), 3.38-3.36 (m, 
0.5H), 3.27 (dd, J = 30.7, 9.3 Hz, 1H), 2.93 (dd, J = 13.8, 4.4 Hz, 1H), 2.05-1.96 (m, 1H), 
1.83-1.70 (m, 1H), 1.34 (s, 3H), 1.28 (d, J = 2.3 Hz, 3H), 1.18 (d, J = 38.7 Hz, 3H), 0.88 (d, J 
= 1.5 Hz, 9H), 0.03 (t, J = 3.2 Hz, 6H). 
13
C NMR (100 MHz, CDCl3): δ = 73.0/72.8, 71.8/70.4, 69.9/69.8, 56.6/55.9, 51.5/50.8, 
29.9/29.7, 29.0/28.5, 28.2/27.7, 27.1/27.0, 26.0/26.0/25.9, 18.4/18.4, -5.3/-5.3. 
HRMS: calc’d for [M+H]+: 287.2037, found: 287.2039; calc’d for [M+Na]+: 309.1856, found: 
309.1858. 
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((2S,4S,5S)-2,2,4-Trimethyl-3,7-dioxabicyclo[4.1.0]heptan-4-yl)methanol ((2S,4S,5S)-
2.38) 
V2.94 
(ZY-625) 
Based on AVV8, to a solution of (S)-2.37 (496 mg, 3.18 mmol) in 30 mL dry DCM was 
added disodium hydrogen phosphate (677 mg, 4.77 mmol) and mCPBA (70%-75% in water, 
1.18 g, 4.77 mmol,) at 0 °C. After being stirred for 48 h at room temperature, the reaction 
mixture was quenched with sat. aq. Na2CO3 and extracted three times with DCM. The 
organic layer was washed with brine, dried with MgSO4, and concentrated under vacuum. 
The residue was purified by column chromatography using pentane-Et2O (2:1) to give 
(2S,4S,5S)-2.38 (427 mg, 2.48 mmol, 78%, dr = 6.3:1.0) as yellow oil. 
1
H NMR (400 MHz, CDCl3): δ =4.47-4.45/3.41-3.39 (m, 1H), 3.34-3.28 (m, 2H), 2.95 (d, J = 
4.4 Hz, 1H), 2.18 (ddd, J = 15.4, 6.1, 1.8 Hz, 1H), 1.80 (dd, J = 15.4, 3.6 Hz, 1H), 1.36 (s, 
3H), 1.31 (s, 3H), 1.15 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 72.4/72.3, 71.1/70.9, 70.5/69.8, 56.8/55.5, 52.2/50.6, 
29.6/29.2, 28.3/28.0, 27.4/27.2, 26.9/25.2. 
IR (v cm
-1
): 3441, 2975, 2933, 2875, 2360, 1722, 1649, 1575. 
HRMS: calc’d for [M+H]+: 173.1172, found: 173.1172. 
 
2,2,4-Trimethyl-3,7-dioxabicyclo[4.1.0]heptan-4-yl)methanol (rac-2.38) 
V2.95 
(ZY-595) 
Based on AVV8, to a solution of rac-2.37 (680 mg, 4.36 mmol) in 43 mL dry DCM was 
added disodium hydrogen phosphate (1237 mg, 8.72 mmol) and mCPBA (70%-75% in water, 
2148 mg, 8.72 mmol,) at 0 °C. After being stirred for 48 h at room temperature, the reaction 
mixture was quenched with sat. aq. Na2CO3 and extracted three times with DCM. The 
organic layer was washed with brine, dried with MgSO4, and concentrated under vacuum. 
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The residue was purified by column chromatography using pentane-Et2O (2:1) to give rac-
2.38 (550 mg, 3.20 mmol, 73%, dr = 4.0:1.0) as yellow oil. 
Spectroscopic data of rac-2.38: see experiment V 2.94. 
 
V2.96 
(ZY-252) 
Based on AVV8, to a solution of rac-2.37 (48 mg, 0.31 mmol) in 3 mL dry DCM was added 
disodium hydrogen phosphate (65 mg, 0.46 mmol) and mCPBA (70%-75% in water, 113 mg, 
0.46 mmol,) at 0 °C. After being stirred for 5 days at 0 °C, the reaction mixture was quenched 
with sat. aq. Na2CO3 and extracted three times with Et2O. The organic layer was washed with 
brine, dried with MgSO4, and concentrated under vacuum. The residue was purified by 
column chromatography using pentane-Et2O (2:1) to give rac-2.38 (20 mg, 116 umol, 37%, 
dr = 4.0:1.0) and recovered A14 (10 mg, 64 umol, 20%) as yellow oil. 
 
V2.97 
(ZY-259) 
Based on AVV8, to a solution of rac-2.37 (166 mg, 1.06 mmol) in 12 mL dry DCM was 
added disodium hydrogen phosphate (452 mg, 3.18 mmol) and mCPBA (70%-75% in water, 
784 mg, 3.18 mmol,) at 0 °C. After being stirred for 44 h at room temperature, the reaction 
mixture was quenched with sat. aq. Na2CO3 and extracted three times with Et2O. The organic 
layer was washed with brine, dried with MgSO4, and concentrated under vacuum. The 
residue was purified by column chromatography using pentane-Et2O (2:1) to give rac-2.38 
(30 mg, 174 umol, 16%, dr = 4.0:1.0) as yellow oil. 
 
V2.98 
(ZY-476) 
Based on AVV8, to a solution of rac-2.37 (110 mg, 0.7 mmol) in 10 mL dry DCM was added 
mCPBA (70%-75% in water, 345 mg, 1.4 mmol,) at 0 °C. After being stirred for 39 h at room 
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temperature, the reaction mixture was quenched with sat. aq. Na2CO3 and extracted three 
times with DCM. The organic layer was washed with brine, dried with MgSO4, and 
concentrated under vacuum. The residue was purified by column chromatography using 
pentane-Et2O (2:1) to give rac-2.38 (61 mg, 0.354 mmol, 51%, dr = 4.0:1.0) as yellow oil. 
 
V2.99 
(ZY-536) 
Based on AVV8, to a solution of rac-2.36 (40 mg, 0.14 mmol, dr = 1:1) in 1.5 mL THF was 
added tetrabutylammonium fluoride trihydrate (88 mg, 0.28 mmol) at room temperature. 
Then the solution was heated at reflux for 7.5 h. After cooled to room temperature, the 
reaction mixture was quenched with saturated aqueous NH4Cl solution, filtered through celite, 
and concentrated under vacuum. The residue was purified by column chromatography using 
pentane-Et2O (4:1) to give rac-2.38 (23 mg, 134 umol, 96%, dr = 1:1) as light yellow oil. 
 
V2.100 
(ZY-248) 
To a suspension of VO(acac)2 (1.4 mg, 5.3 umol) in 2 mL Toluene was added rac-2.37 (24.6 
mg, 157.6 umol) and TBHP (50 uL, 275umol, 5.5 M in decane) at room temperature. The 
reaction was stirred at MW irradiation (113 
o
C, 150 W max) for 100 min. After being cooled 
to room temperature, the mixture was quenched with sat. aq. Na2S2O3 and extracted three 
times with DCM. The organic layer was washed with brine, dried with MgSO4, and 
concentrated under vacuum. The residue was purified by column chromatography using 
pentane-Et2O (2:1) to give rac-2.37 (20 mg, 128 umol, 81%) as light yellow oil and trace rac-
2.38.  
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V2.101 
(ZY-244) 
To a suspension of VO(acac)2 (0.3 mg, 0.96 umol) in 2 mL DCM was added rac-2.37 (10 mg, 
64.1 umol) and TBHP (17.5 uL, 96.1 umol, 5.5 M in decane) at 0 
o
C. After being stirred 
about 5 days at room temperature, it still had a lot of rac-2.37 and trace rac-2.38. 
 
(2S,4S,5S)-2,2,4-Trimethyl-3,7-dioxabicyclo[4.1.0]heptane-4-carbaldehyde ((2S,4S,5S)-
2.59) 
V2.102 
(ZY-629) 
Based on AVV9, to a solution of (2S,4S,5S)-2.38 (50 mg, 0.29 mmol) in 3.0 mL DCM was 
added Dess–Martin periodinane (148 mg, 0.35 mmol) at room temperature under argon. After 
being stirred for 2.5 h at room temperature, the reaction mixture was quenched with sat. aq. 
NaHCO3 and extracted three times with DCM. The organic layer was washed with brine, 
dried with MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (10:1) to give (2S,4R,5R)-2.59 (3 mg, 17.6 umol, 6%) 
and (2S,4S,5S)-2.59 (22 mg, 129.3 umol, 45%) as light yellow oil.  
(2S,4S,5S)-2.59:  
1
H NMR (400 MHz, CDCl3): δ = 9.60 (d, J = 1.4 Hz, 1H), 3.34 (t, J = 3.9 Hz, 1H), 2.99 (d, J 
= 4.5 Hz, 1H), 2.74 (dd, J = 14.7, 3.4 Hz, 1H), 1.94 (dt, J = 14.7, 1.0 Hz, 1H), 1.43 (s, 3H), 
1.34 (s, 3H), 1.08 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 204.1, 78.1, 70.7, 57.1, 50.6, 32.9, 28.7, 28.4, 24.8. 
IR (v cm
-1
): 2981, 2973, 2951, 2929, 2870, 2810, 2687, 2361, 2342, 1806, 1721. 
HRMS: calc’d for [M+Na]+: 193.0835, found: 193.0822. 
[𝛼]𝐷
20 = +33.4 (c = 0.70, CHCl3). 
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2,2,4-Trimethyl-3,7-dioxabicyclo[4.1.0]heptane-4-carbaldehyde (rac-2.59) 
V2.103 
(ZY-485) 
Based on AVV9, to a solution of rac-2.38 (60 mg, 0.35 mmol) in 4 mL DCM was added 
Dess–Martin periodinane (178 mg, 0.42 mmol) at room temperature under argon. After being 
stirred for 1 h at room temperature, the reaction mixture was quenched with sat. aq. NaHCO3 
and extracted three times with DCM. The organic layer was washed with brine, dried with 
MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (10:1) to give rac-2.59 (42 mg, 0.25 mmol, 71%) as 
light yellow oil. 
Spectroscopic data of rac-2.59: see experiment V 2.102. 
 
6-(Hydroxymethyl)-2,2,6-trimethyltetrahydro-2H-pyran-3,4-diol (rac-2.39) 
V2.104 
(ZY-324) 
To a solution of rac-2.42 (87 mg, 0.27 mmol) in 5 mL MeOH/DCM (3:2) was added PdCl2 
(58 mg, 0.33 mmol) at room temperature. After being stirred for 40 min at room temperature, 
the mixture was filtered through celite and saturated aqueous NaCl was added. The aqueous 
phase was extracted four times with DCM. The organic layer was washed with brine, dried 
with MgSO4, and concentrated under vacuum. The residue was dissolved in MeOH (5 mL) 
and Pd/C (30 mg) was added. The suspension was stirred for 2 h under hydrogen atmosphere 
at room temperature. The mixture was filtered through celite and the solvent was removed in 
vacuo. The residue was purified by column chromatography using DCM-MeOH (20:1) to 
give rac-2.39 (30 mg, 157.8 umol, 58%) as colorless viscous oil. 
1
H NMR (400 MHz, (CD3)2CO): δ = 3.98-3.97 (m, 1H), 3.82-3.75 (m, 1H), 3.73-3.71 (m, 
1H), 3.52-3.45 (m, 2H), 3.37 (dd, J = 7.2, 4.4 Hz, 1H), 3.13-3.10 (m, 1H), 2.13 (dd, J = 13.2, 
4.8 Hz, 1H), 1.37-1.29 (m, 1H), 1.21 (s, 3H), 1.19 (s, 3H), 1.13 (s, 3H). 
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13
C NMR (100 MHz, (CD3)2CO): δ = 80.9/80.9/80.8/80.8, 76.9/76.0, 68.0/67.9, 67.1/67.0, 
41.4/41.3, 31.2, 28.7, 23.6/23.6. 
HRMS: calc’d for [M+Na]+: 213.1097, found: 213.1094. 
 
V2.105 
(ZY-253) 
To a solution of rac-2.38 (4 mg, 23.2 umol) in 1.5 mL H2O concentrated acetic acid (0.5 mL) 
was added. After being stirred overnight at room temperature, another concentrated acetic 
acid (1.0 mL) was added. After being stirred 10 h at room temperature, another concentrated 
acetic acid (4.5 mL) was added again. It was continued to stir 4 days and monitored by thin 
layer chromatography. A low conversion was observed, however starting materials was 
complete decomposition and the reaction was terminated. 
 
V2.106 
(ZY-263) 
To a solution of rac-2.38 (20 mg, 116 umol) in 7 mL H2O concentrated acetic acid (28 mL) 
was added. After being stirred 22 h at room temperature, another concentrated acetic acid (7 
mL) was added. It was continued to stir 74 and monitored by thin layer chromatography. A 
low conversion was observed, however starting materials was complete decomposition and 
the reaction was terminated. 
 
V2.107 
(ZY-257) 
To a solution of rac-2.38 (2.5 mg, 14.5 umol) in 0.1 mL H2O and 2 mL THF three drops 
HClO4 (60% in water) was added. After being stirred 23 h at room temperature, another three 
drops HClO4 (60% in water) was added. After being stirred 46 h at room temperature, 
another four drops HClO4 (60% in water) was added again. It was continued to stir 2.5 h and 
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monitored by thin layer chromatography. A low conversion was observed, however starting 
materials was complete decomposition and the reaction was terminated. 
 
V2.108 
(ZY-258) 
To a solution of rac-2.38 (2.5 mg, 14.5 umol) in 1 mL acetone H2SO4 (0.5 mL, 1M in water) 
was added. After being stirred 23 h at room temperature, another H2SO4 (0.5 mL, 1M in 
water) was added. After being stirred 46 h at room temperature, another H2SO4 (0.5 mL, 1M 
in water) was added again. It was continued to stir 2.5 h and monitored by thin layer 
chromatography. A low conversion was observed, however starting materials was complete 
decomposition and the reaction was terminated. 
 
V2.109 
(ZY-266) 
To a solution of rac-2.38 (3 mg, 17.4 umol) NaOH (0.5 mL, 10% in water) was added at 
room temperature. It was stirred 48 h and monitored by thin layer chromatography. A low 
conversion was observed, however starting materials was complete decomposition and the 
reaction was terminated. 
 
V2.110 
(ZY-267) 
To a solution of rac-2.38 (3 mg, 17.4 umol) in 0.5 ml acetone NaOH (0.5 mL, 10% in water) 
was added at room temperature. It was stirred 48 h and monitored by thin layer 
chromatography. A low conversion was observed, however starting materials was complete 
decomposition and the reaction was terminated. 
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V2.111 
(ZY-268) 
To a solution of rac-2.38 (3 mg, 17.4 umol) H2SO4 (0.5 mL, 2M in water) was added. It was 
stirred 48 h and monitored by thin layer chromatography. A low conversion was observed, 
however starting materials was complete decomposition and the reaction was terminated. 
 
V2.112 
(ZY-269) 
To a solution of rac-2.38 (3 mg, 17.4 umol) in 0.5 mL acetone H2SO4 (0.5 mL, 2M in water) 
was added. It was stirred 48 h and monitored by thin layer chromatography. A low 
conversion was observed, however starting materials was complete decomposition and the 
reaction was terminated. 
 
V2.113 
(ZY-280) 
To a solution of rac-2.38 (2 mg, 11.6 umol) in 1 mL THF H2SO4 (0.2 mL, 2M in water) was 
added at room temperature. It was stirred 24 h at 65 
o
C and monitored by thin layer 
chromatography. A low conversion was observed, however starting materials was complete 
decomposition and the reaction was terminated. 
 
V2.114 
(ZY-282) 
To a solution of rac-2.38 (14 mg, 81.3 umol) in 1 mL THF H2SO4 (0.2 mL, 2M in water) was 
added at room temperature. It was stirred 19 h at 65 
o
C and monitored by thin layer 
chromatography. A low conversion was observed, however starting materials was complete 
decomposition and the reaction was terminated. 
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V2.115 
(ZY-281) 
To a solution of rac-2.38 (2 mg, 11.6 umol) in 1 mL THF and 0.1 mL H2O HClO4 (0.1 mL, 
60% in water) was added at room temperature. It was stirred 48 h at 65 
o
C and monitored by 
thin layer chromatography. A low conversion was observed, however starting materials was 
complete decomposition and the reaction was terminated. 
 
V2.116 
(ZY-285) 
To a solution of rac-2.38 (6 mg, 34.9 umol) in 1 mL THF and 0.1 mL H2O HClO4 (0.1 mL, 
60% in water) was added at room temperature. It was stirred 46 h at 65 
o
C and monitored by 
thin layer chromatography. A low conversion was observed, however starting materials was 
complete decomposition and the reaction was terminated. 
 
6-(((tert-Butyldimethylsilyl)oxy)methyl)-2,2,6-trimethyltetrahydro-2H-pyran-3,4-diol 
(rac-2.40) 
V2.117 
(ZY-270) 
To a solution of rac-2.36 (2 mg, 6.6 umol) NaOH (0.5 mL, 10% in water) was added at room 
temperature. It was stirred 48 h and monitored by thin layer chromatography. A low 
conversion was observed, however starting materials was complete decomposition and the 
reaction was terminated. 
 
V2.118 
(ZY-271) 
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To a solution of rac-2.36 (2 mg, 6.6 umol) in 0.5 mL acetone NaOH (0.5 mL, 10% in water) 
was added at room temperature. It was stirred 48 h and monitored by thin layer 
chromatography. A low conversion was observed, however starting materials was complete 
decomposition and the reaction was terminated. 
 
V2.119 
(ZY-272) 
To a solution of rac-2.36 (2 mg, 6.6 umol) H2SO4 (0.5 mL, 2M in water) was added at room 
temperature. It was stirred 2 h and monitored by thin layer chromatography. A low 
conversion was observed, however starting materials was complete decomposition and the 
reaction was terminated. 
 
V2.120 
(ZY-273) 
To a solution of rac-2.36 (2 mg, 6.6 umol) in 0.5 mL acetone H2SO4 (0.5 mL, 2M in water) 
was added at room temperature. It was stirred 2 h and monitored by thin layer 
chromatography. A low conversion was observed, however starting materials was complete 
decomposition and the reaction was terminated. 
 
V2.121 
(ZY-283) 
To a solution of rac-2.36 (2 mg, 6.6 umol) in 1mL THF H2SO4 (0.2 mL, 2M in water) was 
added at room temperature. It was stirred 48 h at 65 
o
C and monitored by thin layer 
chromatography. A low conversion was observed, however starting materials was complete 
decomposition and the reaction was terminated. 
 
 
 Chapter 2. The total synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin 
115 
 
 
V2.122 
(ZY-284) 
To a solution of rac-2.36 (2 mg, 6.6 umol) in 1 mL THF and 0.1 mL H2O HClO4 (0.1 mL, 60% 
in water) was added at room temperature. It was stirred 48 h at 65 
o
C and monitored by thin 
layer chromatography. A low conversion was observed, however starting materials was 
complete decomposition and the reaction was terminated. 
 
(2S,4S,5S)-4-((Benzyloxy)methyl)-2,2,4-trimethyl-3,7-dioxabicyclo[4.1.0]heptane 
((2S,4S,5S)-2.41) 
V2.123 
(ZY-635) 
Based on AVV10, to a solution of (2S,4S,5S)-2.38 (320 mg, 1.86 mmol) in 20 mL THF/DMF 
(3:1) was added NaH (165 mg, 4.09 mmol) was added and stirred for 30 min at 0 
o
C. BnBr 
(0.47 mL, 3.91 mmol) was added dropwise to the solution. After being stirred for 6 h at room 
temperature, the reaction mixture was quenched with water carefully and the aqueous phase 
was extracted five times with ethyl acetate. The organic layers were dried with MgSO4, the 
solvent was removed. Toluene (3 x 60 mL) was added and removed in vacuum to remove 
traces of DMF. The residue was purified by column chromatography using pentane-Et2O 
(10:1) to give (2S,4S,5S)-2.41 (439 mg, 1.67 mmol, 90%, dr = 4.5:1.0) as light yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.34-7.26 (m, 5H), 4.57-4.51 (m, 2H), 3.41-3.35/3.25-3.20 
(m, 2H), 3.39-3.37 (m, 1H), 2.95 (d, J = 4.4 Hz, 1H), 2.07 (dd, J = 15.3, 2.0 Hz, 1H), 1.77 
(dd, J = 15.3, 3.5 Hz, 1H), 1.35 (d, J = 5.1 Hz, 3H), 1.31 (s, 3H), 1.22 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 138.9/138.7, 128.5, 128.4/128.4, 127.7/127.7, 127.6/127.6, 
127.6/127.5, 78.7/78.5, 73.5/73.4, 72.5/72.1, 70.0/69.9, 56.4/56.0, 51.4/50.9, 30.5/30.3, 
28.8/28.7, 28.0/27.7, 27.6/26.4. 
IR (v cm
-1
): 3029, 2975, 2929, 2861, 2360, 2116, 1952, 1812, 1737, 1605, 1497, 1454. 
HRMS: calc’d for [M+Na]+: 285.1461, found: 285.1471. 
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4-((Benzyloxy)methyl)-2,2,4-trimethyl-3,7-dioxabicyclo[4.1.0]heptane (rac-2.41) 
V2.124 
(ZY-477) 
Based on AVV10, to a solution of rac-2.38 (240 mg, 1.39 mmol) in 16 mL THF/DMF (3:1) 
was added NaH (122.4 mg, 3.06 mmol) was added and stirred for 30 min at 0 
o
C. BnBr (355 
uL, 2.92 mmol) was added dropwise to the solution. After being stirred for 4 h at room 
temperature, the reaction mixture was quenched with water carefully and the aqueous phase 
was extracted five times with ethyl acetate. The organic layers were dried with MgSO4, the 
solvent was removed. Toluene (3 x 10 mL) was added and removed in vacuum to remove 
traces of DMF. The residue was purified by column chromatography using pentane-Et2O 
(10:1) to give rac-2.41 (300 mg, 1.14 mmol, 82%) as light yellow oil. 
Spectroscopic data of rac-2.41: see experiment V 2.123. 
 
V2.125 
(ZY-439) 
Based on AVV10, to a solution of rac-2.38 (160 mg, 0.93 mmol) in 16 mL THF/DMF (1:1) 
was added NaH (81.6 mg, 2.04 mmol) was added and stirred for 30 min at 0 
o
C. BnBr (237 
uL, 1.95 mmol) was added dropwise to the solution. After being stirred for 23.5 h at room 
temperature, the reaction mixture was quenched with water carefully and the aqueous phase 
was extracted five times with ethyl acetate. The organic layers were dried with MgSO4, the 
solvent was removed. Toluene (3 x 10 mL) was added and removed in vacuum to remove 
traces of DMF. The residue was purified by column chromatography using pentane-Et2O 
(10:1) to give rac-2.41 (163 mg, 0.62 mmol, 67%) as light yellow oil. 
 
V2.126 
(ZY-311) 
Based on AVV10, to a solution of rac-2.38 (20 mg, 116 umol) in 2 mL THF/DMF (1:1) was 
added NaH (10.6 mg, 264 umol) was added and stirred for 30 min at 0 
o
C. BnBr (30 uL, 252 
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umol) and TBAI (2.2 mg, 6 umol) were added to the solution. After being stirred for 47.5 h at 
room temperature, the reaction mixture was quenched with water carefully and the aqueous 
phase was extracted five times with ethyl acetate. The organic layers were dried with MgSO4, 
the solvent was removed. Toluene (3 x 10 mL) was added and removed in vacuum to remove 
traces of DMF. The residue was purified by column chromatography using pentane-Et2O 
(10:1) to give rac-2.41 (19.8 mg, 75.5 umol, 65%) as light yellow oil. 
 
V2.127 
(ZY-308) 
Based on AVV10, to a solution of rac-2.38 (4 mg, 23.2 umol) in 1 mL DMF was added NaH 
(2.1 mg, 51 umol) was added and stirred for 30 min at 0 
o
C. BnBr (6 uL, 48.7 umol) was 
added dropwise to the solution. After being stirred for 22 h at room temperature, there is no 
any product and the reaction mixture was quenched with water carefully. 
 
V2.128 
(ZY-295) 
Based on AVV10, to a solution of rac-2.38 (10 mg, 0.06 mmol) in 2 mL THF was added 
NaH (4.8 mg, 0.12 mmol) was added and stirred for 25 min at 0 
o
C and 30 min at room 
temperature. BnBr (14 uL, 0.12 mmol) and some TBAI were added dropwise to the solution. 
After being stirred for 1h at room temperature, 2 mL DMF was added. It was continued to stir 
about three days, the product was still very weak. 
 
(2S,4R,5S)-4-(Allyloxy)-6-((benzyloxy)methyl)-2,2,6-trimethyltetrahydro-2H-pyran-3-ol 
((2S,4R,5S)-2.42) 
V2.129 
(ZY-636) 
To a solution of (2S,4S,5S)-2.41 (400 mg, 1.53 mmol) in 20 mL allyl alcohol was added 
HClO4 (70% in water, 0.46 mL, 7.65 mmol) was added slowly at 0 °C. The reaction mixture 
Chapter 2. The total synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin 
 
118 
 
was stirred at 0 °C for 2 h, then at room temperature for 5 h. The solution was diluted with 
DCM and sat. aq. NaHCO3 was added. The aqueous solution was extracted five times with 
DCM. The organic layer was washed with brine, dried with MgSO4, and concentrated under 
vacuum. The residue was purified by column chromatography using pentane-Et2O (10:1) to 
give (2S,4R,5S)-2.42 (353 mg, 1.10 mmol, 72%) as yellow oil.  
1
H NMR (400 MHz, CDCl3): δ = 7.36-7.28 (m, 5H), 5.91 (ddd, J = 22.8, 10.5, 5.7 Hz, 1H), 
5.28-5.17 (m, 2H), 4.59-4.47 (m, 2H), 4.10 (dd, J = 12.6, 5.5 Hz, 1H), 3.92 (dd, J = 12.6, 5.8 
Hz, 1H), 3.52 (ddd, J = 11.1, 9.0, 4.8 Hz, 1H), 3.47 (d, J = 9.1 Hz, 1H), 3.31 (d, J = 4.9 Hz, 
1H), 3.30 (d, J = 4.8 Hz, 1H), 2.51 (brs, 1H), 2.30 (dd, J = 13.1, 4.8 Hz, 1H), 1.35-1.33 (m, 
1H), 1.31 (s, 3H), 1.26 (s, 3H), 1.20 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 138.3, 135.0, 128.5, 127.8, 117.2, 78.2, 76.2, 75.7, 75.0, 
74.8, 73.5, 69.9, 37.3, 30.6, 29.2, 23.4. 
IR (v cm
-1
): 3472, 2976, 2930, 2863, 2362, 1873, 1647, 1605, 1587, 1496, 1454. 
HRMS: calc’d for [M+Na]+: 343.1880, found: 343.1900. 
[𝛼]𝐷
20 = -37.8 (c = 2.05, CHCl3). 
 
4-(Allyloxy)-6-((benzyloxy)methyl)-2,2,6-trimethyltetrahydro-2H-pyran-3-ol(rac-2.42) 
 
V2.130 
(ZY-604) 
To a solution of rac-2.41 (490 mg, 1.87 mmol) in 27 mL allyl alcohol was added HClO4 (70% 
in water, 556 uL, 9.35 mmol) was added slowly at 0 °C. The reaction mixture was stirred at 
0 °C for 2 h, then at room temperature for 4 h. The solution was diluted with DCM and sat. 
aq. NaHCO3 was added. The aqueous solution was extracted five times with DCM. The 
organic layer was washed with brine, dried with MgSO4, and concentrated under vacuum. 
The residue was purified by column chromatography using pentane-Et2O (10 : 1) to give rac-
2.42 (419 mg, 1.31 mmol, 70%) as yellow oil. 
 Chapter 2. The total synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin 
119 
 
Spectroscopic data of rac-2.42: see experiment V 2.129. 
 
(2S,4R,5S)-4-(Allyloxy)-6-((benzyloxy)methyl)-2,2,6-trimethyltetrahydro-2H-pyran-3-yl 
3,5-dinitrobenzoate ((2S,4R,5S)-2.70) 
 
V2.131 
(ZY-642) 
To a solution of (2S,4R,5S)-2.42 (8.0 mg, 25 umol) in pyridine (1.6 mL) 3,5-dinitrobenzoyl 
chloride (28.8 mg, 125 umol) was added at room temperature. The yellow solution was 
stirred for 1 h. sat. aq. NH4Cl (15 mL) was added and the aqueous layer was extracted with 
DCM (4 x 10 mL). The combined organic layers were dried with Na2SO4 and the solvent was 
removed in vacuo. The residue was purified by column chromatography using pentane-Et2O 
(20:1) to give (2S,4R,5S)-2.70 (12.7 mg, 24.7 umol, 99%) as white solid.  
1
H NMR (400 MHz, CDCl3): δ = 9.24 (t, J = 2.1 Hz, 1H), 9.12 (d, J = 2.1 Hz, 2H), 7.36-7.34 
(m, 4H), 7.32-7.29 (m, 1H), 5.75-5.68 (m, 1H), 5.14-5.10 (m, 2H), 5.06-5.04 (m, 1H), 4.63-
4.55 (m, 2H), 4.07-4.04 (m, 1H), 3.91-3.84 (m, 2H), 3.50 (d, J = 9.3 Hz, 1H), 3.39 (d, J = 9.3 
Hz, 1H), 2.40 (dd, J = 13.6, 4.9 Hz, 1H), 1.61 (dd, J = 13.6, 10.3 Hz, 1H), 1.35 (s, 3H), 1.34 
(s, 3H), 1.32 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ = 162.1, 148.9, 138.2, 134.6, 134.1, 129.5, 128.6, 127.9, 
127.8, 122.6, 117.0, 80.3, 76.2, 75.0, 74.9, 73.6, 72.6, 69.9, 37.1, 30.3, 28.6, 24.8. 
HRMS: calc’d for [M+H]+: 515.2024, found: 515.2026; calc’d for [M+Na]+: 537.1844, found: 
537.1841. 
[𝛼]𝐷
20 = -19.3 (c = 1.13, CHCl3). 
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4-(Allyloxy)-6-((benzyloxy)methyl)-2,2,6-trimethyltetrahydro-2H-pyran-3-yl 3,5-
dinitrobenzoate (rac-2.70) 
V2.132 
(ZY-507) 
To a solution of rac-2.42 (20 mg, 62.5 umol) in pyridine (4 mL) 3, 5 -dinitrobenzoyl chloride 
(72 mg, 312.5 umol) was added at room temperature. The yellow solution was stirred for 1 h. 
Sat.  aq. NH4Cl (15 mL) was added and the aqueous layer was extracted with CH2Cl2 (4 x 10 
mL). The combined organic layers were dried with Na2SO4 and the solvent was removed in 
vacuo. The residue was purified by column chromatography using pentane-Et2O (20:1) to 
give rac-2.70 (29 mg, 56.4 umol, 90%) as white solid.  
Spectroscopic data of rac-2.70: see experiment V 2.131. 
 
4-(Allyloxy)-6-((benzyloxy)methyl)-2,2,6-trimethyltetrahydro-2H-pyran-3-yl 4-
bromobenzoate (rac-2.72) 
V2.133 
(ZY-538) 
To a solution of rac-2.42 (10 mg, 31.2 umol) in pyridine (2 mL) 4-bromobenzoyl chloride 
(34 mg, 156 umol) was added at room temperature. The yellow solution was stirred for 23.5 h. 
Sat. aq. NH4Cl (15 mL) was added and the aqueous layer was extracted with DCM (4 x 10 
mL). The combined organic layers were dried with Na2SO4 and the solvent was removed in 
vacuum. The residue was purified by column chromatography using pentane-Et2O (20:1) to 
give rac-2.72 (13 mg, 25.9 umol, 83%) as light yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.87 (d, J = 8.5 Hz, 2H), 7.55 (d, J = 8.5 Hz, 2H), 7.35 (d, J 
= 4.3 Hz, 4H), 7.30 (dt, J = 8.7, 4.0 Hz, 1H), 5.74 (ddd, J = 22.6, 10.6, 5.4 Hz, 1H), 5.16-5.12 
(m, 1H), 5.07-5.03 (m, 2H), 4.62-4.55 (m, 2H), 4.03 (dd, J = 13.1, 5.3 Hz, 1H), 3.91 (dd, J = 
12.4, 4.8 Hz, 1H), 3.81-3.76 (m, 1H), 3.42 (dd, J = 49.5, 9.4 Hz, 2H), 2.31 (dd, J = 13.7, 4.8 
Hz, 1H), 1.64 -1.59 (m, 1H), 1.34 (s, 3H), 1.31 (s, 3H), 1.29 (s, 3H). 
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13
C NMR (100 MHz, CDCl3): δ = 165.2, 138.5, 134.9, 131.9, 131.3, 129.2, 128.5, 128.3, 
127.8, 127.8, 116.7, 77.6, 76.6, 75.0, 74.7, 73.6, 72.9, 70.3, 36.5, 29.9, 28.2, 25.2. 
HRMS: calc’d for [M+H]+: 503.1428, found: 503.1432; calc’d for [M+Na]+: 525.1247, found: 
525.1249; calc’d for [M+K]+: 541.0987, found: 541.0990. 
 
4-(Allyloxy)-6-((benzyloxy)methyl)-2,2,6-trimethyltetrahydro-2H-pyran-3-yl 4-
iodobenzoate (rac-2.74) 
V2.134 
(ZY-547) 
To a solution of rac-2.42 (10 mg, 31.2 umol) in pyridine (2 mL) 4-iodobenzoyl chloride (41.5 
mg, 156 umol) was added at room temperature. After being stirred for 11 h, DMAP (7.6 mg, 
62.4 umol) was added. It was continued to stir for 60 h and monitored by thin layer 
chromatography. No conversion was observed and the reaction was terminated. 
 
Ferrocenecarboxylic ester (rac-2.76) 
V2.135 
(ZY-628) 
To a solution of rac-2.42 (10 mg, 31.2 mmol) in 1 mL DCM was added ferrocenecarboxylic 
acid 2.75 (71.8 mg, 312 umol), DCC (64.4 mg, 312 umol) and DMAP (38.1 mg, 312 umol) at 
room temperature. After being stirred for 48 hours at room temperature, the resulting slurry 
was filtered through celite and concentrated under reduced pressure. The residue was 
dissolved in ether and filtered through celite again and the filtrate concentrated under reduced 
pressure. The residue was purified by column chromatography using pentane-Et2O (10:1) to 
give rac-2.76 (10 mg, 18.8 umol, 60%) as yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.37 (d, J = 4.3 Hz, 4H), 7.31 (dt, J = 8.6, 4.1 Hz, 1H), 5.86 
(ddt, J = 15.8, 10.5, 5.3 Hz, 1H), 5.24 (d, J = 17.2 Hz, 1H), 5.12 (d, J = 10.3 Hz, 1H), 4.96 (d, 
J = 7.5 Hz, 1H), 4.80 (s, 2H), 4.60 (s, 2H), 4.40 (s, 2H), 4.23 (s, 5H), 4.10-4.00 (m, 2H), 3.76 
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(td, J = 8.5, 4.9 Hz, 1H), 3.58-3.35 (m, 2H), 2.33-2.27 (m, 1H), 1.60 (dd, J = 13.7, 8.9 Hz, 
1H), 1.36 (d, J = 7.6 Hz, 6H), 1.29 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 171.1, 138.6, 135.0, 128.5, 127.7, 127.7, 116.8, 75.8, 74.8, 
74.4, 73.6, 72.8, 71.7, 70.5, 70.4, 70.0, 35.8, 30.4, 29.9, 28.0, 25.7. 
HRMS: calc’d for [M+H]+: 533.1985, found: 533.1981; calc’d for [M+Na]+: 555.1804, found: 
555.1809. 
 
(2S,4R,5S)-6-((Benzyloxy)methyl)-2,2,6-trimethyltetrahydro-2H-pyran-3,4-diol 
((2S,4R,5S)-2.50) 
V2.136 
(ZY-641) 
To a solution of (2S,4R,5S)-2.42 (300 mg, 0.94 mmol) in 30 mL MeOH/DCM (1:1) was 
added PdCl2 (16.5 mg, 0.09 mmol) at room temperature. After being stirred for 2 hours at 
room temperature, the mixture was filtered through celite and saturated aqueous NaCl was 
added. The aqueous phase was extracted four times with DCM. The organic layer was 
washed with brine, dried with MgSO4, and concentrated under vacuum. The residue was 
purified by column chromatography using pentane-Et2O (1:1) to give (2S,4R,5S)-2.50 (189 
mg, 0.67 mmol, 72%) as colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.36-7.27 (m, 5H), 4.56 (d, J = 12.2 Hz, 1H), 4.50 (d, J = 
12.2 Hz, 1H), 3.80 (ddd, J = 11.6, 9.4, 4.9 Hz, 1H), 3.44 (d, J = 9.2 Hz, 1H), 3.36 (d, J = 9.2 
Hz, 1H), 3.20 (d, J = 9.4 Hz, 1H), 2.27 (brs, 2H), 2.19 (dd, J = 13.1, 4.8 Hz, 1H), 1.42 (dd, J 
= 13.0, 11.8 Hz, 1H), 1.29 (s, 3H), 1.26 (s, 3H), 1.19 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 138.2, 128.5, 127.9, 127.8, 80.5, 76.3, 75.3, 74.8, 73.6, 
67.3, 41.0, 30.7, 29.1, 22.9. 
IR (v cm
-1
): 3375, 2976, 2933, 2864, 2352, 1605, 1587, 1496, 1454. 
HRMS: calc’d for [M+H]+: 281.1747, found: 281.1753. 
[𝛼]𝐷
20 = -17.4 (c = 1.05, CHCl3). 
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6-((Benzyloxy)methyl)-2,2,6-trimethyltetrahydro-2H-pyran-3,4-diol (rac-2.50) 
V2.137 
(ZY-605) 
To a solution of rac-2.42 (320 mg, 1.0 mmol) in 32 mL MeOH/DCM (1:1) was added PdCl2 
(17.7 mg, 0.1 mmol) at room temperature. After being stirred for 2 hours at room temperature, 
The mixture was filtered through celite and saturated aqueous NaCl was added. The aqueous 
phase was extracted four times with DCM. The organic layer was washed with brine, dried 
with MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (1:1) to give rac-2.50 (200 mg, 0.71 mmol, 71%) as 
colorless oil. 
Spectroscopic data of rac-2.50: see experiment V 2.136 
 
V2.138 
(ZY-460) 
To a solution of rac-2.42 (100 mg, 0.31 mmol) in 5 mL MeOH/DCM (3:2) was added PdCl2 
(5.5 mg, 31 umol) at room temperature. After being stirred for 2 hours at room temperature, 
The mixture was filtered through celite and saturated aqueous NaCl was added. The aqueous 
phase was extracted four times with DCM. The organic layer was washed with brine, dried 
with MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (1:1) to give rac-2.50 (53 mg, 189 umol, 61%) as 
colorless oil. 
 
V2.139 
(ZY-443) 
To a solution of rac-2.42 (32 mg, 0.1 mmol) in 2 mL MeOH/DCM (3:2) was added PdCl2 
(21 mg, 0.12 mmol) at room temperature. After being stirred for 20 min at room temperature, 
the mixture was filtered through celite and saturated aqueous NaCl was added. The aqueous 
phase was extracted four times with DCM. The organic layer was washed with brine, dried 
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with MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (1:1) to give rac-2.50 (10.9 mg, 39 umol, 39%) as 
colorless oil. 
 
V2.140 
(ZY-444) 
To a solution of rac-2.42 (150 mg, 0.47 mmol) in 10 mL MeOH/DCM (3:2) was added PdCl2 
(83 mg, 0.47 mmol) at 0 
o
C. After being stirred for 10 min at 0 
o
C and 25 min at room 
temperature, the mixture was filtered through celite and saturated aqueous NaCl was added. 
The aqueous phase was extracted four times with DCM. The organic layer was washed with 
brine, dried with MgSO4, and concentrated under vacuum. The residue was purified by 
column chromatography using pentane-Et2O (1:1) to give rac-2.50 (51.1 mg, 182 umol, 39%) 
as colorless oil. 
 
V2.141 
(ZY-481) 
To a solution of rac-2.42 (20 mg, 62.5 umol) in 1.5 mL MeOH/DCM (1:2) was added PdCl2 
(1.1 mg, 6.25 umol) at room temperature. After being stirred for 40 min at room temperature, 
the mixture was filtered through celite and saturated aqueous NaCl was added. The aqueous 
phase was extracted four times with DCM. The organic layer was washed with brine, dried 
with MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (1:1) to give rac-2.50 (10 mg, 35.7 umol, 57%) as 
colorless oil. 
 
V2.142 
(ZY-482) 
To a solution of rac-2.42 (23 mg, 71.8 umol) in 2.0 mL MeOH was added PdCl2 (1.1 mg, 
6.25 umol) at room temperature. After being stirred for 15 min at room temperature, 1.0 mL 
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DCM was added. After being stirred for another 20 min, PdCl2 (1.1 mg, 6.25 umol) was 
added. After being stirred for another 25 min, 1.0 mL DCM was added again. The mixture 
was filtered through celite and saturated aqueous NaCl was added. The aqueous phase was 
extracted four times with DCM. The organic layer was washed with brine, dried with MgSO4, 
and concentrated under vacuum. The residue was purified by column chromatography using 
pentane-Et2O (1:1) to give rac-2.50 (18 mg, 64.2 umol, 89%) as colorless oil. 
 
(2S,4R,5S)-6-((Benzyloxy)methyl)-2,2,6-trimethyltetrahydro-2H-pyran-3,4-diyl bis(3,5-
dinitrobenzoate) ((2S,4R,5S)-2.77) 
 
V2.143 
(ZY-643) 
 
To a solution of (2S,4R,5S)-2.50 (10 mg, 35.7 umol) in pyridine (2.3 mL) 3,5-dinitrobenzoyl 
chloride (123.3 mg, 535.5 umol) was added at room temperature. The yellow solution was 
stirred for 1 h. sat. aq. NH4Cl (15 mL) was added and the aqueous layer was extracted with 
DCM (4 x 10 mL). The combined organic layers were dried with Na2SO4 and the solvent was 
removed in vacuo. The residue was purified by column chromatography using pentane-Et2O 
(20:1) to give (2S,4R,5S)-2.77 (23.6 mg, 35.3 umol, 99%) as colorless viscous oil.  
1
H NMR (400 MHz, CDCl3): δ = 9.20-9.19 (m, 1H), 9.17 (t, J = 2.1 Hz, 1H), 9.07 (d, J = 2.1 
Hz, 2H), 9.03 (d, J = 2.1 Hz, 2H), 7.41-7.37 (m, 4H), 7.31 (t, J = 7.1 Hz, 1H), 5.78 (ddd, J = 
11.0, 9.6, 5.3 Hz, 1H), 5.42 (d, J = 9.5 Hz, 1H), 4.64 (s, 2H), 3.63 (d, J = 9.6 Hz, 1H), 3.52 (d, 
J = 9.0 Hz, 1H), 2.65 (dd, J = 13.3, 5.3 Hz, 1H), 1.95 (dd, J = 13.2, 11.1 Hz, 1H), 1.39 (s, 3H), 
1.36 (s, 3H), 1.26 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 162.3, 162.0, 148.9, 148.9, 137.9, 133.3, 133.0, 130.0, 
129.5, 129.5, 128.6, 128.0, 127.8, 123.0, 122.8, 79.5, 75.8, 75.3, 75.2, 73.7, 71.9, 38.0, 30.6, 
28.9, 24.0. 
HRMS: calc’d for [M+Na]+: 691.1494, found: 691.1467. 
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[𝛼]𝐷
20 = -34.1 (c = 1.23, CHCl3). 
 
(2Z,2'Z)-(2S,4R,5S)-6-((Benzyloxy)methyl)-2,2,6-trimethyltetrahydro-2H-pyran-3,4-diyl 
bis(2-methylbut-2-enoate) ((2S,4R,5S)-2.51) 
V2.144 
(ZY-634) 
To a solution of (2S,4R,5S)-2.50 (128 mg, 0.46 mmol) in 25 mL DCM was added angelic 
acid (184 mg, 1.84 mmol), DCC (380 mg, 1.84 mmol) and DMAP (112 mg, 0.92 mmol) at 
room temperature. After being stirred for 48 hours at 40 °C and then cooled to room 
temperature. The resulting slurry was filtered through celite and concentrated under reduced 
pressure. The residue was dissolved in ether and filtered through celite again and the filtrate 
concentrated under reduced pressure. The residue was purified by column chromatography 
using pentane-Et2O (10:1) to give (2S,4R,5S)-2.51 (161 mg, 0.36 mmol, 79%, Z/E = 4.7:1.0) 
as light yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.37-7.33 (m, 4H), 7.29-7.27 (m, 1H), 6.82-6.75 (m, 2 H), 
5.30-5.26 (m, 1H), 5.04 (dd, J = 9.7, 4.5 Hz, 1H), 4.61-4.55 (m, 2H), 3.50-3.45 (m, 2H), 
2.36-2.32 (m, 1H), 1.93-1.74 (m, 12H), 1.68-1.63 (m, 1H), 1.30 (t, J = 5.9 Hz, 6H), 1.24 (d, J 
= 3.8 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 167.5/167.3, 167.2/167.1, 138.4/138.2, 137.8/137.8, 137.7, 
128.4, 128.3, 127.7, 127.6, 76.3/76.2, 75.5/75.4, 75.3/75.2, 74.7/74.7, 73.5, 68.3/67.7, 
38.1/38.0, 30.2/30.2, 28.5/28.4, 23.9/23.8, 14.4, 12.1, 11.9. 
IR (v cm
-1
): 2980, 2930, 2857, 2364, 1711, 1651, 1519, 1497, 1453. 
HRMS: calc’d for [M+H]+: 445.2585, found: 445.2579; calc’d for [M+Na]+: 467.2404, found: 
467.2388. 
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(2Z,2'Z) -6-((Benzyloxy)methyl)-2,2,6-trimethyltetrahydro-2H-pyran-3,4-diyl bis(2-
methylbut-2-enoate) (rac-2.51)  
V2.145 
(ZY-631) 
To a solution of rac-2.50 (150 mg, 0.54 mmol) in 30 mL DCM was added angelic acid (216 
mg, 2.16 mmol), DCC (446 mg, 2.16 mmol) and DMAP (132 mg, 1.08 mmol) at room 
temperature. After being stirred for 48 hours at 40 °C and then cooled to room temperature. 
The resulting slurry was filtered through celite and concentrated under reduced pressure. The 
residue was dissolved in ether and filtered through celite again and the filtrate concentrated 
under reduced pressure. The residue was purified by column chromatography using pentane-
Et2O (10:1) to give rac-2.51 (171 mg, 0.38 mmol, 72%, Z/E = 4.0:1.0) as light yellow oil. 
Spectroscopic data of rac-2.51: see experiment V 2.144. 
 
(2Z,2'Z)-(2S,4R,5S)-6-(Hydroxymethyl)-2,2,6-trimethyltetrahydro-2H-pyran-3,4-diyl 
bis(2-methylbut-2-enoate) ((2S,4R,5S)-2.53) 
V2.146 
(ZY-648) 
To a solution of (2S,4R,5S)-2.51 (100 mg, 0.23 mmol) in 20 mL DCM/H2O (9:1) was added 
DDQ (204 mg, 0.9 mmol) at room temperature. After being stirred for 24 hours at 40 °C and 
then cooled to room temperature. Saturated aqueous NaHCO3 was added and the resulting 
dark red solution was stirred vigorously for 2 h. The layers were separated and the aqueous 
layer was extracted three times with DCM. The organic layer was washed with brine, dried 
with MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (4:1) to give (2S,4R,5S)-2.53 (15 mg, 42.3 umol, 19%, 
Z/E = 1:1) and (2S,4R,5S)-2.53 (40 mg, 113 umol, 50%) as colorless viscous oil.  
(2S,4R,5S)-2.53: 
1H NMR (400 MHz, CDCl3): δ = 6.84-6.76 (m, 2H), 5.21 (td, J = 8.8, 5.1 Hz, 1H), 5.05 (d, J 
= 8.5 Hz, 1H), 3.66 (d, J = 11.2 Hz, 1H), 3.39 (d, J = 11.2 Hz, 1H), 2.28 (dd, J = 13.9, 5.1 Hz, 
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1H), 1.99-1.92 (m, 1H), 1.80-1.75 (m, 11H), 1.69 (dd, J = 13.9, 9.0 Hz, 1H), 1.31 (d, J = 4.0 
Hz, 6H), 1.28 (s, 3H), 1.25 (s, 1H). 
13C NMR (100 MHz, CDCl3): δ = 167.5, 167.1, 138.3, 138.2, 128.3, 128.3, 75.2, 74.7, 74.7, 
68.5, 68.3, 36.0, 29.6, 27.4, 24.7, 14.6, 12.2, 12.1. 
IR (v cm
-1
):3431, 2987, 2929, 2858, 2809, 2360, 2325, 1704, 1653. 
HRMS: calc’d for [M+H]+: 355.2115, found: 355.2118; calc’d for [M+Na]+: 377.1935, found: 
377.1937. 
[𝛼]𝐷
20 = -41.1 (c = 0.65, CHCl3). 
 
(2Z,2'Z)-6-(Hydroxymethyl)-2,2,6-trimethyltetrahydro-2H-pyran-3,4-diyl bis(2-
methylbut-2-enoate) (rac-2.53) 
V2.147 
(ZY-637) 
To a solution of rac-2.51 (150 mg, 0.34 mmol) in 30 mL DCM/H2O (9:1) was added DDQ 
(309 mg, 1.36 mmol) at room temperature. After being stirred for 48 hours at 40 °C and then 
cooled to room temperature. Saturated aqueous NaHCO3 was added and the resulting dark 
red solution was stirred vigorously for 2 h. The layers were separated and the aqueous layer 
was extracted three times with DCM. The organic layer was washed with brine, dried with 
MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (4:1) to give rac-2.53 (96 mg, 0.27 mmol, 80%, Z/E = 
4:1) as colorless viscous oil.  
Spectroscopic data of rac-2.53: see experiment V 2.146. 
 
V2.148 
(ZY-464) 
To a solution of rac-2.51 (3.8 mg, 8.6 umol) in 2.2 mL DCM/H2O (10:1) was added DDQ 
(2.3 mg, 10.3 umol) at 0 °C. After being stirred for 1 h at 0 °C and 1 h at room temperature, 
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DDQ (2.3 mg, 10.3 umol) was added again. After being stirred for another 17.5 h at room 
temperature, sat. aq. NaHCO3 was added and the resulting dark red solution was stirred 
vigorously for 2 h. The layers were separated and the aqueous layer was extracted three times 
with DCM. The organic layer was washed with brine, dried with MgSO4, and concentrated 
under vacuum. The residue was purified by column chromatography using pentane-Et2O (4:1) 
to recover rac-2.51 (2.5 mg, 5.6 umol, 66%) as light yellow oil and give trace rac-2.53.  
 
V2.149 
(ZY-465) 
To a solution of rac-2.51 (10 mg, 22.5 umol) in 5 mL DCM was added BCl3 (33.8 umol, 33.8 
umol, 1 M in DCM) at -78 °C. The reaction mixture was stirred for 6.5 h while the 
temperature was slowly warmed from -80 °C to -50 °C. 1 mL MeOH was added stirred for 2 
h. The layers were separated and the aqueous layer was extracted three times with DCM. The 
organic layer was washed with brine, dried with MgSO4, and concentrated under vacuum. 
The residue was purified by column chromatography using pentane-Et2O (4:1) to give rac-
2.53 (5 mg, 14.1 umol, 63%, Z/E = 4:1) as colorless viscous oil. 
 
6-(Hydroxymethyl)-2,2,6-trimethyltetrahydro-2H-pyran-3,4-diyl bis(2-methylbutanoate) 
(rac-2.52) 
V2.150 
(ZY-459) 
To a solution of rac-2.51 (52 mg, 117 umol) in 15 mL MeOH was added Pd(OH)2 (15 mg, 
mmol) under hydrogen atmosphere at room temperature. After being stirred for 24 h at room 
temperature, Pd(OH)2 (10 mg, mmol) was added again. It was continued to stir 7 h under 
hydrogen atmosphere at room temperature. The mixture was filtered through celite and the 
solvent was removed in vacuum. The residue was purified by column chromatography using 
pentane-Et2O (4:1) to give rac-2.52 (27 mg, 75.4 umol, 64%) as colorless viscous oil. 
1
H NMR (400 MHz, CDCl3): δ = 5.14 (ddd, J = 14.8, 9.0, 5.7 Hz, 1H), 4.97 (d, J = 8.8 Hz, 
1H), 3.65 (dd, J = 11.2, 3.7 Hz, 1H), 3.38 (d, J = 11.2 Hz, 1H), 2.38-2.30 (m, 2H), 2.25-2.21 
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(m, 1H), 1.97 (s, 1H), 1.69-1.60 (m, 3H), 1.47-1.42 (m, 2H), 1.29 (s, 3H), 1.26 (s, 6H), 1.11 
(dt, J = 14.6, 7.2 Hz, 6H), 0.91-0.86 (m, 6H). 
13
C NMR (100 MHz, CDCl3): δ = 176.2/176.0/175.7/175.6/175.6, 75.2/75.2, 
74.7/74.7/74.7/74.6/74.5/74.4, 68.3/68.3/68.2, 67.9, 41.4/41.4/41.3/41.2/41.0, 
36.4/36.4/36.3/36.2, 29.8/29.8, 27.5/27.5/27.5, 26.9/26.8/26.7/26.6/26.5, 24.4/24.4, 
16.8/16.5/16.4, 11.7/11.8/11.7. 
HRMS: calc’d for [M+H]+: 359.2428, found: 359.2431; calc’d for [M+Na]+: 381.2248, found: 
381.2249. 
 
(2Z,2'Z)-(2S,4R,5S)-6-Formyl-2,2,6-trimethyltetrahydro-2H-pyran-3,4-diyl bis(2-
methylbut-2-enoate) ((2S,4R,5S)-2.54) 
V2.151 
(ZY-671) 
Based on AVV9, to a solution of (2S,4R,5S)-2.53 (38 mg, 107.3 umol) in 1.2 mL DCM was 
added Dess-Martin periodinane (54.3 mg, 128.8 mmol) at room temperature under argon. 
After being stirred for 1 h at room temperature, the reaction mixture was quenched with sat. 
aq. NaHCO3 and extracted three times with DCM. The organic layer was washed with brine, 
dried with MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (10:1) to give (2S,4R,5S)-2.54 (29 mg, 82.3 umol, 77%) 
as light yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 9.60 (d, J = 1.7 Hz, 1H), 6.78-6.71 (m, 2H), 5.14-5.08 (m, 
1H), 5.01 (d, J = 10.3 Hz, 1H), 2.82 (dd, J = 12.9, 5.2 Hz, 1H), 1.75-1.73 (m, 12H), 1.63-1.57 
(m, 1H), 1.25 (s, 3H), 1.21 (s, 3H), 1.20 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 203.1, 167.2, 138.3, 138.0, 128.3, 128.2, 79.2, 76.9, 75.7, 
67.1, 35.5, 28.9, 24.3, 22.2, 14.6, 12.2, 12.0. 
IR (v cm
-1
):2983, 2931, 2860, 2799, 1716, 1650. 
HRMS: calc’d for [M+H]+: 353.1959, found: 353.1965. calc’d for [M+Na]+: 375.1778, found: 
375.1781. 
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[𝛼]𝐷
20 = -2.2 (c = 0.58, CHCl3). 
 
(2Z,2'Z)-6-Formyl-2,2,6-trimethyltetrahydro-2H-pyran-3,4-diyl bis(2-methylbut-2-
enoate) (rac-2.54) 
V2.152 
(ZY-639) 
Based on AVV9, to a solution of rac-2.53 (80 mg, 0.23 mmol) in 2.4 mL DCM was added 
Dess–Martin periodinane (119 mg, 0.28 mmol) at room temperature under argon. After being 
stirred for 1 h at room temperature, the reaction mixture was quenched with sat. aq. NaHCO3 
and extracted three times with DCM. The organic layer was washed with brine, dried with 
MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (10:1) to give rac-2.54 (62 mg, 0.18 mmol, 78%) as 
light yellow oil. 
Spectroscopic data of rac-2.54: see experiment V 2.151. 
 
(E)-3-Methylpenta-2, 4-dien-1-ol ((E)-2.44) 
V2.153 
(ZY-207) 
To a solution of (E)-3-methylpent-2-en-4-yn-1-ol (E)-2.43 (800 mg, 8.3 mmol) in 25 ml of 
abs. Methanol, Lindlar catalyst (191 mg) was added. While the solution was stirred under a 
hydrogen atmosphere (H2 balloon. 1 atm.) at room temperature for 90 minutes, the reaction 
was monitored by gas chromatography (1 min 40 °C, then 5 °C/min to 280 °C, Rt (starting 
material) = 5.99 min, Rt (product) = 6.20 min). Followed by filtration through celite, 
evaporation of the solvent in vacuum (200 mbar minimal) and distillation (1.4 mbar, 43 °C) 
to give (E)-2.44 (550 mg, 68%) as colorless viscous oil. 
1
H NMR (400 MHz, CDCl3): δ = 6.39 (dd, J = 17.4, 10.7 Hz, 1H), 5.67 (t, J = 6.8 Hz, 1H), 
5.22 (d, J = 17.4 Hz, 1H), 5.06 (d, J = 10.7 Hz, 1H), 4.29 (d, J = 6.8 Hz, 2H), 1.79 (s, 3H). 
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13
C NMR (100 MHz, CDCl3): δ = 140.8, 136.6, 130.5, 113.3, 59.5, 12.0. 
The NMR data are consistent with the literature data.
[39]
 
 
(E)-2-((3-Methylpenta-2,4-dien-1-yl)thio)benzo[d]thiazole ((E)-2.45) 
V2.154 
(ZY-209) 
To a solution of (E)-2.44 (260 mg, 2.65 mmol) in 16 mL abs. THF, 2-mercaptobenzothiazole 
(665 mg, 3.98 mmol) and triphenylphosphine (1114 mg, 4.24 mmol) were added. After 
cooling to 0 °C, Diisopropylazodicarboxylate (DIAD) (840 uL, 3.98 mmol) dissolved in 5 
mL abs. THF was added dropwise. After being stirring 30 minutes at this temperature, the 
solvent was removed in vacuum and the crude product was purified by column 
chromatography using cyclohexane/ethyl acetate (30:1) to give (E)-2.45 (620 mg, 2.51 mmol, 
95%, E/Z = 95:5) as yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.88 (d, J = 8.1 Hz, 1H), 7.76 (d, J = 8.0 Hz, 1H), 7.44-7.40 
(m, 1H), 7.32-7.28 (m, 1H), 6.92-6.85 (m, 0.05H), 6.38 (dd, J = 17.4, 10.7 Hz, 0.95H), 5.73 (t, 
J = 8.0 Hz, 0.95H), 5.63 (t, J = 8.2 Hz, 0.05H), 5.23 (d, J = 17.4 Hz, 1H), 5.07 (d, J = 10.7 Hz, 
1H), 4.15 (d, J = 8.0 Hz, 2H), 1.89 (s, 3H). 
13
C NMR (101 MHz, CDCl3): δ = 166.6, 153.4, 140.5, 138.9, 135.5, 126.2, 125.2, 124.4, 
121.7, 121.1, 113.7, 31.9, 12.1. 
IR (v cm
-1
): 3060, 2962, 2923, 2857, 1678, 1640, 1606, 1591, 1560, 1456. 
HRMS: calc’d for [M+H]+: 248.0562, found: 248.0569. 
 
(E)-2-((3-Methylpenta-2,4-dien-1-yl)sulfonyl)benzo[d]thiazole ((E)-2.46) 
V2.155 
(ZY-621) 
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To a solution of (E)-2.45 (300 mg, 1.21 mmol) in 15 mL normal ethanol, ammonium 
molybdate tetrahydrate (300 mg, 0.24 mmol) in 5.2 ml hydrogen peroxide (35% in water) 
was added slowly. After being stirring 25 minutes at room temperature, the reaction mixture 
was quenched with sat. aq. NH4Cl and extracted with diethyl ether. The organic layer was 
washed with water, dried with Na2SO4, and concentrated under vacuum. The residue was 
purified by column chromatography using cyclohexane/ethyl acetate (30:1-10:1) to give (E)-
2.46 (240 mg, 0.86 mmol, 71%, E/Z = 83:17) as light yellow viscous oil. 
1
H NMR (400 MHz, CDCl3): δ = 8.24-8.21 (m, 1H), 8.02-7.98 (m, 1H), 7.66-7.57 (m, 2H), 
6.55 (dd, J = 17.5, 11.2 Hz, 0.17H), 6.35 (dd, J = 17.3, 10.9 Hz, 0.83H), 5.52 (t, J = 8.2 Hz, 
0.83H), 5.45 (t, J = 8.2 Hz, 0.17H), 5.25-5.19 (dd, J = 17.2, 5.4 Hz, 1H), 5.12-5.08 (m, 1H), 
4.38 (d, J = 8.1 Hz, 2H), 1.70 (s, 3H). 
13
C NMR (101 MHz, CDCl3): δ = 165.8, 152.8, 144.2, 139.7, 137.2, 128.1, 127.8, 125.6, 
122.5, 115.6, 114.8, 55.0, 12.4. 
IR (v cm
-1
): 3065, 2926, 2858, 2361, 2342, 2292, 2251,1684, 1607, 1554, 1471, 1459. 
HRMS: calc’d for [M+H]+: 280.0461, found: 280.0462. 
 
(2Z,2'Z)-(2S,4R,5S)-2,2,6-Trimethyl-6-((1E,3E)-4-methylhexa-1,3,5-trien-1-
yl)tetrahydro-2H-pyran-3,4-diyl bis(2-methylbut-2-enoate) (2.2) 
V2.156 
(ZY-647) 
To a solution of (E)-2.46 (44.5 mg, 159.5 umol) in 1.2 ml dry THF was added Sodium 
bis(trimethylsilyl)amide NaHMDS (1 M in THF, 164.5 umol, 164.5 uL) at -80 
o
C. After 
being stirred for 30 minutes from -80 
o
C to -65 
o
C, A solution of (2S,4R,5S)-2.54 (29 mg, 
82.3 umol) in 0.4 mL dry THF was added dropwise and the reaction mixture was stirred for 4 
h while the temperature was slowly warmed from -80 °C to 0 °C. The reaction is still stirring 
under 0 °C for 1 h. Then, the reaction mixture was quenched with sat. aq. NH4Cl and 
extracted three times with Et2O. The organic layer was washed with brine, dried with MgSO4, 
and concentrated under vacuum. The residue was purified by column chromatography using 
pentane-Et2O (20:1) to give 2.2 (19 mg, 45.6 umol, 55%, E/Z = 83:17) as colorless oil.  
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1H NMR (400 MHz, CDCl3): δ = 6.81-6.72 (m, 3H), 6.43 (dd, J = 17.3, 10.7 Hz, 1H), 6.07 (d, 
J = 10.9 Hz, 0.78H), 5.99 (d, J = 11.0 Hz, 0.22H), 5.82 (d, J = 15.9 Hz, 1H), 5.27-5.23 (m, 
1H), 5.19-5.14 (m, 1H), 5.07 (d, J = 1.9 Hz, 1H), 5.05 (d, J = 2.2 Hz, 1H), 2.72 (dd, J = 13.0, 
4.3 Hz, 1H), 1.98 (s, 2H), 1.91 (s, 1H), 1.76 (t, J = 7.9 Hz, 12H), 1.72-1.68 (m, 1H), 1.26 (d, J 
= 4.4 Hz, 6H), 1.19 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 167.9/167.9, 167.4, 141.3, 141.0, 138.0, 137.8, 136.2, 
134.7, 133.6, 130.9, 129.4, 128.5, 128.5, 124.0, 123.1, 113.0, 76.5, 76.4, 75.1, 69.1, 38.9, 
32.0, 30.0, 23.2, 20.0, 16.9, 14.6, 14.5, 12.3, 12.2, 12.0. 
IR (v cm
-1
): 2977, 2954, 2926, 2856, 1714, 1651. 
HRMS: calc’d for [M+Na]+: 439.2455, found: 439.2449. 
[𝛼]𝐷
20 = -20.1 (c = 0.50, CHCl3). 
 
(2Z,2'Z)-2,2,6-Trimethyl-6-((1E,3E)-4-methylhexa-1,3,5-trien-1-yl)tetrahydro-2H-
pyran-3,4-diyl bis(2-methylbut-2-enoate) (rac-2.2) 
V2.157 
(ZY-644) 
To a solution of (E)-2.46 (24 mg, 85.2 umol) in 0.8 ml dry THF was added Sodium 
bis(trimethylsilyl)amide NaHMDS (1 M in THF, 85.2 umol, 85.2 uL) at -80 
o
C. After being 
stirred for 30 minutes from -80 
o
C to -65 
o
C, a solution of rac-2.54 (20 mg, 56.8 umol) in 0.4 
mL dry THF was added dropwise and the reaction mixture was stirred for 4 h while the 
temperature was slowly warmed from -80 °C to -20 °C. Then, the reaction mixture was 
quenched with sat. aq. NH4Cl and extracted three times with Et2O. The organic layer was 
washed with brine, dried with MgSO4, and concentrated under vacuum. The residue was 
purified by column chromatography using pentane-Et2O (20:1) to give rac-2.2 (12.4 mg, 29.8 
umol, 53%) as colorless oil. 
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Spectroscopic data of rac-2.2: see experiment V 2.156. 
 
V2.158 
(ZY-492) 
To a solution of (E)-2.46 (9.5 mg, 34.1 umol) and rac-2.54 (8 mg, 22.7 umol) in 1 ml dry 
THF was added Sodium bis(trimethylsilyl)amide NaHMDS (2 M in THF, 34.1 umol, 17 uL) 
at -80 
o
C. The reaction mixture was stirred for 3 h while the temperature was slowly warmed 
from -80 °C to 7 °C. Then, the reaction mixture was quenched with sat. aq. NH4Cl and 
extracted three times with Et2O. The organic layer was washed with brine, dried with MgSO4, 
and concentrated under vacuum. The residue was purified by column chromatography using 
pentane-Et2O (20:1) to give rac-2.2 (2 mg, 4.8 umol, 21%) as colorless oil. 
 
4-Methylhexa-1,3,5-trien-1-yl)benzene (2.56) 
V2.159 
(ZY-487) 
To a solution of (E)-2.46 (19.7 mg, 70.7 umol) and benzaldehyde 2.55 (5 mg, 47.1 umol) in 1 
ml dry THF was added Sodium bis(trimethylsilyl)amide NaHMDS (2 M in THF, 70.7 umol, 
35.4 uL) at -80 
o
C. The reaction mixture was stirred for 1.5 h while the temperature was 
slowly warmed from -80 °C to -19 °C. Then, the reaction mixture was quenched with sat. aq. 
NH4Cl and extracted three times with Et2O. The organic layer was washed with brine, dried 
with MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using pentane-Et2O (20:1) to give 2.56 (6 mg, 35.3 umol, 75%) as colorless 
oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.35 (d, J = 4.4 Hz, 4H), 7.27-7.22 (m, 1H), 6.60-6.42 (m, 
4H), 5.28 (d, J = 17.3 Hz, 1H), 5.08 (d, J = 10.6 Hz, 1H), 1.98/1.98/1.95/1.93 (4s, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 141.5/141.3, 137.9/137.7, 130.6, 129.3/128.8, 128.4/128.3, 
127.6/127.6, 127.1/127.1, 126.5/126.2, 113.3/113.1, 12.4/12.1. 
The NMR data are consistent with the literature data.
[39]
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2,2,4-Trimethyl-4-((1E,3E)-4-methylhexa-1,3,5-trien-1-yl)-3,7-
dioxabicyclo[4.1.0]heptane (rac-2.57) 
V2.160 
(ZY-488) 
To a solution of (E)-2.46 (25 mg, 89.6 umol) and rac-2.59 (10 mg, 58.8 umol) in 1 ml dry 
THF was added Sodium bis(trimethylsilyl)amide NaHMDS (2 M in THF, 89.6 umol, 44 uL) 
at -80 
o
C. The reaction mixture was stirred for 4 h while the temperature was slowly warmed 
from -80 °C to -10 °C. Then, the reaction mixture was quenched with sat. aq. NH4Cl and 
extracted three times with Et2O. The organic layer was washed with brine, dried with MgSO4, 
and concentrated under vacuum. The residue was purified by column chromatography using 
pentane-Et2O (20:1) to give rac-2.57 (5 mg, 21.3 umol, 36%) as colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 6.81-6.37 (m, 2H), 6.23-6.02 (m, 1H), 5.91-5.61 (m, 1H), 
5.23-5.00 (m, 2H), 3.43-3.42 (m, 1H), 2.94 (d, J = 5.5 Hz, 1H), 2.20-2.15 (m, 1H), 1.93-1.87 
(m, 1H), 1.84 (d, J = 17.7 Hz, 3H), 1.34 (d, J = 6.4 Hz, 6H), 1.27 (d, J = 8.9 Hz, 3H). 
The NMR data are consistent with the literature data.
[39]
 
 
4-(Allyloxy)-2,2,6-trimethyl-6-((1E,3E)-4-methylhexa-1,3,5-trien-1-yl)tetrahydro-2H-
pyran-3-ol (rac-2.58) 
V2.161 
(ZY-490) 
To a solution of rac-2.57 (5 mg, 21.3 umol) in 0.5 mL allyl alcohol was added HClO4 (70% 
in water, 2.5 uL, 42.6 umol) was added slowly at 0 °C. The reaction mixture was stirred at 
0 °C for 2 h, then at room temperature for 24 h. And the reaction was monitored by thin layer 
chromatography. A low conversion was observed, however starting materials was complete 
decomposition and the reaction was terminated. 
 
 Chapter 3. Studies on the total synthesis of 3-O-Feruloylcassine 
137 
 
 
 
 
 
 
 
Chapter 3. Studies on the total synthesis of 
(+)-3-O-Feruloylcassine 
 
  
Chapter 3. Studies on the total synthesis of 3-O-Feruloylcassine 
 
138 
 
3.1 Introduction 
After the total synthesis of 9α,10β-Bisangeloyloxy-agerafastin, which contains an O-
containing 6-membered ring as the main building block, the second natural product with an 
N-containing 6-membered ring was selected. The 6-membered nitrogen heterocycles are 
particularly attractive for us because the preparation of them could start from β-aminoallenes, 
and the cycloisomerization of these allenes has been rarely studied so far. The gold-catalyzed 
cycloisomerization of β-aminoallenes to produce 6-membered nitrogen heterocycles was 
previously examined by Gockel
[39]
 and Sun
[77]
 from our group. Compared to the synthesis of a 
5-membered nitrogen heterocycle in this way, the synthesis of 6-membered nitrogen 
heterocycles is more challenging.

 
(+)-3-O-Feruloylcassine 3.1 was first isolated by Nair et al. from the green fruits of Senna 
spectabilis in 2007.
[78]
 The structure was determined by HRMS, EA, IR, NMR (
1
H-, 
13
C-, 
COSY-, HMBC- and NOSY NMR) and the relative configuration by NOSY experiments and 
comparison of coupling constants with structurally similar compounds 3.2 and 3.3
[79] 
detected 
(Figure 3.1). Besides the interesting structure, this new alkaloid has broad biological 
activities including lipoperoxidation inhibitory, cyclooxygenase enzymes inhibitory, 
antioxidant and anti-inflammatory activities.
[78]
 
 
                                                          
[77] T. Sun, PhD Thesis, TU Dortmund, 2011. 
[78] J. C. Viegas, D. H. S. Silva, M. Pivatto, A. de Rezende, I. Castro-Gamboa, V. S. Bolzani, M. G. Nair, J. Nat. 
Prod. 2007, 70, 2026-2028. 
[79] (a) M. S. A. Moreira, C. Jr. Virgas, A. L. P. de Miranda, V. S. Bolzani, E. J. Barreiro, Planta Med. 2003, 69, 795-799; 
(b) C. Jr. Virgas, V. S. Bolzani, M. Furlan, E. J. Barreiro, M. C. M. Young, D. Tomazela, M. N. Eberlin, J. Nat. Prod. 2004, 
67, 908-910. 
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As a 2,3,6-trisubstituted piperidine alkaloid, Feruloylcassine 3.1 is a suitable target for testing 
our methods, the gold-catalyzed cycloisomerization of aminoallenes and the CuH-catalyzed 
SN2'-reduction to synthesize aminoallenes. However, the total synthesis and absolute 
configuration is not yet known. Therefore, we have chosen 3-O-Feruloylcassine 3.1 with the 
absolute configuration (2R,3R,6S) as the target for our total synthesis. 
3.2 Retrosynthetic Analysis 
Based on previous work of Sun,
[77]
 the retrosynthetic analysis is shown in Scheme 3.1. The 
(+)-3-O-Feruloylcassine 3.1 could be obtained from acid 3.4, commercially available 10-
undecene-1-ol 3.5 and tetrahydropyridine derivative 3.6 by means of a sequence of SN2-
reaction/Mitsunobu esterification/Wacker oxidation. The key intermediate 3.6 could be 
synthesized from the protected β-aminoallene 3.7 by gold-catalyzed cycloisomerization. The 
CuH-catalyzed SN2'-reduction of propargyl dicarbonate 3.8 should provide the β-aminoallene 
3.7. The propargyl dicarbonate 3.8 should be accessible from the aminoenyne 3.9 that could 
be synthesized by the enynone 3.10 resulting from the propargyl alcohol 3.11. 
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3.3  Synthesis of β-aminoallene 
According to the retrosynthetic analysis of 3-O-Feruloylcassine 3.1, starting from propargyl 
alcohol 3.11, the protected propargyl alcohol 3.12 was obtained with high yield. Next, 3.12 
was reacted with n-butyllithium and DMF to provide the aldehyde 3.13 efficiently (Scheme 
3.2).

 
 
The phosphonate 3.15 was prepared from commercially available chloroacetone 3.14 and 
triethyl phosphite by a means of a modified Arbuzov reaction
[80]
 with a moderate yield of 62% 
(Scheme 3.3). Subsequent Horner-Wadsworth-Emmons (HWE) reaction
[81]
 transferred 3.13 
and 3.15 to the ketone 3.10 in good yield of 72% and excellent 98:2 E/Z ratio (Scheme 3.3).

 
 
The asymmetric reduction of ketone 3.10 was performed with 20 mol% (R)-Me-CBS-
oxazaborolidine
[82]
 and 1 equivalent of borane-dimethylsulfide-complex at -30 °C to -20 °C to 
afford the product (S)-3.16 only with a moderate yield and enantiomeric excess (ee) because 
the borane-dimethylsulfide-complex was old (rac-3.16: 99%) (Scheme 3.4). The new borane-
dimethylsulfide-complex will be utilized later and good result should be obtained based on 
Sun’s work. 
                                                          
[80] (a) M. Kitamura, M. Tokunaga, R. Noyori, J. Am. Chem. Soc. 1995, 117, 2931-2932; (b) J. Pietruszka, A. Witt, 
Synthesis 2006, 4266-4268. 
[81] J. Villieras, M. Rambaud, Synthesis 1983, 300-303. 
[82] (a) E. J. Corey, C. J. Helal, Angew. Chem. Int. Ed. 1998, 37, 1986-2012; (b) C. Ohta, S.-i. Kuwabe, T. Shiraishi, S. 
Ohuchida, T. Seko, Org. Process Res. Dev. 2009, 13, 933-935. 
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The alcohol (S)-3.16 was used in a Mitsunobu reaction
[49]
 to give phthalimide (S)-3.17 with a 
moderate yield of 57% (rac-3.17: 55%) (Scheme 3.5). 
 
Then, phthalimide (S)-3.17 was reacted with 30 equivalents of methylamine
[83] 
to provide the 
desired product aminoenyne (S)-3.9 in good yield of 78% (rac-3.9: 70%).

 
 
Protection of the amino group of (S)-3.9 produced carbamate (S)-3.18 in good yield (rac-3.18: 
75%) (Scheme 3.7). 
 
The carbamate (S)-3.18 treated in a Sharpless dihydroxylation
[50] 
with AD-Mix-β and 2 
equivalents of methane sulfonamide, which was used for accelerating the reaction, at 0 °C to 
                                                          
[83] D. Oves, M. Ferrero, S. Fernández, V. Gotor, J. Org. Chem. 2003, 68, 1154-1157. 
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afford the mixture diol (S)-3.19 with moderate yield of 65% (rac-3.19: 71%) (Scheme 3.8). 
However, this reaction was stirred four days which it is very time-consuming. Therefore, 
additional catalyst K2OsO2(OH)4 and chiral ligand (DHQD)2PHAL, as well as additional 
methane sulfonamide need be added to make the reaction more efficient. 
 
Reaction of the diol (S)-3.19 with 4 equivalents of DMAP, 30 equivalents of pyridine and 10 
equivalents of methyl chloroformate afforded the desired product (S)-3.8 with a good yield of 
88% (rac-3.8: 83%) (Scheme 3.9). 
 
With synthesizing propargyl dicarbonate (S)-3.8 successfully, the next step should be the 
CuH-catalyzed SN2'-reduction to provide the significant key intermediate, β-aminoallene 3.7 
(Scheme 3.1). Before performing of CuH-catalyzed SN2'-reduction, the required N-
heterocyclic carbene NHC ligand needed to be synthesized.

 
As shown in Scheme 3.10, the synthesis route
[84]
 started from cyclododecanone 3.20 through 
seven steps to give the desired NHC ligand 3.27 which is the most suitable NHC ligand for 
the CuH-catalyzed SN2'-reduction.
[19,20]
 
                                                          
[84] G. Altenhoff, R. Goddard, C. W. Lehmann, F. Glorius, J. Am. Chem. Soc. 2004, 126, 15195-15201. 
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Then,

a test reaction
[85]
 for the CuH-catalyzed SN2'-reduction was performed because this 
reaction is very sensitive and easily fails. Firstly, the propargyl acetate 3.30 was obtained 
from the propargyl alcohol 3.29 which was synthesized from 4-methoxybenzyl aldehyde 3.28 
and benzyl propargyl ether 3.12 with n-BuLi. Subsequent CuH-catalyzed SN2'-reduction of 
propargyl acetate 3.30 was performed with 3 mol% copper(I) chloride, 9 mol% sodium tert-
butoxide, 3 mol% NHC ligand 3.27 and 2 equivalents of PMHS to give the desired allene 
3.31 (Scheme 3.11), albeit in low yield of 24%. 
                                                          
[85] C. Deutsch, PhD Thesis, TU Dortmund, 2008. 
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Furthermore, the CuH-catalyzed SN2'-reduction of propargyl dicarbonate rac-3.8 was 
performed to afford the desired allene rac-3.7 successfully. The reaction conditions of CuH-
catalyzed SN2'-reduction were optimized and results are shown in Table 3.1.  
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Table 3.1: The CuH-catalyzed SN2'-reduction of propargyl dicarbonate rac-3.8. 
 
Entry L-CuH/mol% PMHS/eq. T/
o
C t/h Yield%
a
 
1 5 2 35 to RT 88 30 
2 5 2 RT 86 40 
3 5 2 RT 115 29 
4 5 4 60 24 53 
5 5 4 80 24 49 
6 10 4 RT 24 30 
7 10 4 RT 41 38 
8 10 4 RT 96 53 
9 10 4 15 72 45 
a 
Isolated yield of rac-3.7. 
It is obvious that an excess of the hydride source PMHS can improve the reaction yield and 
the best yield was 53% (Table 3.1, Entry 4 and 8). Different reaction temperatures have not 
influenced the reaction strongly. Considering the efficiency of reaction, the CuH-catalyzed 
SN2'-reduction of propargyl dicarbonate rac-3.8 should be performed with 5 mol% catalyst 
NHC-CuCl and 4 equivalents of PMHS at 60 
o
C for 24 h to synthesize allene rac-3.7 for the 
further study (V3.27). Based on Sun’s work, the reason why the reaction yield is not good is 
the formation of a vinyl carbonate. An other disadvantage is the similar polarity of the 
substrate and the by-product. Therefore, it is not possible to estimate the turnover by thin 
layer chromatography and to separate the two compounds by column chromatography. 
3.4 Gold catalyzed cycloisomerization of β-aminoallene 
With the isolated β-aminoallene rac-3.7 in hand, the gold-catalyzed cycloisomerization was 
investigated. According to Sun’s work,[77] it is possible to obtain the desired piperidine rac-
3.6 with 28% yield by using 15 mol% Ph3PAuNTf2·1/2 toluene as catalyst for 18 h reaction 
time (Scheme 3.12). When 5 mol% Ph3PAuNTf2·1/2 toluene was used, the reaction yield was 
31% after 10 days reaction time. Therefore, this reaction needs to be further studied. 
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In order to optimize the gold-catalyzed cycloisomerization, large amounts of allene rac-3.7 
are required. For reasons of time, the study was not continued at this point. 
3.5 Summary and outlook 
In this chapter, a study on the total synthesis of natural product (+)-3-O-Feruloylcassine was 
carried out. The β-aminoallene rac-3.7 was synthesized by CuH-catalyzed SN2'-reduction 
with 53% yield. The gold-catalyzed cycloisomerization of β-aminoallene should be optimized 
by using more active gold catalysts. 
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3.6 Experimental Part 
3.6.1 General Information 
The working techniques and analytical devices used are described in chapter 2.14.1. Unless 
otherwise stated, the reagents used were from those mentioned in chapter 2.14.1. 
3.6.2 General procedures 
AVV11: General procedure for the CuH-catalyzed SN2'-reduction of propargyl 
dicarbonates 
In a Schlenk flask, 5 mol% CuCl, 15 mol% NaOt-Bu, and 5 mol% IBiox12·HOTf were 
suspended in dry toluene (4 mL/mol). The mixture was heated to 40°C for 1 h and allowed to 
cool to room temperature or heated to 100°C for 4 min and cooled to room temperature for 1 
h. PMHS was added and the mixture was stirred for 5 min at room temperature. After 
addition of 1 eq. of the substrate rac-3.8 (85 mg, 0.2 mmol) in dry toluene (2.5 mL/mol), the 
mixture was stirred at room temperature for 96 h. It was poured into a stirred mixture of 
saturated aqueous Na2CO3 (100 mL/mol) and diethyl ether (100 mL/mol). After stirring for 1 
h at room temperature, the layers were separated and the aqueous layer was extracted with 
diethyl ether. The combined organic extracts were dried with MgSO4, and the solvent was 
removed in vacuo. The crude product is purified by flash column chromatography on silica 
gel. 
The solvent toluene is carefully degassed by twice repeating the cycle of freezing in liquid 
nitrogen under argon, evacuating under fine vacuum and then thawing without cooling bath 
under argon. The silane PMHS is also to be degassed by evacuating under fine vacuum. 
3.6.3 The total synthesis of 3-O-Feruloylcassine 
((Prop-2-yn-1-yloxy)methyl)benzene (3.12) 
V3.1 
(ZY-2) 
To a suspension of sodium hydride (60% in mineral oil, 13.2 g, 0.33 mol) in 400 mL THF 
freshly distilled propargyl alcohol 3.11 (17.5 mL, 0.3 mmol) was added at 0 °C. The mixture 
was stirred until no more gas was monitored (30 minutes). Benzyl bromide (33 mL, 0.278 
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mol) was added and the solution heated under reflux for five hours. The reaction was 
quenched with sat. aq. NH4Cl and extracted three times with diethyl ether. The organic layer 
was washed with brine, dried with MgSO4, and concentrated under vacuum. The residue was 
purified by column chromatography using cyclohexane-ethyl acetate (20:1) to give 3.12 (36.8 
g, 0.252 mol, 91%) as colorless oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.39-7.29 (m, 5H), 4.62 (s, 2H), 4.19 (d, J = 2.4 Hz, 2H), 
2.48 (t, J = 2.4 Hz, 1H). 
13
C NMR (100 MHz, CDCl3): δ = 137.4, 128.6, 128.3, 128.1, 79.8, 74.7, 71.7, 57.2. 
The NMR data are consistent with the literature data.
[77]
 
 
4-(Benzyloxy)but-2-ynal (3.13) 
V3.2 
(ZY-18) 
To a solution of the protected propargyl 3.12 (2.92 g, 20 mmol) in 50 ml of THF, n-
butyllithium (2.5 M in hexane, 9.6 ml, 24 mmol) was added dropwise at -40 °C. 
Subsequently, DMF (N, N-Dimethylformamid) (3.4 mL, 27.4 mmol) was added dropwise at 
this temperature and the solution was thawed for one hour at room temperature. The reaction 
mixture was added to a mixture of sodium dihydrogen phosphate monohydrate (26.5 g, 192 
mmol, 8 eq., based on n-butyllithium) in 192 mL of water and 200 mL diethyl ether pre-
cooled to 0 °C. After stirring for five minutes the phases were separated and the aqueous 
phase extracted three times with diethyl ether. The combined organic phases were washed 
with water, dried with MgSO4 and concentrated under vacuum. The residue was purified by 
column chromatography using cyclohexane-ethyl acetate (10:1) to give 3.13 (3.25 g, 18.67 
mmol, 93%) as light yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 9.25 (s, 1H), 7.39-7.32 (m, 5H), 4.63 (s, 2H), 4.37 (s, 2H). 
13
C NMR (100 MHz, CDCl3): δ = 176.5, 136.6, 128.7, 128.4, 128.3, 92.3, 85.8, 72.4, 57.0. 
The NMR data are consistent with the literature data.
[77]
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Diethyl (2-oxopropyl)phosphonate (3.15)
 [137]
 
V3.3 
(ZY-3) 
To a suspension of potassium iodide (8.2 g, 49 mmol) in 10 ml acetone (dried over MgSO4) 
and 12.5 ml dried acetonitrile, chloroacetone 3.14 (3.9 mL, 49 mmol) was added. After being 
stirred for 1 h at room temperature, triethyl phosphite (8.4 mL, 49 mmol) was added slowly. 
The reaction mixture was stirred for 12 h at room temperature and stirred for 2 h at 60 ° C. 
After cooling, the solid was filtered through celite and rinsed with acetone (dried over 
MgSO4). After concentration of the solvent under vacuum, the crude product was purified by 
column chromatography using cyclohexane-ethyl acetate (1:3 to EA) to give 3.15 (5.92 g, 
30.5 mmol, 62%) as yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 4.18-4.09 (m, 4H), 3.09 (s, 1H), 3.04 (s, 1H), 2.30 (s, 3H), 
1.32 (t, J = 7.1 Hz, 6H). 
13
C NMR (100 MHz, CDCl3): δ = 200.1/200.0, 62.7/62.6, 44.1/42.9, 31.5, 16.4/16.4. 
The NMR data are consistent with the literature data.
 [77]
 
 
(E)-7-(Benzyloxy)hept-3-en-5-yn-2-one (3.10) 
[141]
 
V3.4 
(ZY-20) 
To a suspension of sodium hydride (60% in mineral oil, 1.8 g, 44.8 mmol) in 180 ml of THF, 
phosphonate 3.15 (8.70 g, 44.8 mmol) was added slowly at 0 
o
C. The mixture was stirred at 0 
o
C until no more gas was monitored (ten minutes). To this solution aldehyde 3.13 (6.50 g, 
37.3 mmol) dissolved in 75 mL THF was added slowly at 0 
o
C. The solution was stirred for 
20 minutes at room temperature before the reaction was quenched with sat. aq. NH4Cl. The 
aqueous phase was extracted three times with diethyl ether. The combined organic phases 
was dried with MgSO4 and concentrated under vacuum. The residue was purified by column 
chromatography using cyclohexane-ethyl acetate (10:1) to give 3.10 (5.74 g, 26.8 mmol, 72%, 
E/Z = 98:2) as yellow oil. 
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1
H NMR (400 MHz, CDCl3): δ = 7.37-7.30 (m, 5H), 6.64 (d, J = 16.1 Hz, 1H), 6.50 (d, J = 
16.1 Hz, 1H), 4.61 (s, 2H), 4.35 (s, 2H), 2.28 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 197.2, 138.7, 137.2, 128.6, 128.3, 128.2, 123.3, 95.8, 83.7, 
72.1, 57.9, 27.8. 
The NMR data are consistent with the literature data.
 [77]
 
 
(S,E)-7-(Benzyloxy)hept-3-en-5-yn-2-ol ((S)-3.16) 
V3.5 
(ZY-25) 
To a suspension of (R)-Me-CBS-oxazaborolidine (1 M in toluene, 0.6 mL, 0.6 mmol) in 18 
mL THF borane-dimethylsulfide-complex (0.08 mL, 0.9 mmol) was added at -30 
o
C. Then, 
Eninketon 3.10 (642 mg, 3 mmol) in 4 mL THF and borane-dimethylsulfide complex (0.19 
mL, 2.1 mmol) were added dropwise at the same time within 30 minutes. After being stirred 
30 minutes at -30 
o
C to -20 
o
C, 5 mL methanol was added and stirred for 15 minutes at room 
temperature. The solvent was removed in vacuum. The residue was purified by column 
chromatography using cyclohexane-ethyl acetate (5:1) to give (S)-3.16 (590 mg, 2.73 mmol, 
59%) as light yellow oil.  
The ee was determined by chiral HPLC: n-heptane/i-PrOH = 95/5, flow rate: 0.6 mL/min, 
room temperature; retention time, (S)-3.16 36.0 min, (R)-3.16 39.5 min. 
1
H NMR (400 MHz, CDCl3): δ = 7.37-7.28 (m, 5H), 6.21 (dd, J = 15.9, 5.7 Hz, 1H), 5.75 (dd, 
J = 15.9, 1.6 Hz, 1H), 4.61 (s, 2H), 4.39-4.34 (m, 1H), 4.29 (d, J = 1.8 Hz, 2H), 1.65 (bs, 1H), 
1.29 (d, J = 6.5 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 147.3, 137.5, 128.6, 128.2, 128.0, 108.6, 85.9, 84.4, 71.7, 
68.3, 57.9, 23.1. 
ee = 73%. 
The NMR data are consistent with the literature data.
[77]
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(E)-7-(Benzyloxy)hept-3-en-5-yn-2-ol (rac-3.16) 
V3.6 
(ZY-21) 
To a suspension of lithium aluminum hydride (372 mg, 9.8 mmol) in 20 mL diethyl ether, 
ketone 3.10 (2.1 g, 9.8 mmol) dissolved in 10 mL diethyl ether was added dropwise at -60 
o
C. 
After being stirred for 1 h at -60 
o
C to -50 
o
C, the reaction was quenched with 20 mL sat. aq. 
NH4Cl and extracted three times with diethyl ether. The combined organic phases was dried 
with MgSO4 and concentrated under vacuum. The residue was purified by column 
chromatography using cyclohexane-ethyl acetate (5:1) to give rac-3.16 (2.1 g, 9.72 mmol, 
99%) as light yellow oil. 
Spectroscopic data of rac-3.16: see experiment V 3.5. 
 
(R,E)-2-(7-(Benzyloxy)hept-3-en-5-yn-2-yl)isoindoline-1,3-dione ((S)-3.17) 
 
V3.7 
(ZY-26) 
Based on AAV2, to a solution of (S)-3.16 (720 mg, 3.33 mmol) in THF (28 mL) was added 
phthalimide (980 mg, 6.66 mmol), triphenylphosphine (1.75 g, 6.66 mmol) at room 
temperature. After being stirred for 5 minutes at room temperature and then cooled to 0 °C, 
DIAD (1.4 mL, 6.66 mmol) was added dropwise and the solution was stirred at this 
temperature for 1 h and another 2 h at room temperature. The reaction mixture was quenched 
with water and extracted three times with DCM. The organic layer was washed with brine, 
dried with MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using cyclohexane-ethyl acetate (20:1) to give (S)-3.17 (660 mg, 1.91 mmol, 
57%) as yellow viscous oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.82 (td, J = 5.3, 2.1 Hz, 2H), 7.72 (td, J = 5.2, 2.1 Hz, 2H), 
7.35-7.27 (m, 5H), 6.52 (dd, J = 15.9, 7.5 Hz, 1H), 5.76-5.72 (m, 1H), 5.03-4.94 (m, 1H), 
4.58 (s, 2H), 4.26 (d, J = 1.6 Hz, 2H), 1.59 (d, J = 7.1 Hz, 3H). 
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13
C NMR (100 MHz, CDCl3): δ = 167.8, 141.8, 137.5, 134.2, 132.0, 128.5, 128.2, 128.0, 
123.4, 111.6, 86.5, 84.0, 71.7, 57.8, 48.3, 18.4. 
The NMR data are consistent with the literature data.
 [77]
 
 
(E)-2-(7-(Benzyloxy)hept-3-en-5-yn-2-yl)isoindoline-1,3-dione (rac-3.17) 
 
V3.8 
(ZY-22) 
Based on AAV2, to a solution of rac-3.16 (3.52 g, 16.3 mmol) in THF (140 mL) was added 
phthalimide (3.6 g, 24.5 mmol), triphenylphosphine (6.41 g, 24.5 mmol) at room temperature. 
After being stirred for 5 minutes at room temperature and then cooled to 0 °C, DIAD (4.9 mL, 
24.5 mmol) was added dropwise and the solution was stirred at this temperature for 1 h and 
another 2 h at room temperature. The reaction mixture was quenched with water and 
extracted three times with DCM. The organic layer was washed with brine, dried with 
MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using cyclohexane-ethyl acetate (20:1) to give rac-3.17 (3.54 g, 10.3 mmol, 
63%) as yellow viscous oil. 
Spectroscopic data of rac-3.17: see experiment V 3.7. 
 
(R,E)-7-(Benzyloxy)hept-3-en-5-yn-2-amine ((S)-3.9) 
V3.9 
(ZY-27) 
To a solution of (S)-3.17 (650 mg, 1.88 mmol) in fresh distilled ethanol (7.5 mL) 
methylamine (4.8 mL, 40% in water, 56.4 mmol) was added at room temperature. After being 
stirred for 1 h at 65 °C, the reaction mixture was quenched with water and extracted three 
times with Et2O. The organic layer was washed with brine, dried with MgSO4, and 
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concentrated under vacuum. The residue was purified by column chromatography using 
DCM-MeOH (20:1) to give (S)-3.9 (317 mg, 1.47 mmol, 78%) as yellow viscous oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.37-7.27 (m, 5H), 6.16 (dd, J = 15.9, 6.5 Hz, 1H), 5.63 (dd, 
J = 15.9, 1.5 Hz, 1H), 4.60 (s, 2H), 4.28 (s, 2H), 3.57-3.52 (m, 1H), 1.38 (bs, 2H), 1.18 (d, J = 
6.6 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 150.1, 137.6, 128.5, 128.2, 128.0, 107.3, 85.0, 84.8, 71.7, 
58.0, 49.2, 23.4. 
The NMR data are consistent with the literature data.
[77]
 
 
(E)-7-(Benzyloxy)hept-3-en-5-yn-2-amine (rac-3.9) 
V3.10 
(ZY-19) 
To a solution of rac-3.17 (1.29 g, 3.74 mmol) in fresh distilled ethanol (15 mL) methylamine 
(9.8 mL, 40% in water, 112.2 mmol) was added at room temperature. After being stirred for 2 
h at room temperature, the reaction mixture was quenched with water and extracted three 
times with Et2O. The organic layer was washed with brine, dried with MgSO4, and 
concentrated under vacuum. The residue was purified by column chromatography using 
DCM-MeOH (20:1) to give rac-3.9 (560 mg, 2.6 mmol, 70%) as yellow viscous oil. 
Spectroscopic data of rac-3.9: see experiment V 3.9. 
 
(R,E)-Methyl (7-(benzyloxy)hept-3-en-5-yn-2-yl)carbamate ((S)-3.18) 
V3.11 
(ZY-28) 
To a solution of (S)-3.9 (310 mg, 1.44 mmol) in DCM (15 mL) methyl chloroformate (0.14 
mL, 1.73 mmol) and pyridine (2.8 mL, 34.6 mmol) were added at room temperature. After 
being stirred for 1 h at room temperature, the reaction mixture was quenched with water and 
extracted three times with a mixture of cyclohexane and DCM (1/1). The organic layer was 
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washed with brine, dried with MgSO4, and concentrated under vacuum. The residue was 
purified by column chromatography using cyclohexane-ethyl acetate (20:1) to give (S)-3.18 
(338 mg, 1.24 mmol, 86%) as yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.36-7.28 (m, 5H), 6.10 (dd, J = 16.0, 5.6 Hz, 1H), 5.67 (d, 
J = 15.9 Hz, 1H), 4.64 (bs, 1H), 4.59 (s, 2H), 4.35-4.34 (m, 1H), 4.27 (d, J = 1.7 Hz, 2H), 
3.67 (s, 3H), 1.25 (d, J = 6.9 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 156.2, 145.1, 137.5, 128.6, 128.2, 128.0, 109.2, 85.9, 84.3, 
71.7, 57.9, 52.3, 48.2, 20.7. 
The NMR data are consistent with the literature data.
[77]
 
 
(E)-Methyl (7-(benzyloxy)hept-3-en-5-yn-2-yl)carbamate (rac-3.18) 
V3.12 
(ZY-29) 
To a solution of rac-3.9 (800 mg, 3.72 mmol) in DCM (37 mL) methyl chloroformate (0.35 
mL, 4.46 mmol) and pyridine (7.3 mL, 89.28 mmol) were added at room temperature. After 
being stirred for 1 h at room temperature, the reaction mixture was quenched with water and 
extracted three times with a mixture of cyclohexane and DCM (1/1). The organic layer was 
washed with brine, dried with MgSO4, and concentrated under vacuum. The residue was 
purified by column chromatography using cyclohexane-ethyl acetate (20:1) to give rac-3.18 
(758 mg, 2.78 mmol, 75%) as yellow oil. 
Spectroscopic data of rac-3.18: see experiment V 3.11. 
 
Methyl N-((2R,3R,4R)-7-(benzyloxy)-3,4-dihydroxyhept-5-yn-2-yl) carbamate ((S)-3.19) 
V3.13 
(ZY-31) 
To a suspension of AD-mix-β (1.69 g) in n-butanol/H2O (1:1, 15 mL), K3Fe(CN)6 (1.19 g, 
3.6 mmol) and methane sulfonamide (230 mg, 2.4 mmol) were added. The mixture was 
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stirred until all the solids were dissolved about 15 minutes. To the solution, (S)-3.18 (330 mg, 
1.2 mmol) was added at 0 °C. The mixture was stirred at this temperature until the reaction 
was complete. Na2SO3 sodium sulfite (1.8 g) was added and then warmed to room 
temperature and stirred for 30 min. The mixture was extracted three times with DCM. The 
organic layer was washed with brine, dried with MgSO4, and concentrated under vacuum. 
The residue was purified by column chromatography using cyclohexane-ethyl acetate (1:1) to 
give (S)-3.19 (240 mg, 0.78 mmol, 65%) as yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.34-7.28 (m, 5H), 5.22 (dd, J = 25.1, 8.7 Hz, 1H), 4.58 (s, 
2H), 4.38-4.33 (m, 1H), 4.20 (d, J = 1.3 Hz, 2H), 3.92-3.88 (m, 1H), 3.66 (s, 3H), 3.54 (s, 
1H), 3.45 (bs, 1H), 2.24 (bs, 1H), 1.25-1.19 (m, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 157.4/157.3, 137.2, 128.6, 128.2, 128.1, 84.4/84.3, 
82.7/82.3, 73.7/73.5, 71.9, 63.8/63.2, 57.5, 52.5, 48.4, 16.1. 
The NMR data are consistent with the literature data.
[77]
 
 
Methyl N-((3R,4R)-7-(benzyloxy)-3,4-dihydroxyhept-5-yn-2-yl) carbamate (rac-3.19) 
V3.14 
(ZY-70) 
To a mixed solvent of n-butanol/H2O (1:1, 32 mL), (DHQD)2PHAL (75 mg, 95.7 umol), 
K3Fe(CN)6 (3.15 g, 9.57 mmol), K2CO3 (1.32 g, 9.57 mmol) and K2OsO2(OH)4 (14.1 mg, 
38.3 umol) was added. After being stirred 5 minutes at room temperature, methane 
sulfonamide (607 mg, 6.38 mmol) was added. The mixture was stirred until all the solids 
were dissolved about 15 minutes. To the solution, rac-3.18 (870 mg, 3.19 mmol) was added 
at 0 °C. The mixture was stirred at this temperature until the reaction was complete. Na2SO3 
sodium sulfite (4.8 g) was added and then warmed to room temperature and stirred for 30 min. 
The mixture was extracted three times with DCM. The organic layer was washed with brine, 
dried with MgSO4, and concentrated under vacuum. The residue was purified by column 
chromatography using cyclohexane-ethyl acetate (1:1) to give rac-3.19 (700 mg, 2.28 mmol, 
71%) as light yellow oil.  
Spectroscopic data of rac-3.19: see experiment V 3.13. 
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Methyl((2R,3R,4R)-7-(benzyloxy)-3,4-bis((methoxycarbonyl)oxy)hept-5-yn-2-
yl)carbamate ((S)-3.8) 
V3.15 
(ZY-33) 
To a solution of (S)-3.19 (240 mg, 0.78 mmol) in DCM (5 mL) DMAP (382 mg, 3.12 mmol), 
pyridine (1.9 mL, 23.43 mmol) and methyl chloroformate (0.62 mL, 7.81 mmol) were added 
0 °C. After being stirred for 4 h at room temperature, the reaction mixture was quenched with 
sat. aq. NaCl and extracted three times with DCM. The organic layer was washed twice with 
water, dried with MgSO4, and concentrated under vacuum. The residue was purified by 
column chromatography using cyclohexane-ethyl acetate (2:1) to give (S)-3.8 (290 mg, 0.69 
mmol, 88%) as light yellow viscous oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.35-7.28 (m, 5H), 5.39 (d, J = 6.7 Hz, 1H), 5.08 (dd, J = 
6.7, 4.6 Hz, 1H), 4.87 (d, J = 8.4 Hz, 1H), 4.57 (s, 2H), 4.29-4.27 (m, 1H), 4.21 (s, 2H), 3.82 
(s, 3H), 3.79 (s, 3H), 3.65 (s, 3H), 1.25 (d, J = 7.2 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 156.1, 155.4, 154.7, 137.2, 128.6, 128.3, 128.1, 85.3, 79.2, 
78.8, 71.7, 67.0, 57.2, 55.5/55.5, 52.4, 46.9, 15.7. 
The NMR data are consistent with the literature data.
 [77]
 
 
Methyl((3R,4R)-7-(benzyloxy)-3,4-bis((methoxycarbonyl)oxy)hept-5-yn-2-yl)carbamate 
(rac-3.8) 
V3.16 
(ZY-75) 
To a solution of (rac)-3.19 (700 mg, 2.28 mmol) in DCM (15 mL) DMAP (1.11 g, 9.12 
mmol), pyridine (5.6 mL, 68.4 mmol) and methyl chloroformate (1.8 mL, 22.8 mmol) were 
added 0 °C. After being stirred for 4 h at room temperature, the reaction mixture was 
quenched with sat. aq. NaCl and extracted three times with DCM. The organic layer was 
washed twice with water, dried with MgSO4, and concentrated under vacuum. The residue 
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was purified by column chromatography using cyclohexane-ethyl acetate (2:1) to give (rac)-
3.8 (800 mg, 1.89 mmol, 83%) as light yellow viscous oil. 
Spectroscopic data of rac-3.8: see experiment V 3.15. 
 
1,3-Diazaspiro[4.5]decane-2, 4-dione (3.21) 
V3.17 
(ZY-39) 
To a suspension of potassium cyanide (9.8 g, 150 mmol) and ammonium carbonate (31.2 g, 
325 mmol) in a mixture solvent of 62.5 mL water and 62.5 mL ethanol at room temperature, 
cyclododecanone 3.20 (13.7 g, 75 mmol) was added. After being stirred for 6 hours at 60 
o
C, 
the alcohol was distilled. The precipitated solid was filtered and washed with cold water. 
Drying overnight in the air and subsequent azeotropic distillation with toluene at high 
vacuum to give 3.21 (15.69 g, 62.3 mmol, 83%) as white solid. 
1
H NMR (400 MHz, DMSO-d6): δ = 10.47 (s, 1H), 7.98 (s, 1H), 1.64-1.48 (m, 4H), 1.39-1.25 
(m, 18H). 
13
C NMR (100 MHz, DMSO-d6): δ = 178.3, 156.3, 63.8, 31.0, 25.8, 25.3, 22.4, 21.9, 18.8. 
The NMR data are consistent with the literature data.
 [84]
 
 
1-Aminocyclohexanecarboxylic acid (3.22) 
V3.18 
(ZY-40) 
L1 (6.2 g, 24.6 mmol) and 28 mL 3 M NaOH was stirred for 3 days under reflux. Then, the 
reaction mixture was acidified with concentrated hydrochloric acid to pH 6. The precipitated 
solid was filtered and washed with cold water. After drying overnight in the air, subsequent 
azeotropic distillation with toluene at high vacuum to give 3.22 (5.03 g, 22.1 mmol, 90%) as 
a white solid, which was used without further characterization in the following step. 
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(1-Aminocyclododecyl)methanol (3.23) 
V3.19 
(ZY-44) 
To a suspension of lithium aluminum hydride (LiAlH4) (2.94 g, 77.3 mmol) in 140 ml dried 
THF, L2 (7.03 g, 30.9 mmol) was added in small portions within one hour at 0 
o
C. The 
reaction mixture was stirred for 8 hours under reflux and additional 12 hours at room 
temperature. After hydrolysis with 50 mL 2 N NaOH, the phases were separated and the 
aqueous phase extracted three times with 30 mL diethyl ether. The combined organic phase 
was dried with MgSO4 and the solvent was removed in a vacuum to give 3.23 (3.6 g, 17.0 
mmol, 55%) as white solid. 
1
H NMR (400 MHz, CDCl3): δ = 3.24 (s, 2H), 2.39 (s, 3H), 1.31-1.30 (m, 22H). 
13
C NMR (100 MHz, CDCl3): δ = 68.6, 55.7, 31.8, 26.5, 26.1, 22.5, 22.0, 19.0. 
The NMR data are consistent with the literature data.
 [84]
 
 
N1,N2-Bis(1-(hydroxymethyl)cyclododecyl)oxalamide (3.24) 
V3.20 
(ZY-45) 
3.23 (1.57 g, 7.36 mmol) and diethyl oxalate (0.49 mL, 3.5 mmol) were stirred at 90 °C in 18 
mL toluene for 22 h. The 3.24 was crystallized while cooling to room temperature. 
Decantation of the supernatant and washing of the crystals with cold toluene followed by 
washing with hexane gave the 3.24 (1.3g, 2.7 mmol, 77%) as white powder. 
1
H NMR (400 MHz, CDCl3): δ = 7.57 (s, 2H), 4.10 (s, 2H), 3.66 (s, 4H), 1.67-1.59 (m, 8H), 
1.53-1.45 (m, 4H), 1.35 (s, 32H). 
13
C NMR (100 MHz, CDCl3): δ = 159.7, 66.9, 62.5, 29.0, 26.3, 26.1, 22.6, 22.0, 18.7. 
The NMR data are consistent with the literature data.
 [84]
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N
1
,N
2
-Bis (1-(chloromethyl) cyclododecyl) oxalamide (3.25) 
V3.21 
(ZY-46) 
To a suspension of 3.24 (1.26 g, 2.62 mmol) in 26 mL toluene, thionyl chloride (0.56 mL, 7.6 
mmol) was added dropwise slowly at 60 °C. The reaction was stirred at this temperature for 
1.5 h and additional 4 h at 90 °C. Then, the excess thionyl chloride was distilled under water 
pump vacuum and the residual solvent removed on a rotary evaporator and dried the solid 
under high vacuum. This gave 3.25 (910 mg, 1.76 mmol, 67%) as white solid. 
1
H NMR (400 MHz, CDCl3): δ = 7.10 (s, 2H), 3.85 (s, 4H), 1.88-1.83 (m, 4H), 1.58-1.53 (m, 
4H), 1.44-1.24 (m, 36H). 
13
C NMR (100 MHz, CDCl3): δ = 158.9, 60.0, 46.8, 29.1, 26.1, 26.0, 22.3, 21.9, 18.7. 
The NMR data are consistent with the literature data.
[84]
 
 
Bioxazoline (3.26) 
V3.22 
(ZY-47) 
To a solution of 3.25 (910 mg, 1.76mmol) in 35 mL THF, a solution of NaOH in ethanol (0.4 
M; 9.3 mL) was added dropwise. After stirring at room temperature for 30 min, the mixture 
was heated at 90 °C for 3 h. The solvent was evaporated and the residue taken up in 
chloroform, washed with sat. aq. Na2CO3 and the organic phase dried over Na2SO4. 
Evaporation of the solvent and the residue was purified by column chromatography using 
DCM-MeOH (100:1) to give 3.26 (400 mg, 0.9 mmol, 51%) as white solid.  
1
H NMR (400 MHz, CDCl3): δ = 4.06 (s, 4H), 1.80-1.74 (m, 4H), 1.56-1.50 (m, 4H), 1.48-
1.36 (m, 36H). 
13
C NMR (100 MHz, CDCl3): δ = 153.1, 78.6, 74.9, 34.1, 26.5, 26.0, 22.7, 22.3, 19.2. 
The NMR data are consistent with the literature data.
[84]
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IBiox12·HOTf (3.27)  
V3.23 
(ZY-496) 
To a suspension of silver triflate AgOTf (550 mg, 2.14 mmol) in 5 ml dried dichloromethane, 
Chloromethyl pivalate (318.5 mg, 2.1 mmol) was added and the mixture was stirred 
vigorously in the dark for 90 minutes. The supernatant was transferred via syringe to the 
bioxazoline (650 mg, 1.45 mmol) and the resulting solution was stirred in a sealed tube in the 
dark at 40 °C for 20 h. After the solution was cooled to room temperature, the reaction was 
quenched with methanol and the solvent evaporated in vacuum. The resulting oil was purified 
by column chromatographed using DCM-MeOH (100:1). Subsequent crystallisation from 
DCM/diethylether gave the imidazolium triflate 3.27 (520 mg, 0.86 mmol, 59%) as colorless 
crystals. 
1
H NMR (400 MHz, CD2Cl2): δ = 8.68 (s, 1H), 4.73 (s, 4H), 2.25-2.19 (m, 4H), 1.87-1.81 (m, 
4H), 1.63-1.57 (m, 12H), 1.45-1.26 (m, 24H). 
13
C NMR (100 MHz, CD2Cl2): δ = 125.1, 117.9, 114.3, 87.2, 70.8, 30.6, 25.8, 22.2, 21.7, 
19.3. 
The NMR data are consistent with the literature data.
 [84]
 
 
4-(Benzyloxy)-1-(4-methoxyphenyl)but-2-yn-1-ol (3.29) 
V3.24 
(ZY-36) 
To a solution of benzyl propargyl ether 3.12 (500 mg, 3.42 mmol) in 18 ml dried THF, n-
butyllithium (2.3 M in hexane, 1.5 mL, 3.42 mmol) was added dropwise at -78
 o
C. The 
mixture was deprotonated within 30 minutes at this temperature. To the solution, 4-
Methoxybenzyl aldehyde 3.28 (475 mg, 3.42 mmol) dissolved in 2.5 ml THF was added 
slowly. The reaction was stirred for two hours while warming to room temperature. The 
reaction was hydrolyzed with sat. aq. NH4Cl and extracted three times with diethyl ether. The 
combined organic phase was dried with MgSO4 and concentrated. The residue was purified 
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by column chromatography using cyclohexane-ethyl acetate (4:1) to give 3.29 (810 mg, 2.87 
mmol, 84%) as orange oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.47 (d, J = 8.6 Hz, 2H), 7.36-7.29 (m, 5H), 6.91 (d, J = 8.7 
Hz, 2H), 5.48 (d, J = 5.6 Hz, 1H), 4.61 (s, 2H), 4.27 (d, J = 1.7 Hz, 2H), 3.82 (s, 3H), 2.23 (bs, 
1H). 
13
C NMR (100 MHz, CDCl3): δ = 159.9, 137.5, 132.9, 128.6, 128.2/128.2, 128.0, 114.1, 86.6, 
82.6, 71.9, 64.4, 57.6, 55.5. 
The NMR data are consistent with the literature data.
 [85]
 
 
4-(Benzyloxy)-1-(4-methoxyphenyl)but-2-yn-1-yl acetate (3.30) 
V3.25 
(ZY-64) 
To a solution of 3.29 (250 mg, 0.89 mmol) in 10 mL dichloromethane, triethylamine (0.19 
mL, 1.34 mmol), acetic anhydride (0.17 mL, 1.78 mmol) and N,N-dimethylaminopyridine 
(DMAP) (5.5 mg, 45 umol) was added at 0 
o
C. After stirring for 4 hours at room temperature, 
the reaction was hydrolyzed with sat. aq. NH4Cl and extracted three times with diethyl ether. 
The combined organic phase was dried with MgSO4 and concentrated. The residue was 
purified by column chromatography using cyclohexane-ethyl acetate (10:1) to give 3.30 (220 
mg, 0.68 mmol, 76%) as yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.48 (d, J = 8.7 Hz, 2H), 7.35-7.29 (m, 5H), 6.91 (d, J = 8.7 
Hz, 2H), 6.48 (s, 1H), 4.60 (s, 2H), 4.26 (s, 2H), 3.82 (s, 3H), 2.09 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 170.0, 160.2, 137.4, 129.5, 129.2, 128.6, 128.3, 128.1, 
114.1, 83.5, 83.2, 71.8, 65.5, 57.5, 55.5, 21.3. 
The NMR data are consistent with the literature data.
[85]
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1-(4-(Benzyloxy)buta-1, 2-dien-1-yl)-4-methoxybenzene (3.31) 
V3.26 
(ZY-72) 
Based on AVV11, to a suspension of copper (I) chloride (1 mg, 0.01 mmol) and sodium tert-
butoxide (3 mg, 0.03 mmol) in 1 ml toluene, IBiox12·HOTf (6 mg, 0.01 mmol) was added 
and stirred for 1 h at 40 
o
C. After cooling to room temperature, PMHS (33 uL, 0.5 mmol) was 
added. After stirring five minutes, the yellow solution was cooled to 0 
o
C and 3.30 (100 mg, 
0.31 mmol) was added slowly. The mixture was stirred for 40 h at room temperature and 
quenched with a 1:1 mixed solvent of sat. aq. Na2CO3 and diethyl ether. The mixture stirred 
for an hour violently and the aqueous phase was extracted three times with diethyl ether. The 
combined organic phases are dried over MgSO4 and the solvent removed in vacuum. The 
residue was purified by column chromatography using cyclohexane-ethyl acetate (10:1) to 
give 3.31 (20 mg, 75.2 umol, 24%) as yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.36-7.27 (m, 5H), 7.23 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.6 
Hz, 2H), 6.23 (dt, J = 6.0, 2.1 Hz, 1H), 5.70 (q, J = 6.6 Hz, 1H), 4.62-4.55 (m, 2H), 4.19-4.12 
(m, 2H), 3.81 (s, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 205.7, 159.1, 138.2, 128.6, 128.1, 128.0, 127.8, 126.3, 
114.3, 95.1, 92.6, 72.1, 68.3, 55.5. 
The NMR data are consistent with the literature data.
 [85]
 
 
Methyl((3S,5S)-7-(benzyloxy)-3-((methoxycarbonyl)oxy)hepta-4,5-dien-2-yl)carbamate 
(rac-3.7) 
V3.27 
(ZY-347) 
Based on AVV11, in a Schlenk flask, CuCl (1 mg, 0.01 mmol), NaOt-Bu (3 mg, 0.03 mmol), 
and IBiox12·HOTf (6 mg, 0.01 mmol) were suspended in dry toluene (0.8 mL). The mixture 
was heated to 40°C for 1 h and allowed to cool to room temperature. PMHS (25 µL, 0.4 
mmol) was added and the mixture was stirred for 5 min at room temperature. After addition 
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of rac-3.8 (85 mg, 0.2 mmol) in 0.5 mL of dry toluene, the mixture was stirred at 35 
o
C for 
48 h and another 40 h at room temperature. It was poured into a stirred mixture of saturated 
aqueous Na2CO3 (20 mL) and diethyl ether (20 mL). After stirring for 1 h at room 
temperature, the layers were separated and the aqueous layer was extracted with diethyl ether. 
The combined organic extracts were dried with MgSO4, and the solvent was removed in 
vacuo. The residue was purified by column chromatography using cyclohexane-ethyl acetate 
(4:1) to give rac-3.7 (21 mg, 60.1 umol, 30%) as yellow oil. 
1
H NMR (400 MHz, CDCl3): δ = 7.34-7.27 (m, 5H), 5.47-5.41 (m, 1H), 5.30-5.28 (m, 1H), 
5.11-5.10 (m, 1H), 5.06-4.84 (m, 1H), 4.55-4.51 (m, 2H), 4.09-4.04 (m, 3H), 3.76 (s, 3H), 
3.64 (s, 3H), 1.18 (dd, J = 27.7, 6.9 Hz, 3H). 
13
C NMR (100 MHz, CDCl3): δ = 205.5/205.0, 156.6/156.4/155.1/155.1, 138.2/138.1, 
128.5/128.0/127.9/127.8/127.8, 92.1/91.7/89.3, 77.8/77.2, 72.1/71.9, 67.7/67.2, 55.1/55.0, 
52.3/52.2, 49.6/49.4, 17.8/15.8. 
The NMR data are consistent with the literature data.
 [77]
 
 
V3.28 
(ZY-355) 
Based on AVV11, in a Schlenk flask, CuCl (1 mg, 0.01 mmol), NaOt-Bu (3 mg, 0.03 mmol), 
and IBiox12·HOTf (6 mg, 0.01 mmol) were suspended in dry toluene (0.8 mL). The mixture 
was heated to 40°C for 1.5 h and allowed to cool to room temperature. PMHS (25 µL, 0.4 
mmol) was added and the mixture was stirred for 5 min at room temperature. After addition 
of rac-3.8 (85 mg, 0.2 mmol) in 0.5 mL of dry toluene, the mixture was stirred at room 
temperature for 86 h. It was poured into a stirred mixture of saturated aqueous Na2CO3 (20 
mL) and diethyl ether (20 mL). After stirring for 1 h at room temperature, the layers were 
separated and the aqueous layer was extracted with diethyl ether. The combined organic 
extracts were dried with MgSO4, and the solvent was removed in vacuo. The residue was 
purified by column chromatography using cyclohexane-ethyl acetate (4:1) to give rac-3.7 (28 
mg, 80.2 umol, 40%) as yellow oil. 
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V3.29 
(ZY-369) 
Based on AVV11, in a Schlenk flask, CuCl (1 mg, 0.01 mmol), NaOt-Bu (3 mg, 0.03 mmol), 
and IBiox12·HOTf (6 mg, 0.01 mmol) were suspended in dry toluene (0.8 mL). The mixture 
was heated to 40°C for 1 h and allowed to cool to room temperature. PMHS (25 µL, 0.4 
mmol) was added and the mixture was stirred for 5 min at room temperature. After addition 
of rac-3.8 (85 mg, 0.2 mmol) in 0.5 mL of dry toluene, the mixture was stirred at room 
temperature for 115 h. It was poured into a stirred mixture of saturated aqueous Na2CO3 (20 
mL) and diethyl ether (20 mL). After stirring for 1 h at room temperature, the layers were 
separated and the aqueous layer was extracted with diethyl ether. The combined organic 
extracts were dried with MgSO4, and the solvent was removed in vacuo. The residue was 
purified by column chromatography using cyclohexane-ethyl acetate (4:1) to give rac-3.7 (20 
mg, 57.3 umol, 29%) as yellow oil. 
 
V3.30 
(ZY-743) 
Based on AVV11, in a Schlenk flask, CuCl (1 mg, 0.01 mmol), NaOt-Bu (3 mg, 0.03 mmol), 
and IBiox12·HOTf (6 mg, 0.01 mmol) were suspended in dry toluene (1 mL). The mixture 
was heated to 100°C for 4 min and cooled to room temperature for 1 h. PMHS (50 µL, 0.8 
mmol) was added and the mixture was stirred for 5 min at room temperature. After addition 
of rac-3.8 (85 mg, 0.2 mmol) in 0.5 mL of dry toluene, the mixture was stirred at 60 
o
C for 
24 h. After cooling to room temperature, it was poured into a stirred mixture of saturated 
aqueous Na2CO3 (20 mL) and diethyl ether (20 mL). After stirring for 1 h at room 
temperature, the layers were separated and the aqueous layer was extracted with diethyl ether. 
The combined organic extracts were dried with MgSO4, and the solvent was removed in 
vacuo. The residue was purified by column chromatography using cyclohexane-ethyl acetate 
(4:1) to give rac-3.7 (36.9 mg, 105.7 umol, 53%) as yellow oil. 
 
V3.31 
(ZY-745) 
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Based on AVV11, in a Schlenk flask, CuCl (1 mg, 0.01 mmol), NaOt-Bu (3 mg, 0.03 mmol), 
and IBiox12·HOTf (6 mg, 0.01 mmol) were suspended in dry toluene (1 mL). The mixture 
was heated to 100°C for 4 min and cooled to room temperature for 1 h. PMHS (50 µL, 0.8 
mmol) was added and the mixture was stirred for 5 min at room temperature. After addition 
of rac-3.8 (85 mg, 0.2 mmol) in 0.5 mL of dry toluene, the mixture was stirred at 80 
o
C for 
24 h. After cooling to room temperature, it was poured into a stirred mixture of saturated 
aqueous Na2CO3 (20 mL) and diethyl ether (20 mL). After stirring for 1 h at room 
temperature, the layers were separated and the aqueous layer was extracted with diethyl ether. 
The combined organic extracts were dried with MgSO4, and the solvent was removed in 
vacuo. The residue was purified by column chromatography using cyclohexane-ethyl acetate 
(4:1) to give rac-3.7 (34.4 mg, 98.5 umol, 49%) as yellow oil. 
 
V3.32 
(ZY-739) 
Based on AVV11, in a Schlenk flask, CuCl (2 mg, 0.02 mmol), NaOt-Bu (6 mg, 0.06 mmol), 
and IBiox12·HOTf (12 mg, 0.02 mmol) were suspended in dry toluene (1 mL). The mixture 
was heated to 100°C for 4 min and cooled to room temperature for 1 h. PMHS (48 µL, 0.8 
mmol) was added and the mixture was stirred for 5 min at room temperature. After addition 
of rac-3.8 (85 mg, 0.2 mmol) in 0.5 mL of dry toluene, the mixture was stirred at room 
temperature for 24 h. It was poured into a stirred mixture of saturated aqueous Na2CO3 (20 
mL) and diethyl ether (20 mL). After stirring for 1 h at room temperature, the layers were 
separated and the aqueous layer was extracted with diethyl ether. The combined organic 
extracts were dried with MgSO4, and the solvent was removed in vacuo. The residue was 
purified by column chromatography using cyclohexane-ethyl acetate (4:1) to give rac-3.7 (21 
mg, 60.1 umol, 30%) as yellow oil. 
 
V3.33 
(ZY-739) 
Based on AVV11, in a Schlenk flask, CuCl (2 mg, 0.02 mmol), NaOt-Bu (6 mg, 0.06 mmol), 
and IBiox12·HOTf (12 mg, 0.02 mmol) were suspended in dry toluene (1 mL). The mixture 
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was heated to 100°C for 4 min and cooled to room temperature for 1 h. PMHS (48 µL, 0.8 
mmol) was added and the mixture was stirred for 5 min at room temperature. After addition 
of rac-3.8 (85 mg, 0.2 mmol) in 0.5 mL of dry toluene, the mixture was stirred at room 
temperature for 41 h. It was poured into a stirred mixture of saturated aqueous Na2CO3 (20 
mL) and diethyl ether (20 mL). After stirring for 1 h at room temperature, the layers were 
separated and the aqueous layer was extracted with diethyl ether. The combined organic 
extracts were dried with MgSO4, and the solvent was removed in vacuo. The residue was 
purified by column chromatography using cyclohexane-ethyl acetate (4:1) to give rac-3.7 (27 
mg, 77.3 umol, 38%) as yellow oil. 
 
V3.34 
(ZY-742) 
Based on AVV11, in a Schlenk flask, CuCl (2 mg, 0.02 mmol), NaOt-Bu (6 mg, 0.06 mmol), 
and IBiox12·HOTf (12 mg, 0.02 mmol) were suspended in dry toluene (1 mL). The mixture 
was heated to 100°C for 4 min and cooled to room temperature for 1 h. PMHS (48 µL, 0.8 
mmol) was added and the mixture was stirred for 5 min at room temperature. After addition 
of rac-3.8 (85 mg, 0.2 mmol) in 0.5 mL of dry toluene, the mixture was stirred at room 
temperature for 96 h. It was poured into a stirred mixture of saturated aqueous Na2CO3 (20 
mL) and diethyl ether (20 mL). After stirring for 1 h at room temperature, the layers were 
separated and the aqueous layer was extracted with diethyl ether. The combined organic 
extracts were dried with MgSO4, and the solvent was removed in vacuo. The residue was 
purified by column chromatography using cyclohexane-ethyl acetate (4:1) to give rac-3.7 
(37.4 mg, 107.1 umol, 53%) as yellow oil. 
 
V3.35 
(ZY-741) 
Based on AVV11, in a Schlenk flask, CuCl (2 mg, 0.02 mmol), NaOt-Bu (6 mg, 0.06 mmol), 
and IBiox12·HOTf (12 mg, 0.02 mmol) were suspended in dry toluene (1 mL). The mixture 
was heated to 100°C for 4 min and cooled to room temperature for 1 h. PMHS (48 µL, 0.8 
mmol) was added and the mixture was stirred for 5 min at room temperature. After addition 
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of rac-3.8 (85 mg, 0.2 mmol) in 0.5 mL of dry toluene, the mixture was stirred at 15 
o
C for 
72 h. It was poured into a stirred mixture of saturated aqueous Na2CO3 (20 mL) and diethyl 
ether (20 mL). After stirring for 1 h at room temperature, the layers were separated and the 
aqueous layer was extracted with diethyl ether. The combined organic extracts were dried 
with MgSO4, and the solvent was removed in vacuo. The residue was purified by column 
chromatography using cyclohexane-ethyl acetate (4:1) to give rac-3.7 (31.5 mg, 90.2 umol, 
45%) as yellow oil. 
 
(2R,5S)-Methyl2-((benzyloxy)methyl)-5-((methoxycarbonyl)oxy)-6-methyl-5,6-
dihydropyridine-1(2H)-carboxylate (rac-3.6) 
V3.36 
(ZY-497) 
To a solution of β-Aminoallene rac-3.7 (48 mg, 137 umol) in 1.5 mL DCM Ph3PAu-NTf2·1/2 
toluene (5.4 mg, 6.9 umol) was added. After being stirred for 21 h, the reaction mixture was 
filtrated through Celite and the filtrate was concentrated under vacuum. The crude product 
was purified by flash column chromatography on silica gel to give no product. 
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Based on the work described in this thesis, the copper-mediated nucleophilic substitution and 
the gold-catalyzed cycloisomerization were applied to study the synthesis of natural products 
containing 6-membered heterocycles, 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin 4.4 and 
(+)-3-O-Feruloylcassine 4.8 (Scheme 4.1). 
 
In chapter 2, the first total synthesis of 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin was 
demonstrated. Based on Gockel’s work,[39] homoallylic alcohol rac-4.10 was synthesized 
from alcohol 4.9. After protecting the hydroxyl group of rac-4.10, the diol rac-4.11 was 
obtained through Sharpless dihydroxylation with a 1:1 mixture of AD-mix-α and AD-mix-β. 
Then, the propargyl acetate rac-4.12 was provided in three steps with a total yield of 54%. 
The first key step, the copper-mediated SN2'-substitution of propargyl acetate rac-4.12, was 
performed in two ways to provide the allene rac-4.13 with good yield of 84% (Scheme 4.2). 
In this route, different protecting groups, as well as different reaction conditions for the 
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asymmetric Sharpless dihydroxylation were tested for obtaining the (S)- and (R)-configured 
diols with higher selectivity, which will determine the ee of allene 4.13. However, the 
enantiomeric excess was still not satisfactory (17%-67%). 
 
With the gold-catalyzed cycloisomerization of β-hydroxyallene rac-4.14, the significant 
intermediate dihydropyran rac-4.15 was obtained with  good yield. After epoxidation, various 
acids and bases were tested to open the epoxide rac-4.16. Finally, a regio- and stereoselective 
opening of the epoxide with allyl alcohol and HClO4 was successful to give rac-4.17 with 
good yield. Fortunately, through a sequence of esterification/oxidation/olefination, the 
desired racemic agerafastin rac-4.18 was obtained (Scheme 4.3). 
 
Based on the racemic synthesis route, the homoallylic alcohol 4.10 was not a good substrate 
for the Sharpless dihydroxylation. Then, alcohol 4.19 was chosen as starting material and the 
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enantiomerically pure diol (S)-4.20 was obtained in 8-gram scale. After five steps, the desired 
propargyl acetate (S)-4.21 was synthesized. The copper-mediated SN2'-substitution of 
propargyl acetate (S)-4.21 was carried out to give the allene (S)-4.22 in good yield of 81% in 
gram scale. After that, the gold-catalyzed cycloisomerization of β-hydroxyallene (S)-4.14 
was performed to provide the key intermediate (S)-4.15 with a yield of 84% and >99% ee, 
which means the axis-to-center chirality transfer was perfect in this efficient gold-catalyzed 
cycloisomerization (Scheme 4.4). 
 
Next, the diastereoselective epoxidation directed by the free hydroxyl group was conducted 
to give the tetrahydropyran (2S,4S,5S)-4.16 in good yield and good selectivity. After 
protecting the hydroxyl group of (2S,4S,5S)-4.16, the regio- and stereoselective opening of 
the epoxide was carried out with allyl alcohol and HClO4 to provide the optically pure 
tetrahydropyran (2S,4R,5S)-4.17. Then, the deprotection of the allyl group of (2S,4R,5S)-
4.17 proceeded to give the diol, which was transformed to the ester (2S,4R,5S)-4.23 by 
means of Steglich esterification with good Z/E ratio (4.7:1.0). After the deprotection of the 
benzyl group of (2S,4R,5S)-4.23, the pure Z-isomer was separated by column 
chromatography successfully. The optically pure aldehyde (2S,4R,5S)-4.24 was obtained by 
oxidation with Dess-Martin periodinane. The last step, the modified Julia olefination, was 
performed to provide the final product 9α,10β-Bisangeloyloxy-7-epi-3E-agerafastin 4.4 with 
a moderate yield of 55% and good Z/E ratio (83:17) (Scheme 4.5). 
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In chapter 3, the objective is the total synthesis of natural product (+)-3-O-Feruloylcassine. 
Based on Sun’s work,[77] the synthetic route shown in Scheme 4.6 was chosen to study this 
project. The propargyl dicarbonate (S)-4.5 was obtained successfully.  
 
Next, rac-4.5 was used for the further study. The desired β-aminoallene rac-4.6 was obtained 
by CuH-catalyzed SN2'-reduction. After optimization of this reaction, the best yield was 53% 
(Scheme 4.7). 
Chapter 4. Summary and Perspective 
174 
 
 
With the β-aminoallene rac-4.6 in hand, the plan was to optimize the gold-catalyzed 
cycloisomerization to obtain a higher yield of the desired tetrahydropyridine. According to 
Sun’s work, it is possible to obtain rac-4.7 with 28% yield after 18 h reaction time (Scheme 
4.8).
[77]
 Further optimization of this step is required for an efficient synthesis of (+)-3-O-
Feruloylcassine. 
 
Therefore, a more active gold catalysts for synthesizing the tetrahydropyridine should be 
tested. Recently, new cationic gold catalyst system was developed by Malhotra and Xu.
[86]
 
The new gold complex L1-AuCl (Figure 4.1) can catalyze common types of gold-catalyzed 
reactions including intra- and intermolecular X-H (X = C, N, O) additions to alkynes and 
cycloisomerizations efficiently. Then, different ligands, silver salts and reaction conditions 
can be chosen to optimize the gold-catalyzed cycloisomerization.

 
 
                                                          
[86] D. Malhotra, M. S. Mashuta, G. B. Hammond, B. Xu, Angew. Chem. Int. Ed. 2014, 53, 4456-4459. 
[87] H. Muratake, I. Abe, M. Natsume, Chem. Pharm. Bull. 1996, 44, 67-79. 
[88] (a) J. Tsuji, Synthesis 1984, 369-384; (b) D. A. Evans, P. Nagorny, K. J. McRae, L.-S. Sonntag, D. J. Reynolds, F. 
Vounatsos, Angew. Chem. Int. Ed. 2007, 46, 545-548. 
 Chapter 4. Summary and Perspective 
175 
 
After optimizing the gold-catalyzed cycloisomerization, the total synthesis of (+)-3-O-
Feruloylcassine should be continued as shown in Scheme 4.9.
[87-88]
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I. Abbreviations 
Ac Acyl 
AD Asymmetric dihydroxylation 
dihydroxylation 
aq Aqueous 
Ar Aryl 
Bn Benzyl 
Bu Butyl 
Calcd Calculated 
CAN Ceric ammonium nitrate 
CAL-B Lipase B from Candida antarctica 
CBS Corey-Bakshi-Shibata 
CDCl3 Deuterated chloroform 
CHCl3 Chloroform 
COSY (
1
H-
1
H) correlated spectroscopy 
d Day 
DCC Dicyclohexylcarbodiimde 
DCM Dichloromethane 
DDQ 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone 
DEAD Diethylazodicarboxylate 
DKR Dynamic kinetic resolution 
DMAP 4-N,N-dimethylaminopyridine 
DMF Dimethyl formamide 
DMSO Dimethyl sulfoxide 
DMP Dess-Martin periodinane 
DIAD Diisopropylazodicarboxylate 
dr Diastereomeric ratio 
ee Enantiomeric excess 
Eq. Equivalent 
ESI Electron spray inonisation 
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Et2O Diethylether 
Et Ethyl 
Et3N triethylamine 
GC Gas chromatography 
h Hour 
HMBC Heteronuclear multiple bond correlation 
HOTf Trifluoromethanesulfonic 
HPLC High performance liquid chromatography 
HRMS High resolution mass spectroscopy 
HWE Horner-Wadsworth-Emmons 
Hz Hertz 
i-Pr isopropyl 
IR Infrared spectroscopy 
J Coupling constant 
KR Kinetic resolution 
L Ligand 
LiAlH4 Lithium aluminum hydride 
M Metal 
m-CPBA 3-Chloroperoxybenzoic acid 
Me Methyl 
MeCN Acetonitrile 
MeOH Methanol 
min Minute 
n-Bu n-Butyl 
n-BuLi n-Butyllithium 
NHC N-Heterocyclic carbene 
NMR Nuclear manetic resonance 
NOE Nucler Overhauser effect 
NOESY Nuclear Overhauser enhancement spectroscopy 
PG Protecting group 
 I. Abbreviations 
179 
 
Ph Phenyl 
PMHS Polymethylhydridosiloxane 
p-TsOH p-Toluenesulfonic acid 
RT Room temperature 
SN Nucleophilic substitution 
Sat. Saturated 
t tert 
t Time 
T Temperature 
TBAF Tetra-n-butyl ammonium fluoride 
TBAI Tetra-n-butylammonium 
TBDPS tert-butyldiphenylsilyl 
TBS tert-butyldimethylsilyl 
t-Bu tert-butyl 
Tf Trifluoromethanesulfonyl 
THF Tetrahydrofuran 
THP Tetrahydropyranyl 
TLC Thin Layer Chromatography 
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